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A high-throughput hydrogen peroxide-based colorimetric screen used to detect 
oxidase activity was extended to detect racemase activity through the production of 
the specific substrate for an enantioselective oxidase enzyme. A two-plasmid system 
(encoding the racemase and oxidase) was shown to be successful and could have 
possible applications for many different classes of enzymes that produce an oxidase 
substrate. 
Figure 1: The screen for racernase activity using an oxidase/peroxidase cascade 
In order to validate the screening technology, three amino acid racemase genes were 
cloned from genomic DNA and placed into expression vectors. The screen was used 
to confirm the substrate specificities of each racemase. The amino acid racemase 
genes were then subjected to random mutagenesis using the mutator strain method 
and error-prone polymerase chain reaction. Libraries of the variant racemase 
enzymes were screened for novel activities towards substrates not accepted by the 
wild type enzymes: L-arginine; L-lysine and L-leucine. 
Novel activity was discovered in selected Streptomyces coelicolor alanine racemase 
variants. Sequencing revealed that the best variant had three point mutations, 1195T, 
N223D and 1374N. Computer modelling suggested that the 1374N mutation was a 
key mutation and so the variant containing the double mutation (I 195T and N223D) 
was prepared. Partial purification of the wild type enzyme and the variants 
containing the double and the triple mutations was carried out to compare the 
Abstract 
substrate specificities. The 1195T/N223D variant was shown to be ten times more 
active towards L-arginine that the wild type enzyme, and the variant containing all 
three mutations was shown to be 100 times more active towards L-arginine than the 
wild type enzyme. Both variants displayed novel activity towards L-arginine only. 
This work has demonstrated and validated the novel screen for racemase activity and 
was successfully used to select variants with altered substrate specificity. The system 
should then be applicable to a range of screening applications and be a useful tool in 
the development of new biocatalysts. 
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Biocatalysis is a rapidly expanding area of science that combines chemistry, biology, 
chemical and biological engineering. It is an enabling technology that offers unique 
options and solutions to problems faced in organic synthesis.' The broadness of 
application is supported and driven by the large number of enzymes rapidly becoming 
available and the range of reactions that they can carry out selectively and under ambient 
conditions. For example, a review in 2003 noted that 75 % of chemical racemisation 
techniques depend on harsh reaction conditions such as thermal racemisation, catalysis 
using strong acids or bases, or proceed via configurationally labile intermediates.2 In 
contrast, racemase enzymes have optimum working temperatures of 20-45°C, can work 
at atmospheric pressure and prefer a slightly basic pH (7.5-9.0). Developments in 
molecular biology, such as recombinant technologies, have provided access to many of 
the biocatalysts and a number are employed industrially for the manufacture of products 
such as lactose-free milk (>100 000 metric tons per year), acrylamide (>10 000 tons per 
year) and cocoa butter (>10 000 tons per year).4 
Biocatalysts are frequently employed to differentiate between enantiomeric substrates. 
The industrial route by Lonza to both enantiomers of N-Cbz-proline is achieved from the 
racemate using acylases with different activities from Arthroba cter sp. and 
Achromobacter xylosooxidans, 5 Figure 1.1. 
rthrohacter sp. 	 xjlosooxidans 	
(O - o 	 A 	flo 
AchromohacterO
N Acylase 	 Acylase 
OH H OH 	 OH 	 H OH 	 OH 
BnO O 	 BnO 0 	 BnO _1__O 
N-Cbz-D-1 	 1-2 	 rae-I 	 D-2 	 N-Cbz-J-I 
Figure 1.1: The separation of enantiomers of N-Cbz-proline using different acy/ases 
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As well as discriminating between different enantiomers, enzymes are able to synthesise 
enantiomerically pure products from prochiral starting materials. The reduction of 
carbonyl compounds to alcohols is achieved by chemists using metal reducing agents 
such as sodium borohydride. However, the metal reduction produces racemates unless 
chiral agents are included in the reaction mixture and problems can occur when other 
functionality is present in the starting material. Dehydrogenases can reduce ketones to 
produce chiral products with good e.e.s. The reduction of 3 (Figure 1.2) is carried out 
using Zygosaccharomyces rouxii to produce the alcohol (S)-(+)-4 in 95 % yield and 
99.9 % e.e. 6  (S)(+)4 is used as an intermediate in the synthesis of (-)-talampanel, a 
compound with anti-epileptic properties. 
CH 3 CH3 
Zygosacchwoinyces rouxii
0 	




Figure 1.2: The reduction of ketone 3 using a dehydrogenase 
Although many enzymes and microbial sources have been discovered for carrying out a 
wide range of synthetic reactions,7 there is not yet a biocatalyst available for every 
possible chemical reaction. Where possible biocatalysts have been identified, for 
example, by screening microbial libraries or analysing commercially available enzymes, 
they are often not suitable in the desired application as they may have limited substrate 
specificities, slow reaction times and/or poor stability in an industrial environment. 
Directed evolution is a tool that can be used to improve many properties of these 
biocatalysts and optimise them for the desired application. 
2 
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1.2 Principles of Directed Evolution 
Directed evolution is a technique that is carried out at the molecular level to alter the 
gene sequences of enzymes and ultimately the phenotypes. It has been used to broaden 
the substrate specificities of enzymes, 8 9 to introduce enantioselectivity,'° to improve 
stability under various conditions' s  and to completely change the reaction that the 
enzyme performs. 12  The principle of directed evolution relies upon the generation of 
many mutant genes and the subsequent screening or selection of the resulting enzyme 
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Figure 1.3: Principles of Directed Evolution 
The parent gene is subjected to a random mutation process, such as error prone PCR. 
The resulting plasmid library is then used to transform an expression host, such as 
Escherichia coil and the resultant cells are grown and screened for activity using 'life or 
death' selection methods or a solid or solution phase assay. 13 
Iterative cycles of the mutagenesis/screening process can be used to produce an 
optimised enzyme. There are currently two main approaches to altering enzyme function: 
rational enzyme design and random mutagenesis. Despite some successes, 
12,14 rational 
enzyme design is limited by the complicated nature of enzymes, as well as by a general 
Introduction 
lack of knowledge of enzyme/substrate recognition and catalysis. Quite often 
unpredictable changes have led to an improvement in enzyme function.' 5 A limitation of 
rational design is that it is necessary to have a structural model to analyse. More 
frequently, random mutagenesis methods are employed to identify residues of 
importance for catalysis or enzyme stability, which are then subjected to site-directed 
mutagenesis. 
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1.3 Random mutagenesis 
The first key step in directed evolution is to create a library of mutated genes. Many 
techniques have been used over the last 15 years to carry out mutagenesis 
16  and new 
methods are constantly being developed. '7 '9 There are numerous methods that can be 
presented for creation of mutated gene libraries and the most common and more 
established methods are briefly presented here. Random mutagenesis can occur at points 
along the gene resulting in single bases mutations, or over a much wider sequence space 
using gene recombination that results in longer strings of sequence being replaced with a 
homologous gene sequence. The two most commonly used techniques for point 
mutations are error-prone PCR and mutator strains. 
1.3.1 Error-prone PCR 
The most commonly used technique for random point mutagenesis is error-prone PCR 
(epPCR). During a PCR, different DNA polymerases incorporate mismatched 
nucleotides into the gene during synthesis at different rates. The DNA polymerase Taq 
makes approximately 8 errors per 106  base pairs, whereas Pfu hotstart polymerase has a 
lower error rate of 1 per 106  base pairs 
.20 These natural error rates are too low to 
introduce enough mutations to produce a library of genes but they can be increased 
using various conditions. 21,22 
One method to increase error rates during PCR is to introduce different concentrations of 
Mn 2+  (to replace the Mg2  natural cofactor of the polymerase) to aid mispairing; another 
method is to include biased ratios of the dNTPs to encourage mis-incorporation of bases. 
However, specific types of mutation are more common that others which leads to a bias 
in the library. For example, when analysing DNA bases, a pyrimidine (C or T) is more 
likely to be substituted by another pyrimidine, whereas a purine (A or G) will be more 
commonly substituted by a purine. A second bias to consider is that when a mutation is 
introduced in the early stages of amplification, all subsequent daughter strands will 
5 
Introduction 
contain that mutation, leading to an over-representation in the final library. Finally, 
when translating the DNA, there is the codon bias that arises due to the nature of the 
genetic code. For example, three bases constitute a codon and if only one of those bases 
is changed at a time, there are only a limited number of amino acids that the variant 
codon can represent. One Ala codon is GCT, if the last base (T) is substituted for any 
other, the codon still represents Ala, if the second base (C) is varied the possible 
resulting amino acids are Ser, Pro and Thr, if the first base (G) is changed then the 
resulting amino acids are Val, Asp, Glu and Gly. Therefore, only seven other residues 
are obtainable starting with the GCT codon and substituting one base. 
Companies such as BD Biosciences and Stratagene offer commercially available epPCR 
kits that are designed to overcome some of the biases and enable simple control of the 
error rate. The Stratagene kit uses a modified polymerase and the DiversifyTM kit from 
BD Biosciences uses a combination of manganese addition, dNTP ratios and 
amplification cycles to produce variant genes with as little bias as possible. 
The final size of the epPCR library is limited by the subsequent sub-cloning steps, such 
as the purification of the PCR fragments, restriction digestion, ligation and 
transformation. A procedure has been developed using the Quikchange site-directed 
mutagenesis protocol from Stratagene 23  in order to eliminate the ligation step. In this 
procedure, the epPCR fragment products are employed as primers in a whole plasmid 
PCR of the wild type template DNA. Therefore, the mutations that occur in the epPCR 
are incorporated into the plasmid DNA. The wild type template DNA can be eliminated 
after amplification by digestion with DpnI, the restriction enzyme that recognises and 
digests methylated DNA only. DNA is methylated when replicated in E. coil cells, DNA 
synthesised during a PCR is not. 
EpPCR was used as the mutagenesis technique for improving the enantioselectivity of 
an epoxide hydrolase from Aspergiiius niger towards glycidyl phenyl ether. 
14  The 
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enantiomeric ratio (E value) was improved from 4.6 to 10.8 in favour of the (5)-product 
in just one round of epPCR, Figure 1.4. 
Aspergillus niger 	HO 	OH 	HQ 	OH 




rac-5 	 (S)-6 	 (R)-6 
Figure 1.4: The epoxide hydrolase catalysed opening of rae-S 
1.3.2 Mutator Strains 
XL1-Red is a mutator strain of E. coli designed by Stratagene that lacks efficient 
enzymes for DNA repair. 25  When the new DNA is synthesised prior to cell replication 
and division, the DNA sequence is checked for errors by the DNA polymerase. 
Mutations mutT and mutS are present in the DNA polymerase in the XL 1-Red strain that 
lower the efficiency of the DNA repair. There is also a mutation in a subunit of DNA 
polymerase III (mutD) that increases the mutation rate during replication. Therefore, 
when the cells are growing and dividing, any mistakes made are not corrected and the 
error is carried forward into the daughter cells. The candidate DNA for directed 
evolution is used to transform the XL 1-Red cells and the cells allowed to grow for set 
time periods, the longer the growth, the more mutations are introduced. Analysis for 
novel activities is then carried out. However, the mutations also occur throughout the 
plasmid DNA, not just in the gene of interest. Therefore, mutations may occur in the 
antibiotic resistant gene, or in the promoter region, that may affect the ability of the 
plasmid DNA to be sustained in the host and produce the enzymes of interest. 
The mutator strain method of evolution is one of the simplest random mutation strategies 
and has been employed in a number of successful directed evolution experiments. One 
example of a successful directed evolution is the improvement in enantio selectivity of a 
monoamine oxidase from Aspergilius niger towards (S)-ct-methylbenzylamine (MBA) 
with multiple cycles of mutagenesis using the XL 1-Red mutator strain of E. coil, 
(Stratagene) and a colorimetric screen. 10, 26, 27 The Vmax value was increased 100-times 
7 
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from 1 .29x 1 02  tmol/minImg in the wild type, to 1.61 mol/min/mg for the new variant. 
The corresponding values for the (R)-enantiomer were I .42x 1 0-3  pmol/min/mg for the 
wild type enzyme and 2.55x10 2 imol/minImg for the new mutant. The greatest Vmax 
increase was seen with the same variant versus the wild type enzyme when using 1-
methyl- 1,2,3,4-tetrahydroisoquinoline (MTQ) as substrate. The values for the wild type 
on (R) and (S)-MTQ were 6.18x10 4 and 1.48x10 3 jimol/minlmg respectively, in the 
new mutant these values are 2.27x 1 02  and 1.99 respectively. 
1.3.3 Oligonuceotide based methods, random mutations at specific points 
Both epPCR and the mutator strain introduce random mutations at random points in the 
gene. Using oligonucleotide methods the area(s) of randomisation can be specified in a 
process known as saturation mutagenesis. For example, if a number of residues were 
hypothesised as important for defining the active site and so the substrate specificity, it 
is possible to design degenerate primers that substitute the codons in the area of interest 
to result in every other possible residue. Libraries of those variants can then undergo 
activity screening to determine the effects of those substitutions. 
Site specific randomisation has recently been employed in the method of Combinatorial 
Active site Saturation Testing, abbreviated to CASTing. 9, 28, 29 Areas of potential 
importance for controlling substrate specificity were identified using computer 
modelling and subjected to randomisation in a step-wise fashion. The gene of the most 
active variant, discovered after one site was randomised, was used as template for the 
proceeding mutagenesis experiment. To compare CASTing to other methods of 
mutagenesis, the same gene for the epoxide hydrolase shown in Figure 1.4 and improved 
using epPCR, was subjected to CASTing.29 By screening a total number of 20,000 
clones from random step-wise mutagenesis of five areas, the E value of the reaction was 
improved from 4.6 to 115 in favour of the (5)-product. CASTing was also used to evolve 
a Baeyer-Villiger cyclopentanone monooxygenase (CPMO) to improve the resulting e.e. 
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in the oxidation of 4-methoxycyclohexanone.28 The e.e. was improved from 46 % to 
92 % in favour of the (R)-enantiomer. 
1.3.4 Gene Shuffling, a recombination approach 
Gene shuffling is a method frequently used to achieve gene recombination and therefore 
increased diversity and was first introduced in 1994 .30  The technique generates gene 
variants from a set of homologous genes by digestion and recombination. 22  Sets of 
homologous genes are digested with DNase I to create DNA fragments, which are then 
reassembled in a PCR reaction without using separate primers. The fragments of the 
genes are denatured at a high temperature, followed by a temperature reduction that 
allows DNA fragments with complementary areas (but not necessarily from the same 
parent gene) to anneal. A polymerase extension then reconstructs areas of the genes 
where there is no fragment overlap. As the original genes used are homologous, 
recombination can occur between two different genes, creating hybrids that can be 
analysed for novel activities. 30 
Gene shuffling was used to evolve an alanine racemase with a higher expression level 
from two biosynthetic alanine racemases, one from E. coil and the other from 
Salmonella Iyphimurium.3' After one round of shuffling, a novel alanine racemase was 
produced that had three times the specific activity, and was expressed twice as much in 
E. coil as the parental enzymes. The alanine racemase activities of the E. coil and S. 
typhimurium parental racemases were 9.9 and 2.3 units mg', whereas the best chimera 
had a specific activity of 25.6 units mg 1 . 
1.3.5 Other methods of recombination 
Techniques, such as staggered extention PCR (stEP), random chimeragenesis on 
transient templates (RACHITT) and iterative truncation for the creation of hybrid 
enzymes (ITCHY), have been developed to produce libraries of chimeric enzymes. 
22 
Both RACHITT and ITCHY rely on the fragmentation of the parent genes and 
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reassembly. However in stEP, homologous genes are combined and used whole in a 
PCR reaction that has very short extension times. The principle behind the technique is 
that only a very short gene sequence of template 1 is amplified before a rise in 
temperature causes the primer and the template to separate. During the next annealing 
process, the new elongated primer can bind to template 2 and amplify a further short 
gene sequence. 
RACHITT involves the creation of the complementary strand of one of the genes of 
interest. The other genes are then fragmented and the two DNA strands separated. The 
fragments are then annealed to the first whole gene and any gaps are removed using a 
polymerase. The template strand is then removed and the novel chimeric gene amplified 
to produce a whole gene. 
With all stEP and RACHITT, it is necessary to have sets of homologous genes whereas 
ITCHY allows recombination of genes with little similarity. The genes of interest are 
digested with the same restriction enzymes and then the fragments are ligated together to 
form novel variants that can be screened for traits of interest. 
There are many different techniques used to create libraries of genes, both at random 
sites and at specific sites (many more than covered here) and the method chosen depends 
on the researchers aims and the information available concerning the gene of interest. 
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1.4 Screening for novel activities- Current methods 
The first key step in directed evolution is mutagenesis and in the second step it is 
essential to analyse the variant libraries for new activities. Just as many methods have 
been developed for the library creation, there are many methods that have been 
developed for screening/selection to detect improved or novel enzymatic activities. 32 
Screens for novel enzyme activity also have application for analysing microbial isolates 
and libraries for various enzymatic conversions. Bacterial and fungal species are 
constantly being isolated from the environment and being able to characterise them in 
terms of their reactivities aids the area of biotechnology greatly. 
The analysis of large libraries of variant enzymes has long been seen as the bottleneck in 
directed evolution. 33  Although there are always new techniques and ideas of ways to 
produce vast gene libraries (Section 1.3), the development of screens to analyse those 
libraries in a high-throughput format has not been so rapid, even though the outcome of 
directed evolution experiments is critically dependent on how that library is screened. 
Over the last few years numerous groups have published new ideas and introduced novel 
concepts for library screening, 34  both on agar plates and in micro titre-plate format and a 
number of those techniques are presented and discussed here. 
1.4.1 Screening versus Selection 
There are two concepts for detecting novel enzyme activities: Selection and Screening. 
Selection links the characteristic of interest directly to the ability of the expression host 
to survive. For example, the alanine racemase chimeras created in the DNA shuffling 
mutagenesis experiment presented in Section 1.3.4 were analysed using a selection 
screen. As well as evolving racemases with higher expression levels, Ju et al were trying 
to evolve a serine racemase. 31 The group made an E. co/i serine auxotroph strain that 
was unable to grow on minimal media unless a source of L-serine was present and then 
they introduced D-serine into the minimal media. If the variant racemase expressed in 
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the E. coil was able to racemise D-serine, the cell would have a source of L-serine and be 
able to grow. The phenotypic selection method of library analysis greatly reduces the 
final number of variant enzymes that need to be analysed in detail as only those colonies 
that grow can carry out the reaction of interest. However, the use of the selection 
procedure is limited to screening only for reactions that are of direct biological relevance 
or that can be indirectly linked to a selectable phenotype. Another disadvantage is that 
microbes are highly adaptable and can deal rapidly with significant changes in 
environmental conditions and therefore the incidence of false positives is increased. 
The more common method of analysing variant enzyme libraries is to screen for the 
reaction of interest where the product(s) or by-product(s) are easily identified, either 
visually or by instrumental analysis. 
1.4.2 Agar plate-based assays 
The simplest and most high-throughput method to screen for novel activities is to 
monitor the cells when they are growing on an agar plate. A single 8 cm diameter plate 
can hold up to 3,000 separate individual colonies and the ability to screen for activity at 
this level enables the rapid analysis of vast enzyme libraries. Currently, there are three 
approaches to screening on agar plates: 35  (i) by detecting a shift in PH; (ii) by the 
detection of a halo formed around a growing colony, indicating cleavage of an insoluble 
substrate; or (iii) by detecting the formation of a coloured or fluorescent product. 
1.4.2.1 Agar plate-based assays: pH 
Screens using pH are used when the reaction of interest generates an acidic or basic 
product that causes a shift in the pH in the area around the host colony. An indicator dye 
highlights where the reaction is taking place by changing colour. In 2002, Littlechild et 
al developed a screening method for Baeyer-Villiger Monooxygenases (BVMOs) using 
a pH indicator solution and an esterase. 36  Once grown, colonies expressing the BVMOs 
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were lifted using a filter paper method and placed onto fresh agar containing the 
substrate for the cyclohexanone monooxygenase 7, Figure 1.5. 
0 	 0 	 0 
a Baeyer-Villiger Monooxygenase 	 Pig Liver Esterase 	 OH Incubate for 48 h 	 Incubate for 48 ii 
7 	 8 	 9 
Figure 1.5: The detection of B VMO activity using Pig Liver Esterase 
After incubation for 48 h to allow sufficient build up of 8, the filter papers were sprayed 
with pig liver esterase. After a second 48 h incubation, the colonies were sprayed with a 
full range pH indicator solution to detect formation of acid 9. Colour differences 
indicated the presence of a BVMO that was able to oxidise 7. A range of substrates were 
tested to determine the applicability of the screen as the pig liver esterase substrate 
specificity determines the substrates that can be used. 
Bornscheuer first detected the novel activity of a variant pig liver esterase from 
Pseudomonas fluorescens (generated using the mutator strain method, Section 1.3.2) on 
agar plates using pH, in 1998.37The  activity of the esterase was evolved towards 10, an 
intermediate in the synthesis of Epithilon A (Figure 1.6) and activity was identified by 
detection of an increase in medium acidity. 
Pseudornonas fluorescens 
Esterase 	 -O 
0 OH 0 OH 
10 11 
Figure 1.6: First use of pH change detection to monitor esterase activity 
More recently, Schwab et al combined the shift in pH with a fluorescent indicator. 38 
Colonies expressing an esterase from Pseudomonas fluorescens were grown on a nylon 
membrane. The membrane was then transferred onto a gel containing esterase substrate, 
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fluorescein and buffer. The acid generated in the ester hydrolysis was used to quench the 
fluorescence of fluorescein. A camera was used to monitor fluorescence and a decrease 
was shown to correspond to esterase activity in the colonies. 
The use of pH based assay methods on agar plates is limited to detection of enzymes that 
produce, or can be coupled to a second enzyme to produce, acidic or basic products. 
1.4.2.2 Agar plate-based assays: Halo 
Halo assays are used to detect hydrolytic enzyme activity by cleavage of an insoluble 
substrate distributed around the growth medium of the colony. Cleavage of the substrate 
results in solubility and a visible zone clearing in the turbid medium. Halo assay 
methods are commonly used for lipases and proteases.3 ' Initial work with zone clearing 
detection methods were carried out using suspensions of casein or skim milk proteins to 
detect protease activity. 39 Reetz discusses the use of tributyrin, an insoluble compound, 
in a screen for lipase activity. 40 This group identified active lipases by visual analysis of 
colonies growing on solid media containing tributyrin that were surrounded by a clear 
zone. 
In 2004, a group in Korea reported the development and use of a zone clearing, plate-
based screen to detect polysaccharide-degrading activity. 4 ' Different insoluble coloured 
forms of amylose, xylan and hydroxyethyl-cellulose (HE-cellulose) were prepared and 
distributed through the solid growth media of various microorganisms, isolated from soil 
and sludge. Insoluble amylose-blue, amylose-red, xylan-blue, HE-cellulose-blue and 
HE-cellulose orange were prepared using the dyes Cibacron Blue 3GA, Cibacron 
Brilliant Red 313-A and reactive Orange 14. Microorganisms displaying amylase, 
xylanase and/or HE-cellulase activities were identified by appearance of red, blue and/or 
orange haloes around the growing colony. 
14 
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Zone clearing provides an indication of the expression and activities of the enzymes of 
interest as the size and clarity of the halo is a measure of activity. The colorimetric halo 
assay described above was also shown to detect different activities on one plate by using 
combinations of the coloured substrates. In summary, zone clearing can be a very quick 
test for detecting hydrolytic enzyme activities and can give an indication of both the 
expression level and activity. 
1.4.2.3 Agar plate-based assays: Colorimetric and Fluorescent 
The two agar plated based methods for screening enzyme activities presented so far 
provide rapid detection of hydrolytic enzymes and those that produce acidic or basic 
products (or can be coupled to enzymes that can). In the halo assay it is crucial that the 
enzyme converts an insoluble compound into a soluble product. The criteria limit the 
applicability of the halo and the pH based screening methods to more diverse enzymes. 
However, there are many other reactions that enzymes carry out that are desirable to 
detect. 
The most common plate-based assays rely on colorimetric or fluorescent detection. In a 
recent overview of plate-based assay methods by Turner, eight out of the nine examples 
presented identified enzyme activity using colorimetric or fluorescent methods.33 The 
method relies on the incorporation of a chromophore into the enzyme substrate, or a 
cascade reaction that results in colour formation. 
The most well-known plate-based colorimetric screen is the use of 5-bromo-4-chloro-3-
indoyl--D-gaIactose (X-gal) 12 for detecting galactosidase activity (Figure 1.7) and is 
an example of the substrate for the enzyme containing a chromophore. Upon cleavage of 
the sugar from the heterocycle, compound 13 is released and rapidly dimerises to form 
an insoluble blue compound 14. The cleavage of X-gal is used widely in molecular 
biology for Blue/White screening. The principle behind the screening is that the gene for 
the cc-protein of galactosidase is on a cloning plasmid and the 3-protein is encoded by 
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the E. coli host. When both proteins are successfully produced, they combine to create 
an active galactosidase that will cleave 12 to produce a blue colour in a growing colony. 
Disruption of the a-fragment gene on the cloning plasmid by successful insertion of 
another gene prevents production of the u—protein and so does not result in active 
galactosidase, therefore in the presence of X-gal the colony will remain white. Therefore 











Br 	 0 
Blue 
13 	 14 	CI 	Br 
Figure 1.7: cleavage of X-gal 12 to form blue compound 14 
Recently, a very similar colorimetric screen was used in the directed evolution of 1-
galactosidase towards 3-fucosidase activity using 5 -bromo-4-chloro-3 -indoyl-3-D-
fucopyranosidase (X-fuc) instead of X-gal.42 Due to release of the same heterocycle 13, 
formation of the blue compound could be used to detect 3-fucosidase activity. 
The use of a screening reaction utilising release of fluorescence was developed in the 
screening for new glycosynthases.8' 43 The sugar acceptor for the novel glycosynthase 
enzyme contained a fluorophore which was then incorporated into the glycosynthase 
product. The endo-cellulase was then used to cleave and release the fluorescent side 























OH n 	 HOOO 
18 	 19 
Figure 1.8: Detection of glycosyntiwse activity by release of 4-methylumbelljferone 19 
In the above techniques, the substrates containing the chromophores are analogs of the 
natural substrates or the substrate of interest and therefore the selected enzymes may not 
display the same final activities towards the substrate of interest. A different approach is 
to use a cascade reaction that produces colour or fluorescence where the enzyme acts on 
the actual substrate of interest. 
In a screen of microbes for the deracemisation of a-amino acids,44 Ohta et al used the 
conversion of nitroblue-tetrazonium chloride to formazan (blue) to detect the formation 
of L-Phe (from D-Phe) via reaction with an L-Phe dehydrogenase and regeneration of the 
NAD cofactor using phenazine metasulfate (PMS), Figure 1.9. 
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Figure 1.9: Detection of microbial chiral in version via a cascade reaction 
Fifty strains with unknown chiral inversion activities were analysed using the 
colorimetric plate-based assay and nine were found that could produce L-Phe from D-
Phe (the route was shown to proceed via the keto acid and not racemisation with a 
racemase). The best candidate microbe for D-Phe racemisation was identified as 
Nocardia diaphariozonaria. 
The cascade system of enzyme activity identification does not necessarily rely on 
secondary enzymatic reactions. A recent example (2007) used a copper containing 
solution to identify the HCN by-product of a hydroxynitrile lyase (I-[NL).45 Colonies 
expressing variant hydroxynitrile lyases were grown on a membrane on an agar plate. 
The membrane was then removed from the agar and soaked with substrate 21, Figure 
1.10. A second filter paper previously soaked with a chloroform solution of copper 
ethylacetoacetate and 4,4'-methylenebis[N,N-dimethylaniline] and dried, was placed on 
top of the colony covered membrane. The hydroxynitrile lyases that successfully 
converted 21 to 22 were identified by formation of HCN and the resulting blue colour 
(the oxidation product of the 4,4'-methylenebis[N,N-dimethylaniline] base in the 
presence of Cu 11). 
18 
Introduction 
OH 	 0 
Hydroxynitrile lyase 	 I 
CN 	 HCN 
(S)-rn-phenoxybenzaldehyde 
21 	 22 
Figure 1.10: Hydroxynitrile lyase conversion of 21 10 22 and HCN 
The advantage of the assay is that it is not substrate specific but relies on the formation 
of gaseous HCN. Therefore any hydroxynitrile lyase reaction could, in theory, be 
monitored using this assay. 
1.4.3 High-throughput screening in microtitre plates 
Agar plate-based assays are efficient for looking at the same reaction in many thousands 
of colonies and providing a Yes/No answer for activity. For quantitative assays, small 
volume samples can be analysed in 96, 384 or 1536 well microtitre plates and recently 
Verenium have developed GigaMatrix® ultra-highthroughput screening technology with 
up to one million wells in a plate with the same footprint as the 96-well plates. 46  Whole 
cells, cell lysates and pure enzymes can be assayed for small variations in activity. 
Microtitre plate-based assays rely on the detection of a coloured or fluorescent product 
formed either by an enzyme coupled screen, coloured product release during reaction, or 
coordination to a metal. Recent examples of screens developed in each of these areas are 
discussed below and demonstrate that high-throughput screening is still very much an 
area of developing research. 
1.4.3.1 Enzyme coupled assays 
The majority of enzymatic reactions do not produce any detectable changes in UV/Vis 
or fluorescence during substrate turnover. A common method of assay is to couple the 
enzyme of interest with a second enzyme that is NAD(P)tdependent. In agar plate-
based assays, the change in oxidation state of the NAD(P) cofactor can be revealed by 
coupling to nitroblue tetrazolium and phenazine methosulfate (PMS), Figure 1.9. 
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However, in microtitre plates, NAD(P)-dependent enzymes are easily detectable by a 
change in absorbance at 340 nm during cofactor oxidation/reduction. 
In 2001, Bornscheuer developed a method for screening for hydrolases by coupling the 
hydrolysis to an NADH-dependent L-malate dehydrogenase. 
47  The acetic acid produced 
during the reaction of interest was used stoichiometrically in the conversion of NADH to 
NAD, Figure 1.11. The acetic acid is captured by an acetyl-CoA synthase which then 
produces acetyl-CoA. A citrate synthase then catalyses the subsequent reaction between 
acetyl-CoA and oxaloacetate, where oxaloacetate is formed from L-malate using an 
NADH-dependent dehydrogenase. The screen assay is widely used by food industry for 
detecting acetic acid in food products. The esterase from Pseudomonas fluorescens  was 
used as the test enzyme and activity was successfully detected. A method was also 
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Figure 1.11: NAD coupled screen to detect Itydrolase activity 
NAD(P)-dependent enzymes have also been used in other high-throughput screens to 
determine enantioselectivities. In 2001, an enzymatic method for determining 
enantiomeric excess (EMDee) was developed by monitoring the formation of NADPH 
by an alcohol dehydrogenase in a 384-well plate using a UV/fluorescent reader, Figure 
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1.12 .48 Here the e.e. of the (5)-isomer in a mixture of (R) and (5)-23, produced by a 
metal catalysed reaction, was measured using an (5)-alcohol dehydrogenase. 
OH OH 0 OH 
+ 
Alcohol dehydrogenase 
PhEt Ph 	Et PhEt Ph 	Et 
NADP+ 	NADPH 
(S)-23 (R)-23 24 (R)-23 
Figure 1.12: Using an alcohol dehydrogenase to determine e. e. values 
The rate of oxidation of a range of known ratios of (R)- and (S)-23 by the alcohol 
dehydrogenase was measured to make a standard plot of relative rates versus e.e., to 
which the unknown sample was compared. The method was effective but only worked 
when the total concentration of 23 was known. In 2004, the method was further 
developed using two alcohol dehydrogenases with different enantioselectivities to allow 
the determination of the e.e. of a range of chiral alcohols of unknown concentrations. 
49 
1.4.3.2 Coloured or fluorescent product detection 
The simplest way to detect enzyme reaction is by formation of a coloured or fluorescent 
product. In 2005, an assay was developed to detect BVMO activity in microtitre plates 
using fluorescence. 50  Standard substrates for the BVMOs were substituted with a 
fluorescent compound such as umbelliferone 27, for example the cyclohexanone-
umbelliferone 25, and upon oxidation the product hydrolysed and was released to give a 
fluorescent signal, Figure 1.13. 
0 	 Degradation 
BVMO 0 	 O 
or Pig liver esterase 
25 	 26 	 27 
Figure 1.13: B VMO assay using release offluorescence to detect activity 
A range of cyclic and aliphatic substrates were successfully used and the fluorescent 
signal was increased in the presence of pig liver esterase. 
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In 2006, the same group developed an assay for lipases and esterases using fluorescence 
resonance energy transfer (FRET).' Pyrenebutyric acid, a fluorescent reporter, was 
covalently linked using various spacers to a dinitrophenylamino (DNP) group, Figure 
1.14. As the emission spectrum of the pyrene overlaps with the emission spectrum of the 
DNP, the fluorescence was quenched. When the pyrene and the DNP were separated 
from each other by hydrolysis using the lipase or esterase, fluorescence was observed. 
Different spacer groups were used to test the substrate specificities of the lipases and 
esterases. Thirty-six commercially available enzymes were tested against fifteen 
substrates in a microtitre plate assay and compound 28, Figure 1. 14, was identified as an 
efficient reporter system for lipase activity under basic conditions. 







Figure 1.14: FRET substrate for analysing Lipase/Esterase activity 
An EMDee method has also been developed using fluorescence to determine e.e.s of 
allylic acetates using a lipase by the group that developed the original EMDee assay 
using NADPH-dependent enzymes. 52  The hydrolysis of 29 by a lipase released acetate 
that protonated p-nitrophenol 31 present in the assay solution, Figure 1.15. The 
protonation resulted in a change in the absorbance at 405 nm for the p-nitrophenol, 
which was measured for a range of allylic acetate enantiomeric ratios. The e.e. of the 
acetates was then plotted against relative initial rates and could be used to determine 
e.e.s of unknown samples. 
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Figure 1.15: Using p-nitrophenol to detect lipase activity 
The advantage of this method is that it is not substrate dependent since it detects the 
release of acetate, a by-product of many lipase reactions. Eighty-eight samples were 
analysed in twenty-five minutes providing a rapid indication of lipase activity and the 
e.e. of the reaction. 
1.4.3.3 Detection of enzyme activity using metal coordination 
In 2004, Hwang and Kim developed a method to detect w-transaminase activity using a 
copper sulfate/methanol system. 53 In the w-transaminase reaction, an amino donor 32 
and an amino acceptor 33 were converted into a ketone 34 and an amino acid 35. The 
resulting amino acid was shown to form a complex with the copper ion in the copper 
sulfate to produce a blue colour, which was quantified by measurement at 595 nm, 
Figure 1.16. This method was used to detect a novel transaminase with three fold 
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Figure 1.16: Using a copper staining solution to detect amino acid and (ransaminase activity 
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A similar copper staining method was also used for the detection of lipase activity using 
dimedone. 54 A range of lipase substrates were synthesised that contained dimedone, for 
example 36, shown in Figure 1.17. Upon enzyme-catalysed hydrolysis, the dimedone 
was released 38 and bound to Cu 11 present in the microtitre plates as Cu(OAc)2. The 
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Figure 1.17: Hydrolase screening by detection of the copper-dimedone adduct 
Eight lipases and two esterases were used to validate the screen using substrate 36. The 
commercially available lipases displayed activity comparable to activities measured by 
HPLC. However crude enzyme preparations displayed a high level of background 
activity and so the assay could only be used with pure enzyme preparations. 
1.4.4 High-throughput screening using other media 
Enzyme screening systems have also been developed to monitor chemical reactions 
where the reagents were insoluble in water. In 2002, Berkowitz et at developed a 
biphasic system in which the chemical conversion occurred in an upper organic layer 55 
(intramolecular allylic aminations of 39 using transition metal catalysts), Figure 1.18. 
Ethanol was produced as a by-product that diffused into the lower aqueous layer. The 
alcohol was then oxidised twice by the NADH dependent enzymes alcohol 
dehydrogenase and aldehyde dehydrogenase. The formation of NADH was monitored at 
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Figure 1.18: Using NAD dependent hydrogenases to detect intramolecular ally/ic aninations 
Another approach to overcoming solubility problems was reported in 2005 by Babiak 
and Reymond?6 In this assay, fluorogenic substrates were adsorbed onto silica gel plates 
in order to detect lipase, esterase, glycosidase and protease activities. The large contact 
area between the enzyme and the substrate aimed to overcome the poor water solubility 
of the chromogenic/fluorogenic substrates of the enzymes. Silica gel plates and reverse 
phase C 18 thin layer chromatography (RP-C 18 TLC) plates were investigated and it was 
shown that twenty different substrates containing esters and acyloxymethyl ethers of 
umbelliferone could be distributed on one plate. The substrates were transferred onto the 
plates dissolved in dichloromethane and then the plate was dried. A 1 tl solution of a 
lipase was spotted onto the plate and successful reaction resulted in a blue fluorescent 
mark. The group showed that 144 reactions could be observed on a 5x5 cm plate, 
offering a practical alternative to screening on microtitre plates where the required 
enzyme volumes are much larger (5-200 p1). Glycosidase activity was also observed 
using water soluble substrates in the same manner. 
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Glass slides have also been used to attach substrates to analyse enzyme activities. In a 
study by Gronux and Reymond in 2006, lipases were subjected to substrate profiling 
using many different substrates covalently attached to a glass slide. 57  The substrates 
were designed so that upon lipase cleavage, diol 46 remained. Chemical manipulation of 
the substrates after lipase hydrolysis on the glass slides allowed red fluorescent detection 
of the diols using rhodamine sulfohydrazide 48, Figure 1.19. On a glass plate 12x3 cm, 
324 spots of lipase were placed analysing twelve pure substrates and numerous mixtures 
of the substrates. 
RO 
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Figure 1.19: Lipase detection using red fluorescence of substrates on glass slides 
The technique provides a practical alternative to screening in microtitre plates. However 
the screen still requires optimisation as pure enzyme preparations are needed at present. 
Only lipase cleavages that produced 1 ,2-diols were detected and the screen is not 
enantioselective. 
A miniaturized screen recently published by the Reetz group has potential to function in 
high-throughput with lower reagent consumption. Epoxide hydrolase variants were used 
as the test enzymes and enantioselectivities were analysed using mini-channels on a 
microchip electrophoresis device. 58  Four channels were present on each chip enabling it 
to be used for one enzyme and three substrates, or three enzymes and one substrate. The 
enzyme and substrate were pulled and mixed through the chip channels using either a 
vacuum or voltage. A chiral selector compound pumped through the chip enabled UV-
laser analysis to distinguish between enantiomers. These researchers showed that 
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reactions were possible using purified enzymes, cell lysates and whole cells. Epoxide 
hydrolase variants generated by directed evolution were investigated for the conversion 
of epoxide 49 to diol 50 and E value increases from 4 (wild type) to 101 were measured, 
Figure 1.20. The data obtained using the chip was comparable with yields and e.e.s 





Figure 1.20: Epoxide Hydrolase ring opening reaction used to investigate the use of chips for screening 
Another screening method that has been developed by Griffiths and Tawfik is the use of 
emulsions to compartmentalize genes. 9 Water-in-oil emulsions were designed to 
contain all the necessary components for gene expression. Therefore proteins could be 
expressed and contained in the same vesicle as the coding gene, achieving in vitro 
compartmentalization (IVC). The size of the emulsions was designed so that each 
vesicle of water statistically contained one gene. Any additives needed in the water 
compartments were introduced by addition to the oil. The IVC approach has been used 
to examine variants of methyltransferases, RNA ligases, 3-galactosidases, 
phosphotriesterases and Diels-Alder ribozymes. A number of screening and gene 
selection systems have been designed based on the properties of the proteins of interest. 
A fluorescence quenched substrate was added to the IVC and expression of an enzyme 
that could cleave the substrate and produce fluorescence was detected using flow 
cytometry. The fluorescent compartments could then be broken open to isolate the active 
enzyme-coding genes. A second method to examine the expressed proteins was by using 
gene-linked-substrates. The desired conversion of the substrate altered the properties of 
the gene which allowed subsequent isolation. This approach was used to screen for 
methyltransferases, where any active enzymes would methylate the gene. By breaking 
all the compartments and combining the genes, the non-methylated DNA could be 
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removed by digestion, leaving the methylated genes that coded for active enzyme. 
Subsequent amplification using the polymerase chain reaction created many copies of 
the genes of interest for sequencing or further expression. 
The IVC expression and screening method provides an alternative to screening enzymes 
in a cell without the complications of other proteins and cell contents. The method was 




1.5 Screening for novel activities- Developing a new method 
Many of the screens discussed in section 1.4 were designed specifically for detecting 
one reaction, or the conversion of a specific substrate, with the development of each 
being significantly time consuming. Therefore there would be great advantages to a 
screen that was readily adaptable to a range of reactions. In 2006, Sutherland el al 
decided to approach screening in a different manner and design one simple screen for 
many reactions that could be built upon like a 'biosynthetic tree'. 60 Their idea is shown 
in Figure 1.21. If a screen could be developed for the conversion of Y to Z, then that 
screen could be used for the detection of the conversions of V, W, or X to Y. 
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Figure 1.21: The biosynthetic tree approach for enzyme screening 
Once a method of detection for X, W and V was established, a screen for all conversions 
of M-U to Y could be developed using the same reaction cascade. 
In 2003, the idea for the current project was to design a screen based on a similar idea. 
The monoamine oxidase (MAO) work carried out by the Turner group was based on a 
colorimetric enzyme cascade system, 10, 27 shown in Figure 1.22. The screen ultimately 
detects the formation of hydrogen peroxide, an oxidation by-product. 
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Figure 1.22: Detecting peroxide formation in the oxidation of amines 
Amine oxidases are classified into two groups according to which cofactor they possess 
and are widely distributed in Nature. Type I are copper dependent and require 2,4,5-
trihydroxyphenylalanine quinine (TPQ) as a cofactor, whereas type II are flavin 
dependent. The cofactor required by the porcine kidney DAAOx and the MAO in the 
Turner study was flavin adenine nucleotide 53, FAD, Figure 1.23. There are two 
principal steps in the catalytic cycle of MAO catalysed oxidation of an amine substrate 
with the FAD cofactor. The first of these steps is the oxidation of the substrate with 
concurrent reduction of FAD to FADH2, 53 to 54. The protons are removed from the 
substrate. Second, is the regeneration of FADH2 to FAD by molecular oxygen, releasing 
hydrogen peroxide and completing the redox reaction, 54 to 53. 
0 
N 	 2 F  211 
- NH 










N  N 
OH OH 
l.jlO 






0 	 NH2 
54 	0- 0 
H20 	N
HO 
Figure 1.23: The reduction of FAD (53) to FADH2 (54) 
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In the assay, peroxidase is introduced and uses the hydrogen peroxide to oxidise another 
substrate, for example, 3,3'-diaminobenzidine 55, Figure 1.24, which polymerises upon 
oxidation to form an insoluble red/brown compound allowing easy identification of 
active colonies.10 In the solution phase, 4-aminoantipyrine and 2,4,6-
tribromohydroxybenzoic acid can be used to form a pink soluble dye product that is 
detected using a microtitre plate reader at 510 run. 
NH2 
NH2 
H2N 	 55 
NH2 
Figure 1.24: Diaminobenzidine 
The peroxidase catalysed oxidation forming a coloured compound using hydrogen 
peroxide can be seen as the conversion of Y to Z, Figure 1.21. The oxidation of amines 
to produce hydrogen peroxide by MAOs can be compared to the conversion of X to Y. 
There are also amino acid oxidases and alcohol oxidases that are FAD-dependent, such 
as the amino acid oxidase from Trigonopsis variabilis, or the alcohol oxidase from 
Pichia pinus. The oxidation of amino acids by the amino acid oxidases to generate 
hydrogen peroxide can be seen as the conversion of W to V. Therefore, any reaction that 
makes an amine could be detected using the amine oxidase and the peroxidase X, Y, Z; 
any reaction that produces an amino acid can be detected using the amino acid oxidase 
and the peroxidase W, Y, Z; and any reaction that produces an alcohol can be detected 
using an alcohol oxidase and the peroxidase V, Y, Z. The new coupled assay tree is 
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Figure 1.25: The coupled assay model based on the detection of peroxide 
There are many examples of enzymes that require FAD as a cofactor but amine and 
amino acid oxidases will be used as the examples in this work. Enzymes that produce 
amines include transaminases and imine reductases, and enzymes that produce amino 
acids include esterases and amino acid dehydrogenases. The tree can be extended to 






















As presented in Figure 1.26, a wide range of enzymatic reactions can be screened for 
using the peroxide/peroxidase method. The MAO enzyme had been evolved to be highly 
enantioselective for the (S)-enantiomers of amines therefore the screen has the advantage 
of enantiodiscrimination. Amino acid oxidases also generally display high 
enantio selectivity, for example the oxidase from pig kidney, commercially available 
from Sigma, has been shown to preferentially oxidise D-enantiomers. 6 1  The novel screen 
not only has the capability of screening for amines or amino acids, but enantiospecific 
amine and amino acid products. 
In this work, it was decided to use the amino acid oxidase and the peroxidase system to 
develop the screen and test its applicability. It was also decided to select a system that 
would test the ability of the screen to determine enantioselectivity. However, using 
oxidases and peroxidases to detect secondary enzyme activity has been reported 
previously: D-amino acid oxidase, peroxidase and 4-aminoantipyrine (4-AAP) were used 
successfully to screen for thermostable amino acid amidases that could produce D-Phe 
from D-phenylalaninamide.62 Amino acid racemases have also been analysed using a D-
amino acid oxidase, peroxidase and 4-AAP to detect the conversion of L-Ala to D-Ala.63  
The novel aspect of the screen developed here was to introduce the gene for the amino 
acid oxidase into the cells producing the enzyme of interest using a second plasmid, 
followed by the co-expression of the enzyme of interest and the oxidase to successfully 
detect activity. By introducing the oxidase gene into the cell on a second plasmid, any 
enzyme that can produce a substrate for the oxidase can be screened (alcohols using the 
alcohol oxidase, amines using the amine oxidase). 
Successful co-expression of the D-amino acid oxidase from T variabilis with a second 
enzyme in one cell has been achieved for the bioconversion of cephalosporin C to 7-
aminocephalosporanic acid. In the first experiment, a fusion protein was made with the 
oxidase and glutaryl-7-aminocephalosporanic acid acylase.64 In the second, both the 
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genes were cloned into one p1asmid.6 ' It was reported that the oxidase and the acylase 
were active and could turnover substrate. 
Co-expression from two plasmids for enzyme screening has also been employed for 
analysing glycosynthases (Figure 1.9). In 2001, Withers et al described the co-
expression of a glycosynthase with an endo-cellulase, which reported the glycosynthase 
activity by release of fluorescence. Both genes were on separate plamids.43 Later these 




1.6 Racemase Enzymes 
Amino acid racemases were chosen as the class of enzyme of interest for development 
of a novel screen. Amino acid racemases catalyse the interconversion of the two 
enantiomers of an amino acid. The advantage of using amino acid racemases for the 
screen was that the enzymes do not require any additional substrates for amino acid 
conversion, keeping the screen simple for initial development work. The proton on the 
a-carbon is removed and reprotonation occurs using the amino acid side chains already 
present in the active site. The principle of the amino acid racemase screen was to 
introduce the L-amino acid and follow conversion by the oxidation of the D-amino acid 
product and subsequent production of a coloured compound by the peroxidase (Figure 
1.27). 
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Figure 1.27: Principle of the amino acid racemase screen 
L-amino acids are most commonly found in Nature and are mostly used in protein 
synthesis and as a carbon and nitrogen source. For example in Bacillus subtilis, L-Ala is 
converted by an L-alanine dehydrogenase into pyruvate and ammonia as a carbon and 
nitrogen source. 66,67 D-amino acids are not as common but can be found in bacterial cell 
walls (D-Ala and D-Glu),68 D-ser has been found to act as a neuromodulator in 
mammals 69  and D-Ala has been shown to play a role in marine animals in osmotic 
stress .70 The less common D-enantiomers are generally produced using racemase 
enzymes. There are two main categories of amino acid racemases, those that are 
pyridoxal phosphate (PLP) dependent and those that are PLP-independent. 
71  PLP is the 
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active form of pyridoxine, more commonly known as vitamin B6 and is the coenzyme 
required by many enzymes that metabolise amino acids, (racemases, transaminases and 
decarboxylases). Pyridoxal phosphate is covalently bound to the side chain of a lysine 
residue in the enzymes as an imine. Imines are useful functional groups for catalysis as 
they are formed in a reversible process involving nucleophilic attack on the carbonyl by 
the primary amine in a weakly acidic environment. As formation is easily reversible they 
are valuable intermediates as the PLP is not bound strongly to the enzyme and can react 
with other primary amine groups. 
As one aim of the project is to broaden the substrate specificity of the enzyme to include 
unnatural substrates, the amino acid racemase with the widest native substrate specificity 
would be the most appropriate starting point for mutagenesis. In the literature many 
amino acid racemases are documented  and racemases from one species in particular act 
on a wide range of substrates. 72  The broad substrate specificity enzymes are PLP- 
dependent amino acid racemases from Pseudomonas putida.71' ' 	This enzyme was 
chosen as the test candidate for the novel screen, as a number of amino acid 
racemisations could be analysed and used to demonstrate the use of the oxidase reaction 
for detecting a number of substrates. 
1.6.1 Understanding amino acid racemases: The mechanism 
The majority of PLP-dependent enzymes function in the following way: the bond that is 
to be broken (for example, C-H in racemases, C-O in decarboxylases) is held parallel to 
the rr bond system of the PLP. The nitrogen in the PLP is usually protonated creating an 
electron sink. In Figure 1.28, the 'it system is displayed with the amino acid (red) held 
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Figure 1.28: The PLPp1 system with the amino acid C-H bond parallel 
When the proton is abstracted, a negative charge is left on the amino acid carbon that 
can be delocalised through the 7t system and the resulting quinoid intermediate is 
relatively stable. Due to the stability of the resulting intermediate, the pKa of the proton 
on the a-carbon of the PLP-amino acid substrate is therefore reduced compared to the 
amino acid in solution. The activation energy to deprotonate is lower making it easier to 
racemise the asymmetric centre using a basic group. Proton abstraction occurs to give a 
new imine between the nitrogen and the carbon of the amino acid and an enamine in the 
heterocyclic ring. The mechanism of a PLP-dependent racemase is shown in Figure 
1.29."-" It has been shown that the rate determining step in the racemisation of alanine 
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Figure 1.29: The racemase mechanism using the electron sink of the PLP 
Structure 58 shows the PLP covalently bound to the Lys residue in the active site of the 
racemase. When an amino acid (L-Ala 56) is introduced, a new imine bond is formed 
between the amino acid and the PLP 59. The amino acid is held so that the C-H bond is 
parallel to the pi bond system of the ring. A tyrosine in the active site is in the correct 
position to abstract the proton and create the asymmetric centre on the amino acid 60. 
Re-aromatisation is the driving force to re-protonate the a-carbon. In transaminases the 
abstracted proton is transferred to the carbon a to the pyridine ring, transamination has 
been seen to occur with racemases at low pHs.80' 8 ' Reprotonation can occur from either 
face of the planar structure. If reprotonation occurs using the phenolic —OH, then the 
resulting amino acid will be L-. If reprotonation occurs on the opposite face using Lys-
NH3 (as shown) the amino acid is in the D- conformation 61. The Lys-NH2 is 
reprotonated (mechanism unknown, proposed to occur using water molecules)82 and the 
Tyr-OH deprotonated. The amino acid is released from the PLP complex (imine bond 
38 
Introduction 
formation is easily reversible) and the PLP covalently bonds to the Lys residue. All steps 
are reversible and racemisation can proceed in the opposite direction, that is from D-Ala 
to L-Ala. 
The second mechanism that has been proposed does not rely on the electron sink of the 
PLP. In most PLP-dependent enzymes, there is an acidic residue in the active site close 
to the pyridinium nitrogen that allows protonation. However, in amino acid racemases 
there is an arginine residue in this position. The large positively charged guanidinium 
head group of the arginine does not allow protonation of the N and two research groups 
have carried out computer modeling studies which support another possible mechanism 
for racemisation.83' 84 However, it has been calculated computationally that the acidity of 
the proton on the a-carbon is still significantly reduced by the PLP and solvation 
effects. 84  The alternate mechanism uses the acid group of the amino acid in the 
deprotonation of the cc-carbon, 85  (Figure 1.30) and has been proposed by a group that, 
prior to publication in 2002, carried out many of the mechanistic studies of alanine 
racemases used to determine the first mechanism using the protonated PLP nitrogen. 
Once the amino acid has displaced the Lys side chain and formed an imine with the PLP, 
the acidic group of the amino acid abstracts a proton from the tyrosine —OH, which in 
turn abstracts the proton from the amino acid a carbon in a six-membered transition 
state 63. The proton shuttle can move in the opposite direction to release the L-Ala, or 
the C-C bond of the amino acid can rotate and move the deprotonated a-carbon in a 
position to abstract a proton from the Lys side chain 64. The transition state of the 
second proton abstraction is also six-membered 65. The Lys side chain then displaces 
the amino acid from the PLP and D-Ala 56 is released. Again, each step is reversible and 
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Figure 1.30: Alternate mechanism of racemisation 
Various studies have proven that, regardless of the mechanism, the Tyr residue abstracts 
the proton from L-Ala'76,86,87  whereas Lys abstracts the proton from D-Ala.77' 88 Fenn et 
al carried out site directed mutagenesis on the alanine racemase of Geobacillus 
stearothermophilus to remove the Tyr residue and saw that the racemase was 
inactivated 76  and Watanabe et al carried out similar studies with the Lys residue. 
77 
Alanine racemases have been shown to exist as dimers containing two active sites, 
created on the boundary between the monomers. The important Lys residue belongs to 
one monomer and the catalytically important Tyr residue belongs to the other. 89 
1.6.2 Current amino acid racemase screens 
The amino acid racemase from Pseudomonas sp. was chosen as the starting candidate to 
develop the high-throughput screen. A literature search revealed that all high-throughput 
solid phase assays for amino acid racemases described to date relied on a selection 
method. In 1993, a range of bacteria were investigated for threonine racemase activity 
by growing on minimal media containing D-Thr as the sole nitrogen source.90 P. putida 
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ATCC 17642 was identified and shown to have threonine racemase activity. Asano et al 
also used the selection method when examining 200 microorganisms for D-Phe 
racemisation.74 The microorganisms were grown using D-Phe as the only carbon and 
nitrogen source. 
A number of coupled enzymatic screens to detect racemase activity have been used in 
microtitre plate format. Screening using NAD/NADH has been employed to detect 
conversions of D-Ala to L-Ala and L-Ala to D-Ala.91' 92  An NADH dependent L-Ala 
dehydrogenase was used to detect L-Ala produced by the racemase and a D-amino acid 
transferase was coupled to an NADH dependent lactate dehydrogenase to detect D-Ala 
(Figure 1.31). In both studies, the conversion of NAD to NADH, or NADH to NAD 
was monitored at 340 nm and used to examine racemase activity. 
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Figure 1.31: NAD/NADH enzyme coupled racemase screens 
Racemisation of amino acids has also been followed by detection of peroxide using a 
peroxidase and a colour forming substrate. The racemisation of serine by an alanine 
racemase from Geobacillus stearothermophilus was measured using the following step-
wise method: 93  purified racemase enzyme was added to L-Ser, the reaction was 
incubated for twenty minutes and boiled to deactivate the enzyme, a sample was then 
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removed and added to a solution of D-amino acid oxidase, peroxidase and o-
phenylenediamine (OPD) and incubated. The developed colour (polymerised OPD) was 
measured at 492 nm and compared to a standard curve generated previously using 
known concentrations of D-Ser, Figure 1.32. 
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Figure 1.32: The stepwise detection of serine racemase activity 
A similar method of racemase detection was carried out in 2005 using the cell free 
extract of variant racemases created by shuffling the alanine racemases from E. coil and 
Salmonella typhimurium.3 ' The racemase activity was monitored by carrying out 
reactions with L-Ser or L-Ala for 30 or 10 minutes respectively, deactivating the 
racemase using HC1 and adding the remaining mixture of amino acids to a cocktail of D-
amino acid oxidase, peroxidase, 4-AAP and N-ethyl-N-(2-hydroxy-3 -sulfopropyl)-m-
toluidine. The exact same method was used in 2006 by Ono et alto examine alanine 
racemase activity. 63 
Non-enzymatic routes to detect amino acid racemase activities included the analysis of 
amino acid enantiomers by chiral HPLC,3 the development of a HPLC/mass 
spectrometry high-throughput method (56 min per 96 well plate) by DSM,94 using 
deuterated water followed by monitoring the NMR signal of the cc-proton of the amino 
acid and methods based on optical rotations.90 A medium-throughput assay was 
developed by Schonfeld and Bomscheuer in 2004 for partially purified glutamate 
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racemases in microtitre plate format. 95  Cultures grown in deep well plates were 
subjected to a His-tag 96 well plate purification and transferred to a liquid handler for 
addition to L-Glu. The decrease in optical rotation of the solution was followed and 
related to specific activity. It was estimated that three 96-well plates could be examined 
per day. 
Circular dichroism (CD) has also been employed recently to measure amino acid 
racemase activity. 96  The CD spectrums of 1 MM L-Ala, 1 MM D-Ala and a range of 
mixtures of the enantiomers were measured between 205 and 215 nm. The spectrums 
were integrated and plotted against the concentration of L-Ala to generate a standard 
curve. Samples from a D- to L-Ala racemisation reaction were then analysed by CD and 
the integrated spectra compared to the standard to determine L-Ala concentrations. 
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1.7 Summary and Aims 
Directed evolution has been developed as a powerful tool to alter the characteristics of 
proteins and make them useful catalysts in organic chemistry. Despite the many 
developments of techniques for directed evolution, general high-throughput screens are 
not as numerous. Frequently, screens are developed for a specific reaction and this step 
can be very time consuming. 
The goal in this project was to establish a screening method that could be applied in 
many directed evolution experiments that also had the advantage of being 
enantioselective. Amino acid racemases were good candidates for the development of 
the novel two-plasmid screen as current solid phase amino acid racemase assays rely on 
selection methods only. The solution phase screening using the oxidase/peroxidase 
system has been carried out in a step-wise fashion and using a continuous method. 
As candidates for biotransformations, amino acid racemases have the added advantage 
that the cofactor (PLP) is regenerated after each catalytic cycle (although the mechanism 
has not been confirmed) and is covalently attached to the enzyme when not involved in 
catalysis (therefore not free in solution and separated from the enzyme). Amino acid 
racemases do not require any additional substrates for enzymatic action and so with the 
introduction of an amino acid, the process of racemisation should start immediately. 
Once a test candidate enzyme was chosen and the gene cloned, the first aim was to 
establish a method for the screen and show that it could be used to detect wild type 
racemase activity. Then, to show that the assay could be used in conjunction with 
directed evolution experiments to detect novel activities from a background of inactivity, 
the cloned racemase genes were subjected to mutation using a variety of methods and 
screened. 
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2. Results and Discussion 
2.1 	Identification, isolation and expression of amino acid racemases 
The ultimate aim of this project was to develop and demonstrate the application of a new 
screening method, for which amino acid racemase enzymes were chosen as the test 
candidates. This chapter presents the identification of possible racemase candidates, the 
subsequent gene cloning and enzyme expression experiments. The first racemase chosen 
was the amino acid racemase from P. putida, as the broad substrate specificity is well 
documented.' In the first section of the chapter, the cloning and sequencing results of the 
P. putida racemase from genomic DNA is presented. 
In the second section, amino acid racemases with unknown or narrow substrate 
specificities were selected for use in directed evolution studies to prove the application 
of the two-plasmid screen to identify novel specificities. Initial selection of the enzymes 
was carried out using a protein sequence probing method, with the P. pu/ida sequence, 
to identify similar proteins. The bioinformatics search algorithm tool, Basic Local 
Alignment Search Tool (BLAST) was used to identify protein sequences similar to the P. 
putida racemase. BLAST works on the principle that the sequences consist of segments 
of aligned information separated by areas of no alignment. The BLAST algorithm allows 
the user to modify parameters to refine the search, in particular the scoring matrix 
BLOSUM (BLOcks SUbstitution Matrix), which can be changed to evaluate proteins 
with various levels of homology. BLOSUM 62 is usually set as a default, but to widen 
the search to include more distantly related proteins the matrix can be set to 45, or if 
looking at relatively short evolutionary distances, BLOSUM 90 is preferable. The 
sequences returned by the BLAST program are given an E value, which is a statistical 
score giving an indication of how closely related the query and result sequence are. 
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Scores below 0.01 indicate matches, with the smaller the number, the more similar the 
sequences. It is unlikely that matches occur by chance. 
Following identification of the candidate racemases, the genes were isolated and inserted 
into expression vectors. Restriction digests were carried out to confirm the plasmid 
constructions. The genes were sequenced, compared to the reported sequences and 
translated to analyse the protein sequences. Finally, the expression of the racemases was 
tested in a range of E. co/i host cells. 
Results and Discussion 
2.1 .1 Cloning and characterisation of the broad substrate specificity racemase from P. 
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Figure 2.1.1: Cloning plan to insert the racemase gene into pETI6b 
The gDNA from P. putida was prepared as described in section 4.2.3 and the putative 
gene was obtained by PCR. Primers were designed to introduce an NdeI cleavage site at 
the 5' terminus of the gene and a BamHI site at the 3' terminus. Gel electrophoresis was 
used to analyse and isolate the PCR product and a band of approximately 1.2 kbp was 
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excised from the gel. The PCR product and pET16b plasmid DNA were subjected to a 
double restriction digest using NdeI and BamHI and both were purified by gel 
electrophoresis. The gene insert was ligated with the linearised pETl6b and the resultant 
plasmid used to transform into E. co/i BL2 1 (DE3). Only low numbers of small colonies 
were found on the plates after an overnight growth and so the incubation period was 
extended for 24 h. The number of colonies increased slightly after the extended 
incubation period. Colonies were selected and cultures were grown for 36-48 h (as 12-24 
h rarely resulted in visible cell growth) and subjected to plasmid DNA extraction. 
However, no plasmid DNA could be isolated. 
A number of ligation/transformation experiments were performed to ensure that there 
was not a contamination and fresh LB/Agar/Amp plates were prepared to ensure that 
there was no problem with the antibiotic. Miniprep kits from different suppliers (Roche, 
Sigma and Qiagen) were used to eliminate suspicions of any contaminants. The same 
results occurred each time. 
It was a possibility that the enzyme might have a toxic effect on the cell as it could be 
depleting L-amino acids that are essential for cell production and growth, explaining the 
slow growth seen on the plates and in the cultures. When the enzyme becomes too toxic 
for the cell, the cell is unable to grow and replicate properly. Fl co/i without this plasmid 
is able to grow rapidly and dominate the culture when the majority of the ampicillin 
antibiotic is degraded by a secreted 3-lactamase, which occurs by the time the culture is 
becoming slightly turbid (OD600 of approximately 	It had been observed 
previously that pET1 6b can produce low level enzyme expression, even in the absence 
of expression inducers.98 An alternative plasmid, pTTQ18, 
99 was then used here as 
protein expression is strongly regulated by the binding of a variant of the lac repressor to 
the tac operator, (pETl6b contains the T7 promoter). The tac promoter is a hybrid of the 
lac and the trp promoters and is a strong promoter as it matches the consensus sequence 
rii 
pta 6 on 
BamHI 
pTrQ18 (Pput rac) 
(5784 bp) 
rm tenxiinatorJ 
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for the E. co/i RNA polymerase. The repressor is inhibited by isopropy1--D-
thiogalactopyranoside (IPTG) and this can be used to switch on the protein expression. 
2.1.2 Cloning of P. putida racemase gene into pTTQ18 
EcoRl 	 BaniHi 









P. putida racemase for pErl 6b 
(1262 bp) 
EcoRl 
Figure 2.1.2: Cloning plan to insert the racemase gene into p TTQI8 
Oligonucleotides were designed to amplify the gene from P. putida gDNA by PCR with 
EcoRI and BamHI cleavage sites on the 5' and 3' gene termini respectively. The PCR 
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product was purified by gel electrophoresis and subjected to a double digest. When the 












Figure 2.1.3: An agarose gel showing the racemase containing plasmid after digest with EcoRJ 
M= Ladder, Lane 1= Digested PCR product, Lane 2Repeat of digest 
The size of the predicted racemase gene is 1.2 kbp and the largest band in lanes 2 and 3 
is approximately this size. However, there are two bands at 900 bp and 300 bp that were 
not seen on the gel when the PCR product was purified before digestion. The EcoRI was 
presumed to have cleaved the gene unexpectedly as this effect was not seen when using 
BamHI and this gene for cloning into pET16b. The PCR and digestion were repeated to 
demonstrate that the initial PCR had not introduced a mutation and an extra EcoRI 
cleavage site in the gene. For the digestion, EcoRI from a different source was tested 
with the same result and this ruled out contamination. Different buffers were also tested 
to ensure EcoRI was not exhibiting EcoRI star activity. The logical conclusion was that 
the gene must have an unreported EcoPJ site in the gene and alternative restriction sites 
for cloning would have to be used. 
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2.1.3 Cloning of racemase gene into pINGE2 to make pJLM1O1 
The vector pINGE2 (Jngenza Ltd) is a derivative of pTTQI 8 where a second multiple 
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Figure 2.1.4: Cloning plan to insert the racemase gene into pINGE2 
The gene was amplified from the P. putida gDNA with a Spel cleavage site introduced 
at the 5' terminus and a HindIII site at the 3' terminus. A double digest of pINGE2 and 
the PCR product was carried out and the purified fragments were ligated and used to 
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transform E. co/i ToplO cells. The plasmid DNA was isolated and subjected to a 
diagnostic digest to confirm insertion and placement of the gene in pTTQI 8, (Figure 
2.1.5a and b). 
a) 
Figure 2.1. 5a:A plasmid map oJpJLMIOI displaying restriction sites used in a diagnostic digest 
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b: An agarose gel analysis of diagnostic restriction digest. The expected bands are as follows: Lane M = 
I kb Marker (Biorad,; Lane I = double digest with Spel/Hindill showing the expected bands at 1.2 and 
4.8 kbp; Lane 2 = double digest with Sac I/Hind!!!, showing the expected bands at 1.5 and 4.5 kbp; 
Lane 3 = digest with EcoRl only, showing the expected bands at 0.9 and 5.1 kbp; Lane 4 = double 
digest with PvuI/NcoI, showing the expected bands at 0. 9, 2.4 and 2.7 kbp; Lane 5 = Digest with Spe! 
only, showing the expected band at 6.0 kbp corresponding to linearised vector 
The plasmid construct was digested with SpeI/HindlII to excise the racemase gene and 
confirm the size. Digestion with SacI/HindIII confirmed the presence of the gene in the 
second MCS of the vector. EcoRI restriction confirmed the presence of two EcoRI sites. 
Digestion with PvuI/NcoI was used to confirm presence of the amp resistance gene. Spel 
was used to linearise the vector and electrophoresis confirmed the total predicted size. 
2.1.4 Sequencing results of racemase gene in pJLM 101 
The pJLM 101 construct was analysed by sequencing PCR. The sequences were aligned 
with the reported gene sequence, (Appendix 1). 114 base changes between the reported 
sequence and the cloned gene were found. Excluding the first three bases added as a 
result of the cloning strategy, there are a total of 20 amino acid differences. The majority 
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of the base differences are in the third base of the codon and so are generally redundant. 
The amino acid variations are as follows: N35T; T36A; V481; 183V; L129V; G132A; 
A1501,; A155E; T160P; M165L; A180T; 1191V; A273S; R2741-1; K278Q; H286R; 
S311A; V327A; E386D; and N400S. All numbers refer to the P. putida literature 
sequence. It is unlikely that these changes were introduced by PCR given the fidelity of 
Pfu hotstart polymerase. The likelihood is that the literature sequence was from a 
different strain of P. pulida than that used for the PCR. 
One of the single base differences introduced a sequence that is recognised by the 
restriction enzyme EcoRI. The expected GAATTT was found by sequencing to be 
GAATTC (positions 433 to 438, with reference to the P. putida literature sequence), 
explaining the observations when trying to digest the gene with this enzyme (Section 
2.1.2). 
2.1.5 Identification and isolation of other racemase genes: 
Using BLAST to identify other candidate racemases 
A variety of racemases were cloned in parallel. Using the analysis tools available on the 
TIGR website,10° a BLAST search was carried out using the literature P. putida protein 
as the query sequence, focusing on databases of sources of genomic DNA (gDNA) that 
were readily available. Three other racemases were selected as possible candidates, 
using the scoring matrix BLOSUM 62. For a summary of the BLAST search results see 
Table 2.1. A sequence alignment of the protein sequences is shown in Appendix 2. 
Gene Organism Similarity (%) Identity(%) Gene Length 	E-value 
P. putida Query sequence 1227 bp 	- 
putative 
air 
S. coelicolor 189/384 (49) 113/384 (29) 1152 bp 	2.7 x 1032 
-- 
air B. subtilis 171/347 (49) 98/347 (28) 1041 bp 	4.5 x 10
-3T 
dal B. subtiiis 177/369 (48) 110/369 (30) 1107 bp 	2.5x10 31  
Table 2.1: Results of the BLAST search 
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The racemase from P. putida is well documented as a broad substrate specificity 
racemase. The dal racemase from B. subtilis was one of the first racemases to be isolated 
and has been well studied.101 It has narrow substrate specificity, with alanine as the only 
reported substrate. Dar mutants grow in minimal media, but not in the presence of L-Ala, 
suggesting that the dal mutant contains a second racemase, expression of which is 
repressed by L-Ala.66 The B. subtilis air has only been proposed to express a racemase 
enzyme and this has never been isolated or studied and the role maybe different to that 
in other bacteria containing 2 racemases. In bacteria such as E. coli, there is an alanine 
racemase constitutively expressed at a low level to provide D-Ala for the bacterial cell 
wall, from the dadX gene' 02  (this is similar to the dal gene from B. subtilis). In E. coii 
there is a second racemase that is induced in the presence of L-Ala, to convert excess L-
Ala to D-Ala. The D-Ala is then converted by a D-specific alanine dehydrogenase to 
pyruvate and ammonia as a carbon and nitrogen source and also to provide energy. B. 
subtilis contains an L-specific alanine dehydrogenase, removing the need for the second 
air racemase. 
The racemase from S. coeiicoior is an uncharacterised racemase which is assigned as a 
'putative' alanine racemase in the genome databases (www.tigr.org) and there is no 
literature describing the study of this enzyme. This is also the only alanine racemase 
found in the Streptomyces coelicoior genome using a name search and the only gene that 
is returned by the BLAST matrix when using the P. putida racemase sequence as a 
probe (using www.tigr.org  and www.ncbi.nih.nlm.gov) to search the genome. 
In summary, a broad substrate specificity racemase (from P. putida), a well studied 
racemase from B. subtilis (dal) and two racemases were identified for future study. 
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2.1.6 Isolation and cloning of the racemases from B. subtilis and S. coelicolor 
2.1.6.1 The construction of pJLM20 1: the alanine racemase from S. coelicolor 
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Figure 2.1.6: The cloning plan to create pJLM2OI using p TTQJ8 and the racemase gene 
The plasmid pTTQ 18 was chosen as the host vector as the P. putida racemase was in 
pINGE2 (pTTQ18 with a second MCS). To have all racemases in similar constructs 
would reduce the variability in expression that may occur from using different systems. 
The gene was amplified from the gDNA by PCR, introducing an EcoRJ cleavage site at 
the 5' terminus and a BamHI site at the 3' terminus. The PCR product was inserted into 
56 
Results and Discussion 
the corresponding sites of pTTQ 18 and the resultant plasmid used to transform E. coli 
Top 10 cells. Following plasmid purification, a restriction digest analysis was carried out 
(Figure 2.1.7). A gene insert similar to the size of the air gene was shown by digestion 
with EcoRT/BamHI and gel electrophoresis. Digestion with HindIII/NcoI confirmed the 
racemase gene was inserted into the plasmid in the correct orientation. Digestion with 
PvuI was used to check the insert size. Placement of the racemase gene with respect to 
the Laclq gene was confirmed with digestion by EcoRV/SacII. A single digest with 
EcoRI linearised and confirmed the size of the plasmid. 
The pJLM201 construct was subjected to DNA sequencing. The sequences were aligned 
with the reported gene sequence and are shown in Appendix 3. The translation of the 
two sequences is also shown. There are only two base differences between the sequences 
(not including the two extra codons introduced by the cloning strategy at the start of the 
gene). Both of the base changes are the third base in the codon and have no effect on the 
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Figure 2.1.7: Diagnostic digest ofpJLM20l 
Plasn,id map displaying restriction sites used for diagmostic digest 
Agarose gel analysis of diagnostic restriction digest. Expected band sizes are as follows: Lane M = I 
kb Marker (Biorad); Lane I = double digest with EcoRl/BainHi showing the expected bands at 1.2 and 
4.5 kbp; Lane 2 = double digest with HindIII/NcoI showing the expected bands at 0.85 and 4.9 kbp; 
Lane 3 = single digest with Pvul showing the expected bands at 2.7 and 3.0 kbp; Lane 4 = double digest 
with EcoR V/Sad! showing the expected bands at 2.0 and 3.7 kbp, Lane 5 = digest with EcoRJ showing 
the expected band at 5.7 kbpfor the linearised vector 
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2.1.6.2 The construction of pJLM30 1: the Ala racemase (dal) from B. subtilis 
//or, 
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Figure 2.1.8: The cloning plan to create pJLM30I from p TTQJ8 and the racemase gene 
The dal gene was obtained from gDNA using PCR. An EcoRl cleavage site was 
introduced at the 5' terminus and a BamHI site at the 3' terminus. The PCR product was 
purified, digested and ligated into pTTQ 18 using the corresponding restriction sites. E. 
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coli Top 10 cells were used to host the new plasmid. After plasmid purification, an insert 
equal to the size of the racemase gene was detected by restriction digest and gel 
electrophoresis. The plasmid was digested with BamHI/EcoRI to excise the gene and 
confirm the size. Digestion with EcoRV/BamHI confirmed the placement of the multiple 
cloning site with respect to the laclqgene and restriction with EcoRV/NcoI confirmed 
the gene of interest was inserted in the site in the orientation predicted (with the C-
terminus of the gene at the BamHI site). Finally a digest with EcoRI was carried out to 
linearise the vector to confirm the size. The results of this digest are shown in Figure 
2.1.9. 
The gene was sequenced to confirm insertion of the dal gene and the alignment of the 
cloned gene with the expected sequence is shown in Appendix 4. There is only one base 
change at the end of the sequence when compared to the literature sequence (not 
including the codons introduced by cloning). The base change does not change the 
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aCRV 
Figure 2.1.9: Diagnostic digest ofpJLM30I 
Plasmid map displaying restriction sites usedfor a diagnostic digest 
Agarose gel of diagnostic restriction digest with expected bands as follows: Lane 1= double digest 
with EcoRI/Ban?HI showing the expected bands at 1.2 kbp and 5.5 kbp; Lane 2= double digest with 
EcoRV/BamHI showing the expected bands at 2.0 and 3.7 kbp; Lane 3= double digest with 
EcoRV/Ncol showing the expected bands at 2.7 kbp and 3.0 kbp; Lane 4= digest with EcoRI only 
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2.1.6.3 The construction of pJLM302: Plasmid encoding air from B. subtilis 
The PCR amplification of this gene from gDNA was unsuccessful. A range of annealing 
temperatures were tested (40-60°C) combined with various detergents and solvents to 
aid primer binding, (DMSO, BSA and glycerol). The primer and dNTP concentrations 
were varied and different polymerase enzymes (Taq beads, Pfu hotstart and 
Advantage®-HF2 (Clonetech)) were employed but no successful DNA amplification 
was achieved. Multiple DNA fragments between 0.5 and 2.0 kbp were seen on gels at a 
range of annealing temperatures (42-52°C) with 10 % glycerol added and at lower 
annealing temperatures (42 and 45°C) with 1 % BSA added. The next step would have 
been to redesign the primers. The Sigma Genosys Oligo calculator was used to analyse 
the primers used. They were predicted to have weak and very weak secondary structures 
and thus very low probability of forming primer dimers. The calculated melting 
temperatures were within 5°C of each other (64 and 67°C). Therefore no problems were 
expected from the primers. The observed DNA fragment smears suggested non- primer 
binding and longer primers may have eliminated this problem. However, experiments on 
this gene were ended to focus on the other cloned racemases. 
2.1.7 Expression tests of the racemases 
The predicted sizes of the racemase monomers were calculated'°3 from the DNA 
sequencing results. The predicted weights were 44.0 kDa for the P. putida racemase, 
41.2 kDa for the S. coelicolor racemase and 43.6 kDa for the B. subtilis dal racemase. 
2.1.7.1 Transformation of E. co/i BL21(DE3) with pJLM1O1 and expression of the P. 
putida racemase 
The plasmid pJLM1O1, with pTTQ18 as a control, was used to transform E. co/i 
BL21(DE3). After an overnight growth there were few pJLM1O1 colonies visible. The 
plate was left for another 48 h. Colonies were picked and used to inoculate LB/Amp 
media. The three cultures were induced with 1 mM IPTG at 0D600 0.4-0.6 and harvested 
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solution phase assay. No activity towards alanine or amino butyric acid was seen. An 
SDS-PAGE gel of the pTTQI8 and pJLM1O1 containing-cultures is shown in Figure 
2.1 .10 with an equivalent amount of total protein loaded into each lane. Analysis of the 
gel revealed no obvious over-expression of the racemase compared to the control. Due 
to the problems seen previously with the pET16b construct in E. co/i BL21(DE3) and 
the proposal that basal expression of the racemase prior to induction was potentially 
toxic to the expression host, it was decided to try expression in E. co/i Top 10 and E. co/i 
BL21(DE3)pLysS cells. The E. co/i Top 10 cell line was designed for production of high 
amounts of plasmid DNA and is not as efficient at expression as E. co/i BL21(DE3).104  
E. co/i BL21(DE3)pLysS was designed for the expression of toxic proteins as it contains 
a second plasmid (pLysS) that expresses a protein to inhibit T7 RNA polymerase, 
preventing basal expression of the protein of interest. 105 
Figure 2.1. 1O:An SDS gel showing expression of P. putida racemase from pJLMI 01 and the p TTQI8 
negative control. The contents of the lanes were as follows: M= Protein Ladder; Lanes 1-2 = Oh 
induction for pTTQI8 andpJLMIOl respectively; Lanes 3-4 = lh post-induction for pTTQl8 and 
pJLMJOI respectively; Lanes 5-6= 16 h post-induction for pTTQI8 and pJLMIOI respectively 
2.1.7.2 Expression of the racemases in E. co/i Top 10 cells 
The constructs were used to transform E. co/i Top 10 and two colonies from each were 
selected, grown and protein expression was induced with 1 mM IPTG when the OD of 
Il 2 I 3 1 M I 5 I 6 I 7 1 8 I 9 
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the cultures was approximately 0.6. Samples were removed for analysis at 0 h, 1 h and 
18 h post induction by SDS-PAGE (Figure 2.1.11). 
kDa 
25 
Figure 2.1.1 Ia: An SDS gel showing the P. putida racemase expression in E. co/i Top 10 cells. The area 
of interest corresponding to the expected size of the racemase is boxed. The contents of the lanes are as 
follows: M= Ladder; Lanes 1-3 = correspond to the p TTQ18 Culture I (negative control) at 0 h, / It and 
18 It post-induction respectively; Lanes 5-7 = P. putida racemase expression culture I at 0 h, 1 Ii, 18 Ii 
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Figure 2.1.1/b: An SDS gel showing racemase expression in E. co/i Top 10 cells. The area of interest 
corresponding to the expected racemase size is boxed. The contents of the lanes are as follows: M = 
Ladder; Lanes 1-3 = the S. coelicolor racemase containing culture at 0 Ii, I h and 18 h post-induction 
respectively; Lanes 4-6 = the second S. coellcolor racemase containing culture at 0 h, I It and 18 h post-
induction respectively; Lanes 7-9 = the B. subtills racemase containing culture at 0 h, / h and 18 It 
post-induction respectively 
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Figure 2.1.1 Ic: An SDS gel showing expression of the racemases in E. co/i Top 10 cells. The area of 
interest corresponding to the expected racemase size is boxed. The contents of the lanes are as follows: 
M = Ladder; Lanes 1-3 = the second negative control culture at 0 h, I h and 18 h post-induction 
respectively; Lanes 4-6 = the second B. subtilis racemase containing culture at 0 h, I h and 18 1, post- 
induction respectively 
It is possible to see expression of the racemases in the 18 h, post induction lanes. As 
presented in 2.1.7. 1, attempting to express the racemases in E. co/i BL2 1 strains seemed 
to result in slow growth and eventual death of the host cells. The possible lower 
expression of the racemases in E. coil Top 10 resulted in longer cell growth periods and 
visible protein bands by SDS-PAGE. 
2.1.7.3 Expression tests in E. coil BL21(DE3)pLysS 
Since large scale cultures were required for analysis and assay, E. coil BL2 1 (DE3)pLysS 
was investigated as a host cell line for racemase over-expression. The racemase from S. 
coelicoior was chosen as the test candidate as expression in E. co/i Top 10 cells was high 
enough to visualise on an SDS gel (Figure 2.1.11b). It might be suggested that racemase 
expression is primarily toxic to the host when it is growing, as this is when the D-Ala 
and D-Glu are essential for cell wall biosynthesis, therefore it was decided to induce 
expression when the cells had reached late exponential phase of growth. 
Results and Discussion 
Initial experiments using E. co/i BL21(DE3)pLysS[pJLM201] revealed that freshly 
transformed cells are essential. Glycerol stocks of pLysS cells were shown to be 
unstable and over time resulted in degradation of plasmid DNA. Plasmid DNA extracted 
from older glycerol stocks produced long DNA fragment smears when analysed on an 
agarose gel. Plasmids containing the racemase gene were extracted from freshly 
prepared E. co/i ToplO and E. co/i BL21(DE3)pLysS cells and were subjected to a 
restriction digest to extract the gene. It was shown that after a restriction digest to excise 
the racemase gene, both showed a single band corresponding to the size of the racemase 
gene but the pLysS cells also produced a DNA fragment smear. There is a second 
plasmid (the pLysS) in BL21(DE3)pLysS cells to express T7 lysozyme and the second 
antibiotic degrading enzyme (chioramphenicol acetyl transferase). It is suggested that 
the DNA smear in the freshly prepared plasmid is the degraded pLysS and that over time 
the racemase plasmid may also be destroyed. It was also shown that colonies picked 
from LB/agar plates that had been stored at 4°C for more than 2 days gave variable and 
unreliable results when grown and induced. 
Overnight cultures were grown at 37°C from freshly transformed colonies, in 
LB/Amp/Cam/PLP (PLP concentration = 0.5 jiM). A 2 % inoculum was used for five 50 
ml cultures (containing the same antibiotics and PLP at the same concentration). When 
the OD at 600 nm reached approximately 1, two of the flasks were placed at 26'C, To 
two flasks at each temperature, 0.1 mM and 1 mM IPTG was added. The final flask at 
37°C was not induced. 1 mM L-Ala was also added to provide substrate for the induced 
racemase so that it did not deplete amino acids essential for the host. 
Flask (1): 37°C 	+ 1 mM L-Ala 
37°C + 1 mM L-Ala and 0.1 mM IPTG 
37°C + 1 mM L-Ala and 1 mM IPTG 
26°C + 1 mM L-Ala and 0.1 mM IPTG 
26°C + 1 mM L-Ala and 1 mM IPTG 
Me 
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Aliquots from each culture were removed at the point of induction (t = 0) and at t = 1, 2 
and 17 h post induction. The samples were centrifuged and resuspended to a final 0D600 
of 10, then 40 t1 of the cell suspension was used to test for amino acid racemase activity 
using the solution phase assay (Section 2.2) with L-2-amino butyric acid (ABA). The 
results can be seen in Figure 2.1.12. 15 tl of each sample was loaded onto an SDS gel 
for analysis, see Figure 2.1.13. 
E. coli BL21(DE3)pLysS[pJLM20I] 
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Figure 2.1.12: Histogram showing the amount of activity of the racemase enzyme at different times post 
induction at d?[ferent  growth temperatures with increasing IPTG concentrations 
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Figure 2.1.13: SDS gels showing the S. coelicolor expression in E. coil BL2I(DE3) pLysS post 
induction at different growth temperatures with increasing !PTG concentrations. Band corresponding 
to racemase expected at 42 kDa. The conditions for each of the flasks was as follows: ('1 37°C; (2)= 
37°C 0.1 mMJPTG; (3)= 37°C! n,MIPTG; (4)= 26°C 0.1 ,nMIPTG; (5)= 26°C! mMIPTG. The lanes 
in the gel contain CFE from the following flasks: Gel 1: Lane I = cell contents at time of induction; 
Lanes 2-6 = CFE offlasks (j)-(5) respectively at I h post-induction; Lanes 7-8 = Flasks (1)-(2) 
respectively at 2 h post-induction. Gel 2: Lanes 1-3 = CFE offlasks (3)-(5) respectively at 2 h post- 
induction; Lanes 4-8 = CFE offlasks (I)-(5) respectively at 17 h post-induction. 
It was found that conditions (2) and (3), which are 37°C 0.1 mM and 1 mM IPTG 
respectively, produced the most active racemase. However conditions (2) also produced 
the highest final density of cells at 600 nrn at cell harvest (17 h post-induction). 
Results and Discussion 
Condition (2) was therefore used for all large culture preparations. However, it was still 
not possible to positively identify over-expressed racemase on an SDS-PAGE gel 
(Figure 2.1.13). 
2.1.8 Discussion 
The aim of the work in this chapter was to identify and clone a number of amino acid 
racemases for the development of a screen and for directed evolution towards different 
substrates. 
Plasmids containing the genes of three of the four racemases identified were 
successfully produced (pJLM1O1, pJLM201 and pJLM301). The fourth gene, air from B. 
subtilis, was never successfully amplified using the designed primers. It is possible that 
the strain of B. subtilis in the lab has a slightly different sequence for the air gene, 
compared to the published sequence and so the primers could not bind properly to 
amplify the gene, or there was non-specific binding. The next approach would be to 
redesign the primers and elongate them to enable more sites for binding recognition. A 
second approach could involve designing primers where the third base in the codon was 
undefined, (N) and would enable primer binding if the sequence was not as published in 
those positions. 
The three racemases that were successfully cloned provided a good basis for the 
development of the screen to detect racemase activity, as one is a known broad substrate 
specificity racemase, one has high specificity for alanine and the final racemase is 
putative and has never been characterised. 
The poor and inconsistent cell growth observed when cloning the broad substrate 
specificity racemase gene into pET1 6b, led to the proposal that the racemase may be 
toxic to the host when expressed. Attempts to isolate the plasmid of pET 1 6b containing 
the cloned P. putida racemase failed, indicating that the cells had lost the plasmid. 
Results and Discussion 
However, this gene was cloned into pTTQ 18, under the control of a different expression 
promoter, without problems. One explanation for the observed problems could be that as 
D-Ala and D-Glu are essential components in the bacterial cell wall,67' 68  and if the 
racemase was expressed at a low level when the E. coil cells were just starting to grow 
the concentration of available D-Ala and D-glu would be reduced, causing inefficient cell 
wall synthesis. 
The toxicity of this racemase in E. coii would also explain the poor cell growth 
encountered when trying to over-express the enzyme in E. coil BL2 1 (DE3). Expression 
carried out using E. coil Top 10 cells was more successful and the suggestion that can be 
made here is that the cell line was not designed as an expression system and so racemase 
expression levels are lower in growing cells compared to the E. coil 13L21(DE3). For 
larger cultures, the best results for the most active racemase were obtained when using E. 
coil BL21(DE3)pLysS cells and inducing with an IPTG concentration of 0.1 mM when 
the cells were at the end of the exponential growth phase. The lower amount of IPTG 
meant that the racemases were expressed at a lower level and the cells could grow to a 
higher density. 
The P. putida racemase was over-expressed in BL21(DE3)pLysS cells but not in 
BL21(DE3) cells, the difference between the two cell lines being the plasmid pLysS. 
The pLysS plasmid constitutively expresses a low amount of T7 lysozyme, an inhibitor 
of the T7 RNA polymerase used for T7 expression systems such as the pET vector series. 
The lack of functioning polymerase prevents basal expression of the cloned gene, until 
IPTG is added and the amount of expressed T7 RNA polymerase increases. In the 
plasmids constructed here containing the racemase genes, the promoter system is tac 
rather than T7. There is no T7 RNA polymerase to inhibit, yet expression was more 
successful and resulted in active racemase, Figure 2.1.13. Comparison of the two strains 
for expression was repeated later in these studies and confirmed that there was little 
racemase expression in 13L2l(DE3) but expression was observed in BL21(DE3)pLysS. 
Results and Discussion 
The observed instability of the plasmids in stored E. co/i BL2 1 (DE3)pLysS cells may be 
due to the T7 lysozyme. The lysozyme is contained within the cell, but upon storage the 
cell may die, releasing the lysozyme and resulting in lysis of surrounding cells. This 
would be the start of a chain reaction, as surrounding cells would then lyse and release 
their lysozyme. 
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2. Results and Discussion 
2.2 Development of a high-throughput screen to detect racemase 
activity 
The ability to screen for enzyme activity is essential for directed evolution experiments. 
It is generally accepted that the major limiting factor in the application of directed 
evolution approaches is the availability of suitable high-throughput screens or selection 
systems for the enzyme activity of interest. The current methods of screening for 
racemase enzymes described in the introduction are not very high-throughput. The 
following chapter presents the development of an assay to detect racemase activity, both 
in the solution phase and on solid phase using agar-based screening methods. Both 
versions of the screen rely on the detection of hydrogen peroxide, generated by the 
enantioselective oxidation of an amino acid by an amino acid oxidase. The principle of 
the racemase screen was to introduce the unreactive amino acid enantiomer for the 
oxidase, so that if the racemase was able to racemise the substrate, the correct 
enantiomer for oxidation would be produced, oxidation could occur and the hydrogen 
peroxide could be detected using HRP and a colorimetric substrate, Figure 2.2.1. 
Me 	 Me 





56 	 56 	 57 
L-Ala u-Ala 02 	H202 
Peroxidase 
+ colour forming substrate 
Colour 
Figure 2.2.1: The racemase detection assay involving production of hydrogen peroxide that can be 
detected colorimetrically. 
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The first section of this chapter describes the use of the assay in the solution phase using 
commercially available racemase and amino acid oxidase enzymes. The screen was then 
tested using the cloned amino acid racemases and optimised to ensure reproducible 
results. The solution phase assay was used to obtain a substrate specificity profile of the 
expressed racemases against a panel of substrates. As the assay is an indirect detection 
of racemase activity, it had to assumed that the H202 detected by the colorimetric assay 
is produced as a consequence of enzymatic racemisation. To further confirm racemase 
activity and the principle of the solution phase using a direct method, HPLC analysis of 
an amino acid racemisation reaction was carried out. 
Analysis of racemase activity in the solution phase is preferable when working with 
small numbers of samples. However, the aim was to be able to screen large numbers of 
variants in a high-throughput screen. A common technique is the use of agar plate-based 
screening methods. The numbers of variants that can be screened using these methods 
are limited by the number of agar plates used, each plate (15 cm diameter) can hold 
approximately 6 000 to 8 000 colonies when covered. The same reaction principles from 
the solution phase screen were applied in the solid phase, using the oxidase to oxidise 
the racemase product and produce hydrogen peroxide, which in turn could be detected 
using a peroxidase and a colour forming substrate. The development of the solid phase 
screen is presented, from a simple 'pour-over' reaction mixture, to a two-plasmid screen, 
capable of screening large numbers of variant enzymes using a range of oxidases. 
2.2.1 The solution phase assay using commercially available enzymes 
The performance of the screen was tested initially using commercially available; amino 
acid racemase (from Geobacillus stearothermophilus), the D-amino acid oxidase (from 
porcine kidney) and the horse radish peroxidase. (For preparation see Section 4.6.1). 
Assays were performed at pH 8.0 as the optimum D-amino acid oxidase performance has 
been reported to be pH 8.561  and the optimum working pH for racemase activity is 
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between pH 8.0 and 10.0.106  However the optimum activity for the peroxidase has been 
reported between pH 5 and 6.106  Using pH 8.0 enabled optimum activity of the racemase 
and slightly less than optimal activity of the oxidase. The HRP was added in excess to 
compensate for the pH being higher than for optimum activity. 
The commercial enzymes were diluted with dH20, according to the enzyme unit activity 
reported by Sigma towards alanine. Into each well on a 96-well micro-titre plate 
containing 190 il assay mixture (including HRP), 10 il of racemase/oxidase was added 
in increasing concentrations, shown in Table 2.2.1. The plate was then incubated at 37°C 
and the reaction monitored by measuring the absorbance of the coloured product at 510 
nm. Absorbances were plotted as a function of time. A picture of the plate after reaction 
can be seen in Figure 2.2.2, reactions were compared by measuring the greatest increase 
in absorption per min and these results are also shown in Table 2.2.1. 
(mOD/mm) 1 
0 U Oxidase 
2 
1 U Oxidase 
3 
2 U Oxidase 
4 
3 U Oxidase 
0 U Racemase 0 0 0 0 
1 U Racemase 0 3.9 28 79 
C:2URacemase 0 12 168 288 
D: 3 U Racemase 0 53 325 446 
Table 2.2.1: The racemase:oxidase unit ratios used to test the solution phase assay and the mOD/mm 
values for colour formation 
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Figure 2.2.2: Picture ofplate after assay showing gradual increase in colour formation with increasing 
oxidase and raceinase concentrations 
Wells containing both the commercial racemase and oxidase resulted in colour change 
and an increase in either racemase or oxidase resulted in an increase in the rate of 
formation of coloured product. The controls containing no racemase and/or no oxidase 
did not show any colour formation during the reaction time. It is necessary to use a 
negative control in all assays as the dye product forms naturally due to the light 
sensitivity of the reagent, 4-amino antipyrine. In conclusion, the solution phase assay 
was shown to detect racemase activity using the oxidase/peroxidase coupled screen. 
2.2.2 The solution phase assay for the cloned racemases 
The racemases from the three constructs pJLM1O1, pJLM201 and pJLM301 were 
expressed in E. coil ToplO cells and the cell free extracts subjected to a solution phase 
assay against increasing concentrations of L-Alanine. The cells were harvested and lysed 
to obtain the CFE prior to assay (Section 4.5.1.1). The CFE was then added to assay 
mixture containing HRP, L-Ala and the amino acid oxidase, (Section 4.6.1.3). 
Negative controls for each Ala concentration lacking the CFE were assayed and the 
results were subtracted from the racemase data. The results are displayed in Figure 2.2.3. 
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Figure 2.2.3: Histogram showing CFE racemase activity towards different concentrations of L-Ala. 
The culture expressing the P. pu/ida racemase is shown in I; The culture expressing the S. coelicolor 
racemase is shown as 2; The culture expressing the B. sub/i/is racemase is shown in 3. 
There was little colour formation in wells containing the CFE and no substrate. The E. 
coli cells expressing the racemase from B. subtilis (pJLM301) showed the highest 
activity and the lowest activity was seen for the cells expressing the P. putida broad 
specificity racemase (pJLM1O1). 
The solution phase assay was shown to detect racemase activity in expressed cells but 
the results observed above may have been due to limited oxidase activity. Therefore an 
experiment was performed to verify that the amount of oxidase used in the screen (0.2 U) 
was sufficient to detect 0.1 mM, 1.0 mM and 10 mM D-Ala, without being rate limiting 
and the results can be seen in Figure 2.2.4. 
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Sigma oxidase vs D-Ala 
I 
01 	 1.0 	 10.0 
D-Ala (mM) 
Figure 2.2.4: Maximum mODImin values obtainable using 0.2 U Oxidase 
The values obtained for oxidation of 0. 1, 1.0 and 10 MM D-Ala using 0.2 U of oxidase 
are 2-3 times greater than those obtained when combined with the racemase and 
racemase substrate. This confirms that the oxidase and HRP were capable of detecting 
the maximum amount of D-Ala that could be present after racemisation by the racemase. 
2.2.3 Determining substrate specificities of the racemases using the solution phase 
assay 
In order to determine the substrate specificity of the racemases, a solution phase assay 
was carried out using the CFEs of the expressed racemases against a range of amino acid 
substrates. All cells were harvested and lysed to obtain the CFE, which was then assayed 
using the panel of amino acid substrate assays. The reactions were all carried out in 
triplicate and the average taken. Cells containing the plasmid with no racemase gene 
(pTTQ 18) were also assayed to provide a negative control. All averaged results for ten 
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Substrate specificity of amino acid racemases 










Q Negative control (cells only) 
lIP. putida racemase 
o S. coelicolor racemase 
08. sub filis racemase 
100 
:J _I_____ 
L-ala 	L-2-ABA 	L-arg 	L-asp 	Lieu 	L-Iys 	L-phe 	L-pro 	L-ser 	L-val 
Figure 2.2.5: Substrate specificity of racemase activity, including p TTQ18 negative control 
The negative control is displayed in Figure 2.2.5 to indicate the substrate specificity of 
the host E. co/i racemases. The racemase from P. putida has activity towards alanine, 
amino-butyric acid, arginine, leucine, lysine and serine, but no activity towards aspartate, 
phenylalanine, proline and valine. This data correlates very well with the relative 
substrate specificity recorded by Lim et al in 1993,90  the only discrepancy was that they 
observed a higher activity towards lysine. 
The substrate specificity of the putative racemase from S. coelicolor towards the 
substrates screened was shown to be very narrow, with low activity with L-2-ABA and 
high activity with L-alanine. Similar results were obtained for the Dal racemase from B. 
subtilis, which was very active with L-alanine and slightly active with L-2-ABA. This 
correlates well with the information previously recorded for the Dal racemase. '01  
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The substrate specificity of the E. co/i host racemases is visible in the negative control. 
Activity against alanine, phenylalanine, proline and serine was observed. To analyse 
behaviour of the expressed racemases in future experiments, an amino acid that is active 
against the expressed racemases but not against the host racemases should be used. The 
amino acid 2-ABA is a good candidate as no activity was observed against this substrate 
with the negative control, but activity was seen with all the expressed racemases. 
It is possible in these assays that there is a small quantity of the D-amino acid in the L-
amino acid source, manufacturers labelled the L-amino acids as 99% pure. However, 
small contaminants of the D-enantiomer can produce false results in the assay. Assays 
carried out later (Section 2.7.2) suggested that the activity displayed in Figure 2.2.5 by 
the host E. co/i racemases towards substrates phenylalanine and proline were indeed 
false and may have been a result of D-Phe and D-Pro present in the L-Phe and L-Pro 
sources respectively. 
2.2.4 Optimisation of the solution phase screen 
At this stage an analysis of the solution phase assay was carried out to minimise errors. 
It was noticed in the previous assay that the data range within each triplicate could be 
made smaller and more reproducible. The enzyme volumes added to the assay mixture 
were susceptible to great errors, for example, if the required volume addition of oxidase 
was 5 tl, to pipette 4.8 p1, into one well and 5.2 p1 meant a difference between the wells 
of 0.4 p1. To reduce these errors and improve reproducibility, it was decided to increase 
the total volumes added. 
It was decided to prepare a two times concentrated assay mixture and aliquot 100 p1 per 
well. This left 100 p1 for the addition of enzymes, CFE and/or water. For all further 
experiments the remaining volume consisted of 10 p1 HRP 1mg/mi (volume doubled), 
10-20 p1 DAAO 0.2 U (previously 5 p1) and 50-70 p1 CFE. Working with larger 
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volumes minimised pipetting errors and gave more reliable results. Assay data then 
measured in triplicate was shown to be comparable using the new technique. However, 
the relative substrate specificity data obtained previously was shown to be accurate. 
2.2.5 HPLC analysis of racemase activity 
To verify that the colour formation in the solution phase assay was a result of substrate 
racemisation, the reaction of L-2-ABA with whole cells expressing each racemase was 
followed by HPLC. 
2.2.5.1 Preparation and analysis of standard solutions 
To enable analysis of a racemisation experiment, standards of 10 mM L-, D- and rac-2-
ABA were prepared. The rac-2-ABA was prepared and diluted to examine 
reproducibility of sample preparation (labelled Al). Diluting Al to 2.5 mM gave sample 
A2, A2 was then used to make A3 (1.25 mM rac-2-ABA) and A3 used to make A4 
(0.625 mM). Each standard (A2, A3 and A4) was sampled in triplicate, mixed in the 
HPLC injector loop for derivatisation (Section 4.5.3.5) and injected onto the column. 2 
MM L-2-ABA and 2 mM D-2-ABA standards were prepared and each one analysed 
twice on the HPLC to confirm retention times. The peak areas returned for all readings 
of A2, A3 and A4 and for the single enantiomers are shown in Figure 2.2.6. The average, 
standard deviation, standard error and relative standard deviation (%RSD, =100x 
(standard deviation/average)) were calculated to analyse the reproducibility of the 
machine and the sampling. The HPLC sampling and derivatisation varies between 0.7 
and 2.8 %RSD. 
Standard curves for the peak areas against concentrations were plotted and lines of best 
fit were drawn with error bars to determine concentrations from peak areas. The plot of 
both D- and L- peak areas can be seen in Figure 2.2.7. The equation to determine the L-2-
ABA concentration (x) from peak area (y) is y1416.8x. The equation to determine the 
D-2-ABA concentration (x) from peak area (y) is y=1470.3x. 
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A2 A3 A4 
sample sample sample 
D-2- L-2- 
2-ABA Racemic ABA ABA 
Total concn (mM) 2.5 1.25 0.625 
Individual enantiomer concn 
(MM) 1.25 0.625 0.3125 2 2 
Peak 
areas 
L D L D L D 
Injection 1 1761 1775 878 879 452 452 2974 2780 
Injection 2 1799 1813 884 889 444 443 3003 2892 
Injection 3 1732 1743 905 913 448 447 
Average peak area 1764 1777 889 894 448 447 2989 2836 
Standard dev 33.6 35.0 14.2 17.5 4.0 4.5 20.5 79.2 
Standard error 19.4 20.2 8.2 10.1 2.3 2.6 14.5 56.0 
%RSD 1.9 2.0 1.6 2.0 0.9 1.0 0.7 2.8 
Figure 2.2.6: HPLC standard peak areas and error analysis 















Figure 2.2.7: A graph showing the results of the HPLC peak areas at known concentrations of ABA, 
including error bars. The lines of best fit are shown and the equations allow peak areas to be used to 
calculate the unknown 2-ABA concentrations 
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2.2.5.2 Analysis of racemisation reactions by racemase-expressing cells 
E. co/i BL2 1 (DE3) pLysS cells expressing each of the three racemases (from P. putida, 
from S. coelico/or and B. subtilis) were harvested 16 h after induction (Section 4.4.5). 
The racemisation of 12 MM D- and L-2-ABA was attempted using 5 % (w/v) cells in 
phosphate buffer, pH 8.0 (Section 4.6.3.3) in duplicate. Samples were removed at 0.1 h 
and 15 h. HPLC analysis of the enantiomers was carried out and e.e.s were calculated 
for each time point using the peak area and the standard equations and are plotted in 
Figures 2.2.8 and 2.2.9. After 15 h, the e.e. had fallen to between 0 % and 3 % D-2-ABA, 
Table 2.2.2, indicating that successful racemisation had occurred. 
The racemisation of 2-ABA was shown to be successful at substrate concentrations of 12 
MM D- and 12 MM L-2-ABA. In both cases, there was a small e.e. of the L-conformer 
after 15 h. The racemase from B. subtilis appeared to be the most active and produced an 
e.e. of 17 % and 4 % in 0.1 h, starting from 99 % D- and L-2-ABA respectively. 
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Figure 2.2.8: Histogram showing the e.e. values in the racemisation of D-2-ABA using cells expressing 
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Racemisation of L-2-ABA 
Figure 2.2.9: Histogram showing the e.e. values in the racemisahion of L-2-ABA using cells expressing 
the racemases. The % e.e. of L-2-ABA is plotted as a function of time 
2.2.5.3 Observations 
In all cases racemase activity was demonstrated and there was a slight e.e. of L-2-ABA 
after 15 h. The rate of enzyme-catalysed racemisation from L-*D—amino acids has been 
proposed to be faster than the conversion of D-L-amino acids. 107  The difference in 
conversion rates was seen when the e.e.s at t = 0.1 h for all enzymes studied were 
compared for both D- and L-2-ABA racemisations, as L-2-ABA was racemised faster. 
In summary, it has been shown that racemisation of the substrate was occurring, with all 
racemases and importantly, that the correct substrate for a D-amino acid oxidase is being 
formed in the racemase screen. Once the screening had been explored in the solution 
phase, it was possible to begin investigation of the use of the screen in the solid phase. 
2.2.6 Evaluation of the solid phase assay with the cloned and expressed racemases 
8 -, 
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The solution phase assay was shown to be successful in detecting amino acid racemase 
activity. However, the solution phase assay was only medium-throughput (96 different 
samples per plate, each plate was analysed for between 30 and 60 mm). For the 
application of the developed screen in directed evolution, it was crucial to be able to 
assay large numbers of samples more quickly. Therefore a solid phase assay was 
developed for detecting racemase activity using the same principles as the solution phase 
assay, i.e to employ cells expressing the racemase and add the L-amino acid substrate, 
the D-amino acid oxidase and the hydrogen peroxide detecting reagents to identify active 
enzymes. 
Colonies of E. coli cells expressing each of the racemases were grown on nitrocellulose 
membranes on LB/agar plates. The membranes allowed the colonies to grow on normal 
agar-containing media and facilitated the transfer of the colonies to the assay mixture. 
Following incubation of the membranes at —20°C to partially lyse the cells, each 
membrane was cut in half. An assay mixture containing 10 mM L-Ala, DAAO, HRP, 
colour forming substrate (DAB) buffered at pH 8.0 was poured onto one half membrane 
and onto the other half, the same assay mix without the L-Ala substrate. The latter was a 
control to ensure colour change was not the result of a possible contaminant or side 
reaction in the assay mix, but a result of conversion of L- to D- alanine. The results can 
be seen in Figure 2.2.10. 
The expected red/brown colour was observed over the membranes expressing racemase. 
No colour formation was seen in the plates lacking substrate, indicating that the colour 
must have been the result of a reaction between the colonies on the membranes and the 
provided substrate. However, the colour had diffused throughout the agarose and was 
not localised over the colonies as required to allow identification of individual colonies 
with the activity of interest. It seems likely that the racemase was indeed racemising L-
alanine to produce D-alanine, which subsequently diffused through the agarose faster 
than it was oxidised. As the DAAO and colorimetric substrates were distributed evenly 
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throughout the assay plate, colour formation occurred where the D-alanine diffused and 
not only over individual colonies as desired. The D-alanine was seen to diffuse up to 1 
cm from the edge of the membrane, as revealed by coloured product. 
(1) positive control, D-Ala ('ii,) negative control, no sub (iii,) B. subtilis racemase, no sub (iv) Willi L-Ala 
- 	 Topi O(pTTQ1 open 33) 	 Topt 0(pTT01 6)(as dcl) 
no substrate I OeM L-Mn 
"1 
Topi rJ(pTTQI 3) 
no substrate 
pIO(pTTQ1 6)(Sc olr) 
1Omtn1L-la 
 
— I.  
Topi O(pINGET)(Ppnoroo) 	 Topi 0(pINOE2)(Pp aaron) 
no nobstroto 	 10mM L-sla 
(vi,) P. put ida raceinase, no sub (vi) wit!, L-A ía raceniase, L-Ala 
Figure 2.2.10: The solid phase assay performed  on all constructs 
An attempt to reduce the colour distribution was made by using 10 and 100 times less L-
alanine (1 and 0.1 mM) but this approach did not produce definite areas of colour over 
specific colonies. Lowering the concentration of L-Ala also reduced the intensity of the 
colour and would ultimately lower the ability of the screen to detect activity. The 
addition of more DAAO in the assay mixture would have made the cost of the high-
throughput screen unfavourable for extensive use. 
Another approach to solve the problem was considered, involving the co-expression of 
the racemase and the oxidase in the same cell, therefore localising oxidation in the 
colony so that even if any D-alanine diffused through the agarose, it would not result in 
colour as oxidation would occur only in the cell. 
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2.2.7 Development of a two-plasmid screen 
It was decided to introduce an amino acid oxidase into the cell on a second plasmid. If 
both genes were on the same plasmid, problems would occur when making variants 
using the XL 1-Red mutator strain as this could mutate the oxidase gene also. Putting the 
oxidase on a second plasmid that is only introduced for screening reduced the possibility 
that any racemase activity would be missed due to a deactivated oxidase. Additionally, 
the plasmid bearing the oxidase gene could be easily removed for the scale up of 
racemisation reactions. 
The co-expression of two enzymes from separate plasmids in one cell requires that the 
plasmids have compatible origins of replication and different antibiotic resistance 
markers. Most commonly used E. coil plasmids contain the ColE 1 replication origin, or 
a derivative of, which results in a high number of copies of the plasmid per cell (300-500) 
and the racemase genes were constructed on such a plasmid.99' 108  Compatible origins of 
replication, such as pI5a result in a low plasmid copy number (10-12 per cell). It was 
decided to leave the racemase on the high copy plasmid and introduce the oxidase on a 
low copy plasmid and select for cells containing both plasmids using two antibiotics. 
The promoter systems were also chosen to be different to enable selective control of the 
expression of both enzymes. Therefore, a low copy number plasmid containing an 
oxidase gene and an antibiotic resistance gene other than for ampicillin was created. 
Results and Discussion 
2.2.7.1 Creation of plasmid pJLM501 containing an amino acid oxidase gene 
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Figure 2.2.11: Creation ofpJLM401 
The heat inducible promoter and MCS from pPOT3 was inserted into Trp200 
A heat inducible phage promoter (CI 857) was obtained from the plasmid pPOT3109 by 
PCR amplification (to introduce Spel and PstI restriction sites at 5' and 3' ends 
respectively) and inserted into pTrp200 to make pJLM40I, Figure 2.2.11. 
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Step 2: Insertion of a D-amino acid oxidase gene under the control of the heat inducible 
promoter 
The D-amino acid oxidase gene, from Trigonopsis variabilis, was amplified from the 
plasmid pRES151 (Ingenza Ltd). The BamHI and PstI digested gene and plasmid 
pJLM401 were ligated to make pJLM402, Figure 2.2.12. Digestion of pJLM402 
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Figure 2.2.12: Creation ofpJLM402 by insertion of the oxidase gene into pJLM40I 
M. 
Results and Discussion 
Step 3: Transferring the oxidase gene/kan resistant gene/heat inducible promoter cassette 
into pJLM402 
The entire heat inducible promoter and oxidase were excised from pJLM402 using Spel 
and PstI, Figure 2.2.12, as pIrp200 and subsequently pJLM402 were high copy number 
plasmids. The promoter and oxidase gene fragment were inserted into the low copy 
number plasmid pTrp338, to make pGL12, (Figure 2.2.13). 
Step 4: Removing one of two BamHI sites from pGL12 to enable future replacement of 
the oxidase gene 
The high-throughput screen was developed to detect novel amino acid racemase 
activities and relied on the oxidation of the amino acids by an amino acid oxidase. For 
the wider application of the screen to detect activities such as ketone reductase activity, 
an alcohol oxidase would be needed. The restriction site at the beginning of the amino 
acid oxidase gene was BamHI. However, there was a second BamHI restriction site in 
the plasmid, after the heat inducible promoter. To enable replacement of the amino acid 
oxidase gene, the plasmid was subjected to a Quikchange PCR to remove the BamHI site 
in the pGL12 vector backbone, (Section 4.2.14.4). The modified low copy plasmid, 
containing the oxidase gene, a heat inducible promoter and a kanamycin resistant coding 
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Figure 2.2.13: The creation ofpJLMSOl by removal of a BamHI site from the pGL12 backbone 
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The removal of the BamHI site was confirmed by sequencing of the pGL 12 and 
pJLM501 plasmids and by a diagnostic digest of pJLM50I, Figure 2.2.14. The plasmid 
was digested with BamHI/PstI to excise the oxidase gene, with EcoRI to confirm the 
placement of the heat inducible promoter, with Sacl to confirm the presence of the 
oxidase/promoter cassette, with NdeI to check the host vector and with BaniHI to 
linearise the vector and confirm the size. The digest and plasmid map can be seen in 
Figure 2.2.14 and all bands revealed were of the expected size. Once the construction of 
pJLM501 was confirmed it was possible to try the co-transformation and expression and 
repeat the solid phase assay of the racemases. 









Figure 2.2.14 a) Plasmid map displaying restriction sites, double sites are underlined 
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b) An agarose gel of the diagnostic restriction digest. The expected bands are as follows: Lane M= 1kb 
Marker; Lane 1= double digest using Ban,HI/PstI showing expected bands at 1.1 kbp and 6.3 kbp; 
Lane 2= digest using EcoRl only showing expected bands at 1.2 kbp and 6.2 kbp; Lane 3= digest using 
Sacl only showing expected bands at 2.0 kbp and 5.4 kbp; Lane 4= digest with NdeI only showing 
expected bands at 2.8 kbp and 4.6 kbp; Lane 7= digest with Ban,!!! only showing expected band at 7.4 
kbp corresponding to linearised vector. 
Figure 2.2.14: Diagnostic digest ofpJLM501 
2.2.7.2 Using the two-plasmid screen to detect racemase activity 
The plasmids containing the racemase and oxidase genes were used to transform E. coil 
ToplO as described in Section 4.4.4 and plated onto membranes laid on LB/agar plate 
containing kanamycin and ampicillin to select for cells containing both plasmids. The 
plates were incubated overnight at 30°C, after which the membranes were placed onto 
fresh plates containing IPTG (1 mM) and incubated at 37°C for a further 18 h to induce 
racemase and oxidase expression. The membranes were then assayed as described in 
Section 4.6.2.2 against L-alanine and the results can be seen in Figure 2.2.15. The top 
row of the diagram in Figure 2.2.15 shows a positive control with D-Ala as substrate to 
confirm expressed and active oxidase and all as expected, showed colour. The second 
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row shows all constructs with no substrate added, no colour is expected, or seen. The 
third row shows all with L-Ala added. The three with racemase are dark brown and the 
negative control with pTTQ 18 in place of the vectors containing the racemase genes is a 
light brown in colour. A picture of the final plate (B. subtilis racemase) is magnified to 
display the colonies more clearly. 
E. coil 	 P. putida 	 S. coelicolor 	B. subti/is 








Figure 2.2.15: Co-expression assay 
Of Above: Row I =positive control Willi D-Ala 
Row 2= negative control, no substrate 
Row 3= experiment with L-Ala 	 . 
Column I = E. coli only 	 . 
Column 2 = P. putida racemase 	
-. .• 	. 
Column 3 = S. coelicolor racemase - .. . 
Column 4 = B. subtilis racemase 
Right: The B. subtilis racemase-containing cells, 
assayed will, L-Ala, magnified 
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The modified screening procedure now allowed individual colonies expressing racemase 
to be easily identified. The positive control showed that the D-amino acid oxidase was 
expressed and active and rapidly oxidised 10 MM D-Ala (the maximum possible 
concentration of D-Ala present in the racemisation experiments was 5 mM, and would 
occur only if the 10 MM L-Ala was quantitatively racemised). Therefore the 
concentration of expressed oxidase was sufficient to rapidly oxidise any D-Ala formed. 
The negative control showed no colour change in the absence of substrate, ruling out 
other hydrogen peroxide-forming reactions. In the presence of L-alanine, the colour 
appeared gradually, (the magnified picture, Figure 2.2.15, was taken an hour after the 
picture with all the plates). 
2.2.8 Conclusions 
The solution phase assay was developed and used for the detection of alanine racemase 
activity, initially with commercially available enzymes and then with cells expressing 
racemase. HPLC analysis was used to verify racemisation independently of the oxidase 
and confirmed that the expressed racemases were producing a racemate from a single 
enantiomer. The two-plasmid screen was shown to be successful in detecting alanine 
racemase activity in specific colonies. The oxidase gene was present on a low copy 
plasmid and so there should be less of the oxidase enzyme present in the cell, compared 
to the racemase. The screening revealed that this was not a problem, as the positive 
control with 10 MM D-Ala turned dark brown almost immediately. The colonies 
expressing racemase turned brown more slowly demonstrating that the oxidase was not 
rate limiting. 
It was noted that the E. coil cells containing pTTQ18 (without racemase gene) and 
oxidase gene also turned brown, but more slowly than the cells heterologously 
expressing racemase. The background activity is likely due to the endogenous alanine 
racemases in E. coil. In all assays it was necessary to have a negative control to compare 
the background E. coil racemase activity to the expressed racemases under investigation. 
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2.2.9 Future work 
The two-plasmid system has many possible applications as a high-throughput screen. 
The broad substrate specificity of the T variabilis oxidase, investigated in Section 2.3, 
demonstrates that this oxidase could be used to detect a range of racemase substrates. 
In addition, there are many other oxidases that could be used in place of the T. variabilis 
amino acid oxidase. For example, there are enantiospecific amine oxidases such as the 
'135' mutant developed by Turner and coworkers that is specific for a range of amines 
such as (5)-a-methyl benzylamine.10 It would be possible to probe genomic libraries for 
transaminase activity that could convert alanine and acetophenone into a-methyl 
benzylamine by transformation of the library into competent cells containing the amine 
oxidase. There are other oxidases, such as alcohol oxidases and a glucose oxidase that 
could be employed here. Using the current system, the amino acid oxidase can be 
replaced with another oxidase by simple cloning into the BamHI/PstI sites of pJLM501. 
Any libraries or enzymes of interest must be on an antibiotic resistant (other than 
kanamycin) and IPTG induced plasmid. 
The advantage of the oxidase on a second plasmid is that it is independent of the enzyme 
that is being screened. The oxidase can be easily introduced and just as easily removed. 
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2. Results and Discussion 
2.3 	Analysis of the behaviour of the amino acid oxidases used 
In previous chapters, all assays involving the D-amino acid oxidase have been focused 
on the activity of the amino acid racemases, with only a brief investigation into the 
maximum oxidation rates (mOD/mm) possible using different concentrations of D-
alanine (Section 2.2.2). A more in depth study was needed to understand the behaviour 
of the oxidases used throughout this work, in order to identify where reaction rates are 
limited by the racemase and where they are limited by the oxidase. It is important to 
know the substrate specificity of the oxidase to be able to choose substrates that can be 
used to probe racemase activity. In a reported investigation into the specificity, 
inhibition and reaction sequence of a D-amino acid oxidase from pig, 61  it was noted that 
some L-amino acids were competitive inhibitors. Inhibition by L-amino acids would 
present major problems for the racemase screening as the L-enantiomer is initially 
supplied. 
In this chapter the three oxidases used throughout the screening process were 
investigated. First, the substrate specificity of the D-amino acid oxidase from T. 
variabilis is presented, as this was the enzyme used for the two plasmid screen. 
There were two candidate oxidases available for the solution phase screen, the 
commercially available oxidase from porcine kidney and a partially purified T variab ills 
oxidase supplied by Jngenza. Analysis of the behaviour of these two oxidases was 
carried out to determine which was the most appropriate oxidase for the screen, that is, 
which was least affected by the presence of L-amino acids. The amount of oxidase 
required, so not to be rate limiting at a variety of substrate concentrations, was also 
explored. Finally, the substrate specificity of the pig kidney D-amino acid oxidase 
(pkDAAO) was examined. 
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2.3.1 Substrate specificity of the T variabilis amino acid oxidase (tvDAAO) 
The substrate specificity of the oxidase was determined against a panel of substrates 
using CFE of over-expressed oxidase, generated using E. co/i as the host organism. The 
substrate specificity profile is shown in Figure 2.3.1. It can be seen that a range of 
substrates are accepted by this oxidase and so a range of substrates can be used to 
examine racemase activity. 
















D-Ala 	D-Arg 	D-Leu 	D-Lys 	D-Phe 	D-Pro 	D-Ser 	D-Tyr 	D-Val 
Substrate (10 mM) 
Figure 2.3.1: Substrate spec jficity of the tvDAA 0 
2.3.2 Behaviour of the tvDAAO in the presence of D- and L-Arg 
An ammonium sulfate precipitate of the CFE containing the partially purified tvDAAO, 
over-expressed in E. co/i, was supplied for use in the solution phase screen. L-Arg was 
the substrate chosen for racemase evolution (as this was a known substrate for the broad 
substrate specificity racemase, but not a substrate of the other two) and so the behaviour 
of the oxidase towards Arg was investigated. Two experiments were carried out: The 
first was to examine the ability of the oxidase to detect one concentration of D-Arg in the 
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presence of increasing concentrations of L-Arg. The second mimicked the changing Arg 
concentrations in the assay, where the ratio of D:L-Arg was varied from 0:10 to 10:0, 
with the total substrate D/L-Arg concentration maintained at 10 mM 
2.3.2.1 Inhibition studies of L-Arg 
The activity of the tvDAAO towards 5 mM D-Arg was measured in the presence of 
different amounts of L-Arg from (0 to 10 mM). The supplied ammonium sulfate 
tvDAAO pellet (100 mg) was resuspended in 10 ml water and 20 p1 was used for the 
reaction, (assay conditions Section 4.6.1.4). The reaction was followed by formation of 
the coloured product, detected at 510 nm and the results can be seen in Figure 2.3.2. The 
rate values (mOD/mm) for the inhibition reaction can be seen in Figure 2.3.3. A blank 
control was measured using water instead of substrate. The time delay in adding the 
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Figure 2.3.2: The oxidation of 5 mMD-Arg by the tvDAAO in the presence of increasing amounts of L- 
Arg 
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5D10L 5D,9L 5D,8L 5D,7L 5D6L 5D5L 5D4L 5D3L 5D2L 5DIL 5D,0L 
Arg substrate concentrations (mM) 
Figure 2.3.3: The increasing initial rates of oxidation of 5 mM D-Arg, in the presence of decreasing 
amounts of L-Arg 
This analysis reveals that the tvDAAO is inhibited by increasing amounts of L-Arg. The 
rate of oxidation of a constant concentration of D-Arg increases as the amount of L-Arg 
decreases. When there is no L-Arg present, the initial rate of oxidation is almost 400 
mOD/mm, compared with 175 mOD/min in the presence of 10 mM L-Arg. The rate of 
oxidation is more than halved by the introduction of 10 mM L-Arg. 
2.3.2.2 The ability to detect D-Arg in the presence of L-Arg 
The initial rate of oxidation of D-Arg at a range of concentrations (0 and 10 mM) and 
then in the presence of L-Arg, was measured. For example, the initial rate of oxidation of 
3 mM D-Arg was measured, followed by the initial rate of oxidation of 3 mM D-Arg in 
the presence of 7 mM L- Arg. The total concentration of D-Arg and L- Arg was equal to 
M. 
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10 mM, as this was the concentration used for assaying the racemases. The comparison 
of the rates of oxidation can be seen in Figure 2.3.4. 
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Figure 2.3.4: Initial rates of oxidation of D-Arg by tvDAA 0 and in the presence of L-Arg 
It is clearly shown that the oxidation of D-Arg is affected by L-Arg. For the screen to be 
successful, the oxidation of D-Arg cannot be rate limiting otherwise the racemase rate 
cannot be determined. For example, the racemase screening is carried out with 10 mM 
L-Arg and if the racemase converts 0.5 mM of the L- to D-Arg, then the rate that should 
be measured is 181 mOD/mm, (detection of 0.5 mM D-Arg). However due to the 
presence of the remaining L-Arg, the rate measured is only 70 mOD/mm, (Figure 2.3.4, 
measurements at 0.5 D). The tvDAAO is therefore not an ideal candidate to identify 
racemase activity as the rate of oxidation is variable in the presence of L-Arg. 
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2.3.3 Behaviour of the pkDAAO in the presence of D- and L-Arg 
The oxidase used in the initial stages of screen development (Section 2.2) was the 
commercially available amino acid oxidase from porcine kidney. To analyse the 
behaviour of this oxidase in the presence of L- and D-Arg, the same experiments used to 
investigate the tvDAAO were carried out. 
2.3.3.1 Inhibition studies of L-Arg 
The rate of oxidation of 5 mM D-Arg using the pkDAAO was measured in the presence 
of different amounts of L-Arg from (0 to 10 mM), (assay conditions Section 4.6.1.4, 
using 0.2 U D-amino acid oxidase). The reaction was followed by formation of the 
coloured product, detected at 510 nm, the results of which can be seen in Figure 2.3.5. A 
blank control was also measured without any substrate. The rate values (mOD/mm) for 
the inhibition reaction can be seen in Figure 2.3.6. 
Sigma Oxidase: Inhibition by L-Arg 
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Figure 2.3.5: The rate of oxidation of 5 mM D-Arg in the presence of increasing amounts of L-Arg 
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Figure 2.3.6: The initial rates of oxidation of'S mM D-Arg in the presence of L-Arg 
The oxidation carried out in the presence of various concentrations of L-Arg revealed 
that this oxidase is not greatly affected by fluctuating concentrations of L-Arg. The rates 
of oxidation of 5 mM D-Arg do not vary as much (between 150 and 178 mOD/mm), 
compared with the tvDAAO rates (181 to 400 mOD/mm). 
2.3.3.2 The ability to detect D-Arg in the presence of L-Arg 
It was decided to also analyse the rates of oxidation of D-Arg at a range of 
concentrations (0 and 10 mM) and then in the presence of L-Arg, (as for the tvDAAO 
experiments). For example, the initial rate of oxidation of 3 mM D-Arg was measured, 
followed by the initial rate of oxidation of 3 mM D- Arg in the presence of 7 mM L- Arg. 
The total concentration of D- Arg and L- Arg was equal to 10 mM, as this was the 
concentration used for assaying the racemases. The comparison of the rates of oxidation 
can be seen in Figure 2.3.7. 
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Inhibition of Oxidase by L-Arg 
El D-Arg only 
+ L-Arg, total substrate concn=lOmM 
10D 9.50 9D SD 7D 60 5D 4D 3D 2D 1D 0.5D 3D 
Substrate (mM) 
Figure 2.3.7: Initial rates of oxidation of D-Arg by tvDAAO and in the presence of L-Arg 
The data for the pkDAAO suggests that it is not inhibited by L-Arg. The values for 
oxidation rate of each concentration of D-Arg do not vary too much from the values 
obtained with L-Arg present. 
2.3.3.3 Determining the amount of pkDAAO required for maximum rates of oxidation of 
D-Arg 
Although compared to the data for the tvDAAO the oxidation of the pkDAAO is not 
affected by the presence of L-Arg, the final rates obtained for pkDAAO oxidation at 
each of the D-Arg concentrations are much lower than those obtained with the tvDAAO 
and maybe implied that not enough of the pkDAAO was used. For example at 10 MM D-
Arg (no L-) the rate obtained with the tvDAAO was almost 500 mOD/mm, (Figure 2.3.4) 
and with the pkDAAO it was 280 mOD/mm (Figure 2.3.7). An investigation was carried 
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concentrations of pkDAAO (0, 0.05, 0.1, 0.2, 0.4, 0.7, 0.9 U) to determine the 
concentration of oxidase required for high rates of D-Arg oxidation. The rates that were 
obtained are shown in Figure 2.3.8. 















125D-Arg Concentration (mM) 25 
	 50 
Figure 2.3.8: The oxidation of D-Arg using increasing pkDAAO enzyme units 
At 12.5 mM D-Arg, the experiment revealed that the difference in rate using 0.2 U 
compared to 0.4 U of D-amino acid oxidase is 20 mOD/mm. The difference between the 
rates when using 0.2 and 0.1 U oxidase is much greater, (76 mOD/mm). At 25 mM D-
Arg, 0.2 U of oxidase produced a rate very similar to 0.4 U, 429 and 444 mOD/mm 
respectively, but was much more different than for 0.1 U (3 60 mOD/mm). At 50 mM D-
Arg, the same was observed, using 0.2 U oxidase was much faster than when using 0.1 
U, but not very different that when using 0.4 U. It was decided to use 0.4 U of oxidase 
for experiments containing 10 mM substrate as the rate of oxidation was starting to 
plateau and using 0.7 U would almost double the price of the oxidation reaction. 
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2.3.3.4 Substrate specificity of the pkDAAO 
In order to use the pkDAAO to screen for racemase activity, it was important to 
understand the substrate specificity of the oxidase. Only an amino acid that is accepted 
by the oxidase can be used to screen the racemase. A range of D-amino acids were 
analysed using the liquid phase assay (Section 4.6.1.4). 0.4 U of oxidase was used for 
each substrate. Each reaction was run in triplicate, with a negative control containing no 
oxidase and the data was averaged. The final concentration of all substrates was 10 mM. 
Where the D-amino acid was only available as a racemate, a total concentration of 20 
mM was added, to provide 10 mM of the D-enantiomer. The substrate specificity is 
shown in Figure 2.3.9. 
















Ala 	ABA 	A-g 	D/L As 	D/L Asp 	D-Leu 	D-Lys 	0-Met 	D-Phe 	D-Trp 	D/L Va 
Substrate 
Figure 2.3.9: Substrate spec?flcity of the pkDAA 0 
The substrate specificity revealed that the oxidase has a wide substrate specificity, 
accepting Ala, 2-ABA, Arg, Leu, Phe and Val, with lower activity towards Asn, Asp, 
Lys, Met and Tip. 
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2.3.4 Conclusions 
For the purposes of screening in the solution phase, it has been shown that the pkDAAO 
is preferable to the tvDAAO, as the rate of oxidation using the former is not affected by 
presence of L-Arg. For the screen to be useful and provide accurate rates of racemisation, 
the rate of oxidation must not be rate limiting. When developing the screen for oxidase 
activity, the amount of peroxidase was designed to be in large excess to provide accurate 
oxidation rates and in the same way, the screen for racemase activity must not be limited 
by the oxidation rate .27 The oxidase from pkDAAO has been shown to not be greatly 
affected by L-Arg and so is the better candidate for screening in the solution phase. 
The substrate specificity of the pkDAAO was then recorded using a panel of substrates. 
It was shown that all substrates that were screened later in this work (Ala, 2-ABA and 
Arg) are accepted by this oxidase. 
105 
Results and Discussion 
2. Results and Discussion 
2.4 	First attempt at mutation and screening of the racemase genes 
Random mutation of the racemase genes 
The solid and solution phase screens have been shown to be successful at identifying 
amino acid racemase activity. However, the amino acid racemases expressed and tested 
on the solid phase were all wild type and had identical activities. The next stage in 
developing a novel screening method was to show that the screen could be used to detect 
activity against a background of inactivity. It was decided to evolve the racemases to 
accept new substrates and use the screen to isolate and examine possible novel enzymes. 
Examining the substrate specificities of the three cloned racemases (Section 2.2.3) it can 
be seen that there are a number of substrates that are accepted by the broad substrate 
specificity racemase, but not by the other racemases. It is therefore possible to use PLP-
dependent enzymes to racemise substrates other than alanine and 2-amino butyric acid 
and the aim here was to evolve the narrow substrate specificity racemases towards one 
or more of these substrates. There are three substrates that are accepted by the broad 
substrate specificity racemase but not by the other racemases: Arg, Leu and Lys. The 
substrate specificity of the tvDAAO (from the two-plasmid screen) is shown in Section 
2.3.1 and shows that the oxidase accepts arginine, leucine and lysine. It was decided to 
create a variant library of enzymes and screen for activity towards Arg, Leu and Lys. 
This chapter presents the unsuccessful attempts to generate libraries of the racemase 
genes using the XL 1-Red method. The first attempt revealed the presence of small 
quantities of the plasmid encoding the broad substrate specificity racemase in the 
plasmid preparations of the other racemases. Despite this problem, the experiment still 
represented the first example of the selection of racemase activity from a small 
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proportion of a mixed racemase population and was the first validation of the screening 
methodology. The second and third attempts produced very low mutation frequencies 
and revealed a high proportion of the wild type sequence. 
2.4.1 Creation and analysis of variant library one 
2.4.1 .1 Library synthesis and screening 
The plasmids containing the narrow substrate specificity racemase genes were used to 
transform XL1-Red cells (Section 4.4.3, Method 1). The library of variants was screened 
using the two-plasmid solid phase assay (Sections 4.4.4 and 4.6.2.2). For each racemase, 
ten plates, each covered with 2-3000 colonies, were assayed using L-Arg as probe 
substrate. Eight hits were detected from the plates expressing the S. coelicolor racemase 
library and four hits were seen on the plates expressing the B. subtilis dal racemase 
library. The possible variants were re-assayed to confirm activity towards arginine and 
the substrate specificities determined. 
2.4.1.2 Variant enzyme results 
The variant genes were sequenced and it was found that the variants were not novel 
enzymes, but the broad substrate specificity racemase from P. putida. The results 
indicated that a small amount of pJLM 101 DNA was present in the pJLM20 1 and 
pJLM301 stocks. 
2.4.1.3 Conclusions 
The two-plasmid solid phase screen was used to detect contamination of the narrow 
substrate specificity racemases with a small amount of the broad substrate specificity 
racemase. Approximately 25 000 colonies were screened for each racemase. Eight 
colonies were selected from the S. coelicolor library due to their positive effect on the 
solid phase screen and were shown to be the P. putida racemase. Four hits were found in 
the B. subtilis dal library. The screen has been shown to be very powerful as it detected 
the P. putida racemase when only present in 0.016 % and 0.032 % of the colonies (for 
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the B. subtilis dal and the S. coelicolor racemases respectively). The stocks of the 
racemases were discarded as a result of the screen and new stocks prepared. 
2.4.2 Creation and analysis of variant libraries two and three 
2.4.2.1 Library synthesis and screening 
Libraries of the racemase genes were prepared using the same method as for library 1. 
The mutation rate was found by sequencing to be very low and so a third method of 
mutator strain growth was attempted as detailed in Section 4.4.3, Method 2. 
2.4.2.2 Analysis of the variant libraries 
Ten colonies from each racemase gene library (S. coelicolor and B. subtilis) were grown, 
the DNA extracted and the gene sequenced. From the ten colonies in the S. coelicolor 
library, three were seen to have one base mutation in the gene, the other seven were wild 
type racemase. For the ten colonies of the gene library from B. subtilis, only two were 
shown to have one mutation in the whole gene and the remainder were wild type. 
2.4.3 Conclusions 
The two-plasmid screen has been used to detect activity against a background of 
inactivity, by detecting the broad substrate specificity racemase when mixed in with the 
other racemases at very low concentrations. The experiment is analogous to an 
experiment where low concentrations of an enzyme with known activity are purposely 
doped with inactive enzymes and the different activities of the enzymes detected. 
The generation of variant racemase genes was not successful using the XL 1-Red mutator 
method. The mutation rate was too low to produce hit enzymes. It was shown that the 
mutation rate for the S. coelicolor racemase gene was 3 per 12 000 bp (1 per 4 000 bp). 
It was decided to use another method to introduce random mutations in the racemase 
genes. Error-prone PCR was chosen as only the gene of interest is mutated and the 
mutation frequency can be increased depending on the conditions used. 
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2. Results and Discussion 
2.5 	Successful attempt at evolving the racemase genes 
Random mutation of the racemase genes using error-prone PCR 
Error-prone PCR (epPCR) was the second method chosen to randomly mutate the 
racemase genes as using the mutator strain did not produce good quality libraries for 
screening for novel racemase activities. An introduction to epPCR and the principles 
behind the technique are presented in Section 1.3.1. 
Following variant racemase synthesis using epPCR, the racemase libraries were 
screened for novel racemase activity using Arg, Leu and Lys, and a range of variants 
were detected. The initial analysis of the variants and the attempted re-cloning to place 
the genes into a plasmid designed for enzyme purification is presented. The mutations 
were analysed using a 3D model, generated from the known structure of the S. 
lavendulae alanine racemase. The experiments to remove a mutation proposed to be 
important for the novel activity is shown to enable further evaluation of that amino acid 
role. 
2.5.1 The synthesis of a variant library of the S. coelicolor racemase gene, attempt 1 
The DiversifyTM PCR random mutagenesis kit from BD Biosciences was used to create 
racemase gene libraries according to Section 4.2.15. Three reactions were carried out 
simultaneously to introduce an average of 2.7, 4.8 and 8.1 mutations respectively per 
kbp. The epPCR products were prepared for integration into the plasmid pJLM201 
(containing the S. coelicolor racemase gene) using whole plasmid PCR, by restriction 
digestion and removal of single strand DNA termini using the Kienow fragment of DNA 
polymerase I. The procedure ensured that both strands were fully complementary to each 
other and the target vector (except for the mutated bases), a prerequisite for successful 
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whole plasmid PCR. After removal of the template DNA with DpnT, the resulting 
plasmids were used to transform E. co/i XL 1-Blue cells. After cell growth, the plasmid 
DNA was isolated to obtain the libraries of racemase genes. 
2.5.2 Analysis of the variant library of the S. coelicolor racemase gene 
To validate the library of racemase genes, a number of colonies were obtained, the 
plasmid DNA isolated and sequenced. A large number of wild type racemase sequences 
were obtained (90 %). After discussion, it was proposed that the wild type plasmid DNA 
was not efficiently removed after the whole plasmid PCR. The first possible explanation 
was that the template DNA was synthesised using E. co/i ToplO cells, which may not 
efficiently produce methylated DNA. The cells are mrr, hsdRMS and mcrBC deficient, 
which means they lack the enzymes to digest non-methylated DNA, denoted in the 
genotype A(mrr-hsdRMS-mcrBC). Therefore there is no selective pressure on the cells to 
methylate any synthesised DNA. The second explanation was that the template DNA 
used was not freshly prepared; it had been stored for a number of weeks and it was 
proposed that the DNA is gradually demethylated upon storage. The combination of 
these two factors would result in a very low concentration of methylated DNA and 
subsequent digestion with DpnJ would not remove all the template plasmid. It was 
decided to repeat the epPCR using template DNA that had been freshly prepared using 
BL21(DE3). 
2.5.3 The synthesis of a variant library of the S. coelicolor racemase gene, attempt 2 
Using the DiversifyTM PCR random mutagenesis kit, one reaction was carried out 
according to Section 4.2.15. to introduce approximately 4.8 mutations per kbp. The 
epPCR products were blunt ended and then used as primers in a whole plasmid PCR of 
pJLM201 (plasmid containing wild type S. coelicolor racemase gene). After removal of 
the template DNA, the resulting plasmids were used to transform E. co/i XL 1-Blue cells. 
After cell growth, the plasmid DNA was isolated to obtain the library of racemase genes. 
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2.5.4 Analysis of a variant library of the S. coelicolor racemase genes 
To validate the library of racemase genes, nine colonies were obtained, the plasmid 
DNA isolated and sequenced. Four out of the nine genes contained mutations, insertions 
and/or deletions, therefore 55 % of the library was wild type racemase. The alignment of 
the gene sequences is shown in Appendix 5. A summary of the mutations of the nine 
randomly chosen colonies is presented in Table 2.5.1. 
Colony Base Mutations Amino Acid Mutations 
A A46G Aspl3Gly 
C5I0T ArgI68Trp 
C578T Pro unchanged 
Al 126T Thr373Ser 
Cl 176 deleted Frame shift 
B No changes 
C G238A Ala74Thr 
A269T Pro unchanged 
T insert 619 Frame shift 
T662C No change 
D No changes 
E G65A Arg unchanged 
T372A Trpl22Arg 
G447T Glyl47Cys 
CT! IT His unchanged 
T839A Val227Asp 
C894T Thr unchanged 
F No changes 





Table 2.5.1: A summary of the base mutations from nine randomly selected colonies from the epPCR 
library. Effects on the amino acids are shown in column 3. 
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A total of sixteen base changes were found (not including the insertion or deletion), 
resulting in nine amino acid mutations. There were a total of ten transitions and six 
transversions. The average mutation rate was 4.5 per gene. The library contained a large 
number of mutations and therefore could be screened for novel activity. 
2.5.5 Screening the S. coelicolor racemase gene variant library 
The library was combined with the oxidase for the co-transformation of five aliquots of 
E. coil ToplO cells according to Section 4.4.4. The library was screened in the solid 
phase for activity against a combination of substrates, L-Arg, L-Leu and L-Lys. The 
following six control reactions were also carried out 
Negative control: 
WT racemase with L-Arg/Leu/Lys substrate mixture 
-to check that the WT racemase did not react with any of the substrates 
Positive controls: 
WT racemase with L-Arg/Leu/Lys substrate mixture, plus L-Ala 
-confirmed assay mixture prepared correctly 
WT racemase with L-Arg/LeulLys substrate mixture, plus D-Ala 
-confirmed oxidase was working 
WT racemase with L-Arg/Leu!Lys substrate mixture, plus D-Arg 
-checked that substrate mix did not inhibit oxidation of D-Arg 
WT racemase with L-Arg/Leu/Lys substrate mixture, plus D-Leu 
-checked that substrate mix did not inhibit oxidation of D-Leu 
WT racemase with L-Arg/Leu/Lys substrate mixture, plus D-Lys 
-checked that substrate mix did not inhibit oxidation of D-Lys 
The variant library was screened and a total of 101 hits were detected, an individual 
colony colouration can be seen in Figure 2.5.1a. The hits were picked from the plates, 
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re-grown, plated onto membranes and re-assayed against the L-Arg/Leu/Lys substrate 
mixture (without separation of the racemase from the oxidase), Figure 2.5.1b. 
I 
JL 2' 
Figure 2.5.1: Activity Jilts towards L-Arg. 
a) Individual hit in library screen. b) Re-screen positive activities towards L-Arg. 
Forty-two hits were detected by colour formation over the membranes within three hours 
of assay. The plasmids containing the racemase genes were isolated (the plasmid 
containing the oxidase gene was removed by digestion using restriction enzymes that are 
known not to cut the racemase plasmid, Section 4.6.2.3) and used to transform E. co/i 
ToplO cells for assay in the solution phase. At the transformation stage, three hits did 
not grow, reducing the total to thirty-nine. 
2.5.6 Solution phase screening of possible novel S. coelicolor racemases 
The CFE from each of the thirty-nine over-expressed possible racemase variants were 
assayed against a panel of L-amino acids (Ala, Arg, Leu and Lys) to determine their 
individual substrate specificities. The reactions were very slow and so the plates 
containing the assay mixtures were sealed to prevent evaporation of the assay mixture 
and to eliminate light. The plates were then incubated at 37°C and left overnight. In the 
morning the wells were examined to see which had turned pink, indicating racemisation. 
A total of thirteen hits were chosen on their ability to produce a positive result in the 
solution phase assay against the individual substrates, see Table 2.5.2. The majority of 
the variants were active with L-Arg, only one was active with Leu and Lys. 
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Substrate Variant reference 




Table 2.5.2: Successful assay reaction of individual hits with individual substrates 
2.5.7 Sequence analysis of variants displaying novel racemase activity 
The variants listed in Table 2.5.2 were investigated further by forward and reverse 
sequencing of the racemase gene. All except variant 36 were successfully sequenced. 
Repeated attempts to sequence variant 36 failed. 
The gene sequences were translated to reveal the mutated residues. An alignment of the 
twelve amino acid sequences is shown in Appendix 6. All twelve of the sequences were 
identical to eachother and contained three mutations compared to the parent racemase. 
The three mutations were 1195T, N223D and 1374N, as a result of the same base 
mutations. Therefore, the twelve variants were the same racemase picked twelve 
different times from the library. The variant that displayed activity towards all three 
substrates was also shown to be the triple mutant. Therefore the assay results were false 
for variant 69 against L-Leu and L-Lys, and a repeat of the solution phase screen of 
variant 69 confirmed that it did not have activity for L-Leu and L-Lys. From this point 
forward, these variants were treated as one and labelled triple mutant (3M). 
2.5.8 Modelling of the triple mutant racemase 
To better understand the effects of the mutations in 3M, a molecular model of the triple 
mutant was created based on the structure of a similar alanine racemase from S. 
lavendulae. An alignment of the protein sequences revealed that the S. coelicolor and the 
S. lavendulae have 72 % identity and 79 % similarity, Appendix 7. The software used 
was Acceirys Discover Studio (DS) and the PDB of the S. lavendulae used was lvft. The 
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file showed the alanine racemase crystallised structure with cycloserine, an inhibitor 
bound to the PLP cofactor. The original S. lavendulae amino acid sequence was 
subjected to individual mutations using Acceirys DS to match the S. coelicolor wild type 
sequence and the global energy of the structure minimised. The racemase exists as a 
homodimer and contains two active sites, situated at the interface of the monomers, 
Figure 2.5.2. Residues from both monomers are involved in catalysis at each active site. 
Figure 2.5.2: An a- carbon backbone of the alanine racemase dimer PDB Ivfi. The individual 
monomers are coloured blue and yellow with balls indicating C-termini. A space fill model of the PLP 
cofactor bound in the active sites is coloured green 
2.5.8.1 1195T 
The isoleucine at position 195 was identified in the model (also lie in the S. lavendulae 
racemase sequence) and mutated to threonine. The five residues either side of the S. 
lavendulae racemase corresponding 11e195 are PGHPSIRLQLD and in the 3M the 
sequence is PGHPSTAAQLT (Appendix 7). The structure was energy minimized and 
investigated. It was seen that the residue was located at the terminus of an a-helix 
approximately 15 A from the bottom of the active site (Figure 2.5.3) and approximately 
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9 A from the second N223 mutation, Figure 2.5.4. The residue was too far from the 
active site to have an easily rationalised effect on the racemase mechanism. Long range 
effects may be possible and the preceding sequence reveals that this area is almost 
identical to that of the S. lavendulae racemase. However, analysing the proceeding 
residues, only 2/5 are identical (LQLDA in S. lavendulae and AQLTR in S. coelicolor) 
implying that this region is not critical for racemase function. 
Figure 2.5.3: A snapshot of the model showing a surface map with charged regions shaded. The 
distance of the 1195Tn,ulatjon (ball and stick) from active site is labelled. The cofactor is shown in solid 
line and the entrance to the active site can be seen 
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Figure 2.5.4: A carbon backbone ribbon picture of the racemase monomer. 1195 is slzowii near the 
terminus of an a-helix 9.4 A' from the N223 residue found at the bottom of the active site 
2.5.8.2 N223D 
As shown in Figure 2.5.4, the residue 223D could be found near the bottom of the active 
site. Distance measurements using the modeling software showed that the distance from 
the arginine found directly underneath the PLP cofactor to the residue was 3 A, Figure 
2.5.5. It might be proposed that D223 could have formed a catalytic triad with 
neighbouring H183 and Y285 (the latter is the base that abstracts a proton from the 
amino acid during racemisation). However, the stereochemistry required for a catalytic 
triad is not present since it would be necessary to have the acid group of D223 pointed 
directly at the histidine proton. 
It is possible that the new acidic group of D223 interacts with the positive guanidinium 
head group of R239, so disturbing the H-bond between the latter and the nitrogen in the 
pyridinium ring of the PLP, facilitating racemisation of substrates other than alanine. In 
PLP-dependent racemase enzymes, it has been proposed that the positively charged Arg 
underneath the PLP cofactor prevents protonation of the pyridinium nitrogen (normally 
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found with other PLP-dependent enzymes). The lack of a positively charged nitrogen 
means that the negative charge formed during proton abstraction of the amino acid could 
not be stabilized through the pyridinium ring, so preventing by-product formation (see 
Introduction, Section 1.6.1 for detailed racemase mechanism). If the new acidic group 
disturbed the H-bond between R239 and the pyridinium nitrogen, an alternate racemase 
mechanism could occur, explaining the novel racemase activity. 
The sequence region containing the N223D mutation is highly conserved in alanine 
racemase enzymes, suggesting that this area has in important role in the racemase 
function, 93  (see Appendix 2 for protein sequence alignment). The area has been shown to 
support the phosphate substituent of PLP. 110  
Figure 2.5.5: A close up view of key residues in solid line formal in the active site of the alanine 
racemase. The PLP cofactor is shown and the distance to the Arg residue at the bottom of the active site 
is selected. Neighbouring residues that may form a catalytic triad are shown which include the N223D 
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2.5.8.3 1374N 
Modelling revealed that the 1374N mutation was shown to have altered the entrance to 
the active site of the racemase. The 13-Me of the Ile amino acid was shown to stick out 
and restrict the active site entrance, Figure 2.5.6a. As there is no substitution of the f3 - 
carbon in Asn, replacing Ile with Asn removed the obstruction and opened the active site, 
Figure 2.5.6b. The surface of the protein was coloured by electrostatic potential and a 
red (negative) area can be seen close to the active site entrance. The negative charge 
would attract a positive group, possibly the positively charged guanidinium group of Arg 
and the larger entrance to the active site would allow passage of the amino acid, binding 
with the PLP cofactor and racemisatjon. 
Site-directed mutagenesis carried out in 2002 on another alanine racemase from G. 
stearoihermophilus found that the C-terminus region lines one side of the active site, 
binds the phosphate group of the PLP and was proposed to control substrate 
specificity. 93  The group mutated the Tyr354 and found that the racemase accepted new 
substrates by opening the active site to allow larger amino acid side chains to enter. 
Comparing the sequence of the S. coelicolor racemase and the racemase in the paper, it 
can be seen that the Tie residue mutated here, is two residues away from the 
corresponding Tyr residue and has been shown by modelling to play a role in opening 
the active site. 
119 
Results and Discussion 
a) The presence of the lie side chain restricts the entrance to the active site 
b) Lack of the /3-Me group in 13 74N opens the entrance 
Figure 2.5.6: Solid surface maps displaying the entrance to the active site with charged regions shaded. 
The PLP cpfactor is highlighted in solid line format with the inhibitor cycloserine bound. The residue 
1374 or 13 74N is shown in solid line format around the entrance to the active site.. 
2.5.9 Removing the 1374N mutation from 3M to create a double mutant (2M) 
The 1374N mutation was proposed to be important in the evolution of the racemase 
towards arginine. To confirm the importance, it was decided to remove this mutation 
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from the gene and create the double mutant 1195T, N223D. The nucleotide change that 
resulted in the 1374N mutation was shown to occur after a Sacil restriction site in the 
racemase gene. In order to remove this mutation from the triple mutant gene, a fragment 
of the plasmid between the SacII and EcoRV sites was removed by restriction digestion 
and replaced with the identical fragment from the wild type gene, Figure 2.5.7. The 
racemase gene was then sequenced to confirm removal of the nucleotide change that 
caused the 1374N mutation. 
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Figure 2.5.7: The plasmid containing the 3M racemase gene with the restriction sites used to remove 
the 13 74N mutation labelled 
The variant 2M was assayed on the solid phase using the two-plasmid screen for L-Arg 
racemase activity. The wild type gene and the triple mutant were assayed as controls. As 
expected, there was no colour formation (indicating racemase activity) for the wild type 
racemase. The plate containing the 3M racemase went red after 30 min and the 2M 
variant turned red after 2 h incubation at room temperature. 
The assay results indicated that 2M was active towards L-Arg. The delay in colour 
formation may have been due to a lower expression of the racemase, or it may be due to 
the double mutant being less active than the 3M racemase. Any difference in reaction 
rates will be verified with purified protein in the next chapter. 
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2.5. 10 Attempts to clone the racemase genes into a vector to facilitate purification 
It was decided to over-express and purify the wild type racemase and the variants in 
order to obtain kinetic data to compare the overall change in reaction rates. In order to 
purify the racemases using a simple technique, it was decided to clone the racemase 
genes into vectors that would enable His-tagging of the expressed protein. A simple 
metal chelating column could then be used in a one-step purification. 
The vector chosen was pET1 6b as this would attach a His-tag onto the protein at the N-
terminus. It was expected that the base level expression of the racemase during growth 
previously observed with the broad substrate specificity racemase in pET1 6b would not 
be a problem due to the narrower substrate specificity of the S. coelicolor racemase. 
PCR was used to amplify the wild type racemase gene and the 3M racemase gene to 
enable insertion into the pET16b vector using the NdeI and BamHI restriction sites. The 
amplification was carried out using the same PCR conditions originally used to amplify 
the S. coelicolor racemase gene from the gDNA, Sections 4.2. 10 and 4.2.11.2. 
A PCR product was observed using the SyBr Safe DNA stain and the UV 
transilluminator, indication successful amplification. However, subsequent restriction 
digestion of the PCR products and the pETI 6b vector and ligation/transformation 
reactions were never successful. The process was repeated many times varying the 
polymerase source, the restriction digestion enzymes, the digestion time, the pET 1 6b 
source, the ligase and ligase source, the cells transformed, the antibiotics used and the 
template DNA used for amplification. None of these variables resulted in successful 
recloning of the racemase genes into the pET16b plasmid. To proceed with activity 
analysis, it was decided to continue using the racemase genes in their original vectors 
and attempt purification using a variety of separation methods. 
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2.5.11 Conclusions 
The results presented in this chapter summarise the work carried out to create a variant 
library of S. coelicolor racemase genes and the subsequent screening of that library 
Screening the library against a mixture of substrates (L-Arg, Leu and Lys) resulted in 
101 possible variants that were eventually focused to show one variant type, the triple 
mutant. Analysis of the mutations was carried out by modelling the structures and this 
work is presented in the next chapter, 2.6. 
In order to analyse the different rates at which the variants can racemise Arg and Ala, it 
was decided to purify the racemases. Unfortunately, cloning problems prevented the use 
of a simple purification system using a His-tag. In order to proceed with the purification, 
it was decided to attempt purification using different chromatographic techniques. The 
investigation of a purification route is presented in Chapter 2.7. 
The cloning problems experienced were later identified as being the result of the new 
DNA staining method introduced in the Manchester lab. SyBr Safe was used instead of 
the possible carcinogen ethidium bromide. The original manual supplied with the SyBr 
Safe does not mention any possible problems. However, the second manual supplied 
noted that SyBr Safe should not be used with the UV transilluminators as the DNA is 
degraded and difficult to recover. It was also discovered that it is very difficult to 
remove the SyBr safe from the DNA sample upon purification, causing problems with 
subsequent restriction digestion and ligation reactions. Switching to the SyBr Safe 
recommended illuminator resolved the majority of the cloning problems. However, this 
solution was realised too late for recloning to be done during these Ph.D studies. 
During the synthesis of the S. coelicolor racemase gene variant library, the synthesis of 
the dal racemase gene library from B. subtilis was carried out. The initial gene library 
synthesised using the XL 1-Red mutator method was shown to contain a high amount of 
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wild type (80 %) and very few mutations per gene (an average of 0.6 base mutations per 
gene). The epPCR technique was then used and the variant library was confirmed by 
sequencing ten random colonies. The epPCR was shown to have introduced an average 
of three mutations per gene, 40 % of the library was the wild type gene. In summary, 
using the epPCR technique to produce variant gene libraries was shown to be much 
more efficient than the XLI -Red method. The epPCR method also has the convenience 
of being faster as a library can be developed in three days (Day I, epPCR and the whole 
plasmid PCR. Day 2, transformation. Day 3, DNA library isolated), whereas the XLI-
Red method can take up to one week. 
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2. Results and Discussion 
2.6 	Attempted purification of the S. coelicolor putative racemase and 
variants 
This chapter presents the development of a purification protocol for the S. coelicolor 
wild type racemase and the 2M and 3M variants. Purification of the racemase from S. 
lavendu/ae alanine racemase, which has 72 % identity and 79 % similarity to the S. 
coelicolor racemase, was carried out using a polyHis-tag at the C-terminus.89 Using a 
similar approach was not possible here due to the problems experienced with cloning 
techniques so I decided to attempt purification using chromatography and separate the 
protein according to specific properties. The 3M variants was chosen as the candidate 
for purification as it has novel Arg racemase activity and so could be distinguished from 
the E. co/i racemases present. Fractions could be assayed for the arg racemisation 
activity using the oxidase/peroxidase screen, whereas if using the wild type racemase, 
the Ala racemase activity of the expression host would be indistinguishable from the 
protein of interest. 
The first method attempted was metal affinity chromatography. In this method, a column 
containing the chelating agent nitriloacetic acid (NTA) is incubated with a metal-
containing solution (for example Ni2 or Cu2 ) to form coordination compounds. The cell 
lysate is then passed through the column and any proteins with exposed His residues can 
bind to the metal, whilst other proteins pass through the column. The bound protein is 
then eluted by adding increasing concentrations of imidazole. It was suggested that 
although there were no additional histidines at either terminus of the racemase, the 
structure may have displayed enough histidines on the surface to bind to an affinity 
column for partial purification. 
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The second purification technique used was ammonium sulfate precipitation. The 
principle behind this technique is that solubilities of proteins vary according to the ionic 
strength of the solution they are in and this phenomenon can be used to separate proteins. 
As ionic strength increases, so does the protein solubility. However, once the maximum 
solubility is reached, increasing the ionic strength further then decreases the protein 
solubility and eventually it will precipitate. As the solubilities of individual proteins are 
different, changing ionic strength causes proteins to precipitate at different points. 
Precipitated proteins can be re-dissolved by addition of a low salt buffer. To investigate 
the precipitation of the racemase of interest, aliquots of CFE were subjected to 
increasing ammonium sulfate concentrations and the resulting supernatants and 
precipitates were assayed for racemase activity, using the oxidase/peroxidase screen. 
The second chromatographic method investigated was anionic exchange. For this 
method, the isoelectric point (p1) of the protein of interest can be used to separate it from 
proteins with different pls. The p1 is the pH at which the protein has no overall charge 
and this is dependent on the surface residues. At a pH below the p1, a protein will carry a 
net positive charge and at a pH above the p1, a protein will have a net negative charge. 
Using an online p1 prediction tool, 103 the theoretical p1 of the S. coelicolor racemase was 
proposed to be 5.78. Therefore, at pH 8.0, the protein will have an overall negative 
charge and anion exchange chromatography can be used. Proteins with no net charge 
and proteins with pis above 8 (positively charged) will not bind to an anion exchange 
column. The bound proteins are then eluted from the column by increasing the salt 
concentration, as the salt ions compete with the proteins for the charged compounds in 
the column. 
The last chromatographic technique explored was hydrophobic interaction 
chromatography (HIC), where proteins are separated according to their surface 
hydrophobicity. Each protein displays different residues on the surface and this affects 
the behaviour of the protein with a hydrophobic medium. High salt concentrations 
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promote interactions between the protein and the column, causing retention. Any protein 
that has no, or small, hydrophobic areas on the surface will pass straight through the 
column. By lowering the salt concentration, proteins can be gradually eluted as the 
hydrophobic interactions become weakened. Different HIC columns contain different 
hydrophobic mediums and so can be used for many proteins with various hydrophobic 
properties. 
After investigating the different purification methods and alternate orders of application, 
a route to partially purified racemase was developed. 
2.6.1 Metal affinity chromatography 
2.6.1 .1 Cu 2+  affinity purification 
The 3M racemase was expressed in E.coli BL21(DE3)pLysS, according to the 
conditions determined in Section 2.1.7.3. It was decided to attempt metal affinity 
chromatography using copper, as this is reported adsorb proteins displaying one surface 
histidine (Amersham Biosciences Hilrap Chelating HP instruction booklet). A cell 
pellet containing the 3M racemase, of approximately 1.3 g was lysed using the 
BugBuster protocol, Section 4.5.1. The CFE was loaded onto the prepared Cu-NTA, 
containing Buffer A (50 mM Phosphate buffer, pH 8.0, 300 mM KC1). The bound 
protein was eluted from the column using an increasing concentration of Elution buffer 
B (Buffer A + 1 M imidazole). The resulting chromatogram is shown in Figure 2.6.1. 
The total protein eluted in the main peak in Figure 2.6.1 was not very high. The fraction 
was assayed against L-Arg in the solution phase, as was the CFE and the non-binding 
proteins obtained when loading the CFE. The CFE and the non-binding proteins were 
seen to contain most of the Arg racemase activity. The Cu2 was not binding the protein 
of interest and therefore a different metal was tested. 
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Figure 2.6.1: Cu2 affinity purification of the raceniase 3M. The increasing concentration of iinidazole 
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2.6.1.2 Ni2 affinity purification 
As Cu2 for the affinity purification was not successful, the metal Ni2 was employed. 
The column and CFE were prepared as stated for the Cu2 column and the same buffers 
and conditions were used to elute any bound protein. The resulting chromatogram is 
shown in Figure 2.6.2. All fractions were assayed for the racemisation of L-Arg using 
the oxidase/peroxidase screen, the results are shown in Figure 2.6.3. It was shown that 
the majority of the racemase activity was in the CFE and the non-binding proteins and a 
small amount in fractions C2/D2/E2. 
00 	 100 	 200 	 300 	 400 	 5130 	 111 
Figure 2.6.2: Ni2 affinity purification of the racernase 3M. The increasing concentration of imidazole 
(Buffer B) is shown in green. The protein peak starts to elute at approximately 6 % B. 
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Figure 2.6.3: Assay of al/peaks obtainedfrom Ni-N TA purification for the racemisation of L-Arg. The 
CFE and non-binding proteins (LFT) are shown in the first two columns. An SDS-PAGE analysis of 
the key fractions is shown. 
From the assay, it could be seen that the majority of the racemase was eluting with the 
non-binding proteins and a small amount in the peaks B2-E2. A partial purification was 
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observed, but fractions showing racemase activity were shown to still contain many 
other proteins. As the assay of the CFE and the flow-through confirmed that the majority 
of the racemase was not binding to the column, a different purification technique was 
needed. 
2.6.2 Ammonium sulfate precipitation 
The principles of ammonium sulfate precipitation were presented at the beginning of this 
chapter. This technique was chosen to eliminate unwanted proteins from the CFE, prior 
to column chromatography. 
To determine how much ammonium sulfate was needed to separate the racemase from 
other proteins, a 2 g cell pellet containing the expressed racemase 3M, was lysed using 
the BugBuster protocol, Section 4.5.1. The CFE was divided into nine 1 ml aliquots and 
ammonium sulfate added to obtain 0, 20, 30 , 40, 50, 60, 70, 80 and 100 % saturation. 
The amount of solid ammonium sulfate added per sample was calculated using the table 
in Figure 2.6.4. Blank samples containing water in the place of CFE were also tested to 
determine if the ammonium sulfate had any positive effect on the racemase assay. 
Percentage saturation at 0 
Initial concentration 
	
20 	25 	30 	35 	40 	45 	50 	55 	60 	65 	70 	78 	80 	85 	90 	95 	100 
of anunoniutu 
	




106 134 164 194 226 258 291 326 361 398 436 476 516 559 603 650 697 
Figure 2.6.4: Amount of ammonium sulfate to be added (mg/ml or g/i) to obtain different percent 
saturations." 
Each precipitation was carried out at 4°C, whilst stirring, over 4 h. The precipitate was 
then isolated by centrifugation. The pellets and supernatants from each saturation 
percent were assayed for L-Arg racemase activity using the oxidase/peroxidase screen. 
The results of the assay can be seen in Figure 2.6.5. The supernatants and pellets were 
very difficult to separate from each other in the 80 and 100 % saturations and accounts 
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for the increased activity visible in the supernatant. The blank samples confirm that the 
ammonium sulfate does not have any positive effect on the solution phase assay. It can 
be seen that a large proportion of the racemase activity is present in the pellets at 50, 60 
and 70 % saturation. It was decided to add solid ammonium sulfate to 40 % saturation 
and discard the resulting pellet, then add solid ammonium sulfate to 70 % saturation, 
harvest the pellet and resuspend in buffer to obtain the maximum amount of racemase. 
To verify that this was the best approach, CFE containing the 3M racemase was lysed, 
subjected to a 40 % ammonium sulfate cut, followed by a 70 % cut and the two pelleted 
samples were resuspended and assayed for racemase activity towards L-Arg. The 41-
70 % saturated sample was shown to be six times more active towards L-Arg than the 0-
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Ammonium sulfate saturation 
Figure 2.6.5: The racemase activities of the supernatants, pellets and blanks measured at each percent 
ammonium sulfate saturation 
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For the ammonium sulfate saturation experiments, the 0-40 % pellet was initially 
isolated by addition of solid ammonium sulfate. However, it was decided to use 
saturated ammonium sulfate solution, to add drop-wise to the stirring CFE, to avoid 
areas of high concentrations around the solid salt that may cause unwanted precipitation. 
2.6.3 Anion exchange chromatography 
Anion exchange was the next purification method tested. The CFE containing the 3M 
racemase was prepared (Section 4.5.1) and subjected to a 0-40 % ammonium sulfate 
precipitation to remove unwanted proteins, followed by a 41-70 % precipitation to 
obtain the racemase-containing sample. The precipitated proteins were resuspended in 
Buffer A (50 mM Tris.HC1, pH 8.0, 50 mM NaCl and 50 tM PLP) and any excess 
ammonium sulfate was removed using a PD1O column (Section 4.5.3). Purification of 
the sample was then tested using a range of anion exchange columns: ResourceQ, Q 
sepharose fast flow; Q sepharose XL; DEAE sepharose fast flow; and ANX sepharose 4 
fast flow. The protein samples were applied to each of the columns and eluted according 
to Section 4.5.7.2, using Elution Buffer 50 mM Tris.HC1, pH 8.0, 50 mM NaCl and 50 
tM PLP, 1 M NaCl. 
The ResourceQ (ResQ) column provided the best separation of the peak (Figure 2.6.6, 
peak 3, eluted at 18 mS/cm) that displayed racemase activity towards L-Arg. Colour 
formation in assay solution without substrate was also measured and subtracted from the 
L-Arg racemase data. A plot of the chromatogram and an SDS-PAGE analysis of peak 3 
are shown in Figure 2.6.6. A partial purification of the racemase was successful. 
However, it is unknown which of the bands in the 41 kDa area of the gel correspond to 
the racemase. It was decided to attempt a second column to purify the racemase further. 
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Figure 2.6.6: The ResQ separation ofproteins contained in the 41-70 % precipitate of the racemase 
CFE. Peak 3 eluted at 18 mS/cm and was shown to contain L-Arg racemase activity. An SDS-PAGE 
analysis of the fractions in peak 3 is shown. The Load is the protein sample prior to ResQ purification 
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2.6.4 Hydrophobic interaction chromatography 
Hydrophobic interaction chromatography (HIC) relies on protein binding to a 
hydrophobic medium in a high salt solution. It is a technique ideal for following an 
ammonium sulfate precipitation as the sample can be applied to the column without the 
need for desalting. A range of columns were tested for the purification of the racemase: 
Phenyl FF (high and low sub); Phenyl HP; Butyl FF, Butyl-S FF; and Octyl FF. The 
Phenyl HP gave the best separation of the peaks displaying racemase activity and was 
investigated for further separations. 
The CFE containing the 3M racemase was prepared (Section 4.5.1) and subjected to a 
41-70 % ammonium sulfate precipitation to obtain the racemase-containing sample. The 
precipitated proteins were resuspended in Buffer A (50 mM Tris.HCI, pH 8.0, 50 mM 
NaCl, I M (NH4)2SO4  and 50 iM PLP), loaded onto the column and eluted with an 
increasing concentration of Elution buffer 50 mM Tris.HC1, pH 8.0, 50 mM NaCl and 
50 jiM PLP, (decreasing salt concentration). The elution gradient was performed step-
wise starting with 100 % Buffer A, then 60 %, 30 %, 10 %, 1 % and 0 %. The 
chromatogram can be seen in Figure 2.6.7. The CFE, non-binding proteins and fractions 
from each of the four peaks were assayed for L-Arg racemase activity. Colour formation 
in assay solution without substrate was also measured and subtracted from the L-Arg 
racemase data. Peak 2 was shown contain active racemase. The fractions were 
concentrated using a 50 kDa MWCO concentrator to aid purification and remove any 
excess ammonium sulfate, washed three times with 5 ml Elution buffer, to obtain a final 
volume of 2 ml. 
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Figure 2.6.7: a) The separation ofproteins using HIC. Peak 2 was shown to contain the L-Arg racemase 
activity and b) the fractions were analysed by SDS-PA GE and concentrated 
136 
chromatogram can be seen in Figure 2.6.8. 
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2.6.5 Anionic exchange chromatography after HIC 
The partially purified racemase sample from Section 2.6.4 was applied to the ResQ 
column using the buffers and conditions reported in Section 2.6.3. The racemase-
containing peak was eluted with a step-wise gradient of increasing NaCl concentration. 
The racemase fraction was eluted at 10 % Elution buffer (12 mS/cm). The 
}- F;:!h4iL.4I...l:- ,.•L 
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Figure 2.6.8: Protein separation using anionic interaction chromatography after ammonium sulfate 
fractionation and HIC. Peak displaying racemase activity is shown 
All fractions corresponding to peaks were collected, concentrated to 0.5 ml and assayed 
for L-Arg racemase activity. Colour formation in assay solution without substrate was 
also measured and subtracted from the L-Arg racemase data. The racemase-containing 
peak was shown to elute at 10 % elution buffer with a conductivity of 12 mS/cm. 
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The activities of 50 p.1 sample aliquots of the racemase-containing peaks after the HIC 
and the ResQ purifications were shown to be 5.9 and 1.1 mOD/min respectively. 
However, the total volumes of the samples were 4 and 0.5 ml; therefore the total 
activities per sample were 236 and 11 mOD/min after the HIC and the ResQ steps 
respectively. Much racemase activity is lost during the ResQ purification (little activity 
was seen in the other peaks). The gradual loss of activity was observed throughout all 
trial purifications. Initially, racemase activity could be observed in the CFE using the 
solution phase assay within 30 mm. However, after the first column purification the 
activity was not visible until assay for a few hours and fractions from the second column 
were assayed overnight in order to see racemase activity. Samples of the CFE, the 
ammonium sulfate precipitation, the concentrated racemase-containing fractions from 
the HIC and the concentrated racemase-containing fractions from the ResQ were 
analysed by SDS-PAGE and can be seen in Figure 2.6.9. 
Figure 2.6.9: SDS-PA GE analysis of the pur?flcation  of the triple mutant racemase (41 kDa) 
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2.6.6 Conclusions 
The purification process as adopted for the racemase appears to slowly render the 
enzyme inactive. After the purification steps presented so far (ammonium sulfate 
precipitation, HIC and anionic exchange chromatography), the total racemase activity in 
the sample was 11 mOD/mm, compared with 236 mOD/min after the HIC and 2045 
mOD/min in the CFE. Comparing the purity of the racemase using the SDS-PAGE 
analysis in Figure 2.6.9, it was seen that there were many unwanted proteins present; the 
loss of activity after the HIC and ResQ separation did not correspond to a substantial 
purification of the racemase as desired. 
It was decided to partially purify the wild type racemase, the 2M and the 3M racemases 
using the ammonium sulfate precipitation and the HIC and then determine the substrate 
specificities for each. Each racemase would be expressed under exactly the same 
conditions, the same mass of cell pellets would be purified and the total protein present 
in the final samples would be determined. Analysis by SDS-PAGE would confirm the 
ratios of proteins present and allow some comparison of the substrate specificity data. 
Due to time constraints it was not possible to investigate a new purification route, one of 
the major problems with the method was that the racemase was not over-expressed well 
enough in the E. co/i BL21(DE3)pLysS cells to see a large excess of the racemase by 
SDS-PAGE analysis. The expression of the 3M racemase was attempted in E. co/i 
BL21(DE3) but was unsuccessful as there appeared to be less racemase activity than 
when using E. co/i BL2 1 (DE3)pLysS. Ideally, the genes would be cloned into different 
vectors that allow better expression and more efficient purification by affinity 
chromatography, such as metal affinity using a polyhis-tag. Using this method, the 
racemases could be purified more rapidly and avoid the loss of activity observed in the 
current route. The screen has been successfully employed to determine a purification 
route for the racemases. It was possible to assay fractions from each step of the 
purification for L-Arg racemase activity. 
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2. Results and Discussion 
2.7 	Partial purification and substrate specificity determination of the 
wild type racemase and variants 
In Chapter 2.6, a route to the partially purified wild type racemase, the double and the 
triple mutant racemases was explored. The CFE was prepared using BugBuster, an 
ammonium sulfate precipitation was employed, followed by HIC. It was decided to 
determine the substrate specificities of each using the partially purified preparations and 
the data is presented here. It is shown that compared to the wild type racemase, the only 
other amino acid that the double and the triple mutant racemases had novel activity 
towards was L-Arg, whilst the activity towards the wild type substrate L-Ala decreases. 
A 6 g wet cell weight pellet grown and harvested according to the conditions described 
in Section 2.1.7.3, was used for the purification of the wild type racemase from S. 
coelicolor, the double mutant and the triple mutant racemases. To measure and compare 
the substrate specificity of the host E. co/i racemases, vector without racemase gene 
(pTTQ18) was also used to transform E. co/i BL21(DE3)pLysS and a 6 g cell pellet was 
obtained using the identical expression protocol. The cell free extract from each of the 
cell pellets was obtained using BugBuster with added lysonase, protease inhibitor 
cocktail and PMSF (Section 4.5.1.2). 
The CFEs were subjected to an ammonium sulfate precipitation using a saturated 
ammonium sulfate solution (Section 4.5.1). The precipitated proteins were resuspended 
in Buffer A (50 mM Tris.HC1, pH 8.0, 50 mM NaCl, 1 M (NH4)2SO4 and 50 tM PLP), 
filtered and loaded onto the Phenyl HP column pre-equilibrated with the same buffer. 
The non-binding proteins were removed with 40 % Elution buffer (50 mM Tris.HC1, pH 
8.0, 50 mM NaCl and 50 tM PLP). The racemase-containing proteins were eluted with 
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70 % Elution buffer, combined and concentrated using a 50 kDa MWCO concentrator to 
approximately 1 ml. The sample was washed three times on the concentrator with 5 ml 
Elution buffer and the resulting 1 ml sample was diluted to 3.5 ml using the Elution 
buffer. At this stage, samples were removed and diluted 1:10 to enable protein 
concentration determination using the BCA assay kit (Section 4.5.6). The results are 
shown in Table 2.7.1. 
Partially purified sample Protein concentration mg/ml 
E. co/i host only 4.4 
Wild type S. coelicolor racemase 3.7 
Double mutant 4.8 
Triple mutant 5.7 
i arne 1.1.1: rroiein concentrations of the partially purfled samples 
The samples were analysed by SDS-PAGE to visually compare the protein content in 
each, Figure 2.7.1. In the samples containing expressed racemase (not the E. coil 
sample), are the same proteins expressed in similar ratios. Due to the increasing band 
strength, it can be seen that total protein concentration increases from the WT to the 
triple mutant, as recorded in Table 2.7.1. The E. co/i host sample contains almost exactly 
the same proteins in the same ratios as the other samples, except for a more heavy 
protein band at approximately 47.5 kDa. This band does not correspond to either of the 










Protein of interest = 42 kDa 
Figure 2.7.1: SDS-PAGE analysis of the samples used to determine the substrate specificities of the 
racemases. E. coli refers to the expression host, WT is the S. coelicolor wild type racemase, 2M refers to 
the double mutant, 3M refers to the triple mutant 
The partially purified racemases were then assayed using the oxidase/peroxidase screen 
against a panel of L-amino acids to determine their substrate specificities, 50 l was used 
to assay each substrate. The assays were performed in triplicate, with blank assays run 
containing water instead of the racemase preparation. The latter was measured to 
subtract any colour formation resulting from reaction of the oxidase or the HRP with the 
assay mixture. The triplicate measurements were averaged and the blank/water data 
subtracted. The maximum rates of colour formation were then determined per j.tg protein. 
The data is presented in Figure 2.7.2. 
It is observed that as the substrate specificity of the racemases is broadened to accept 
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been seen in the evolution of other enzymes towards novel substrates, for example the 
evolution of a monoamine oxidase towards a-methylbenzylamine that as the substrate 
specificity is broadened, the activity towards the wild type substrate decreases.'°  
Arginine is much larger than alanine, see Figure 2.7.3, and as the enzyme has been 
evolved towards the larger substrate, the specificity for alanine has decreased. 2-ABA is 
one carbon larger than alanine, Figure 2.7.3, and the specificity for this substrate has 
increased. It is possible that either (or both) of the 1195T and N223D mutations have 
created an opening in the active site in the region where the side chains of the amino 
acids bind. 
Substrate specificity 
Activity per ug protein 
Ala ABA Arg Asn Asp Glu Gin His lie Lou Lys Met Orn Phe Pro Ser Trp Tyr Val 
Figure 2.7.2: The substrate specJicities of the E. coil racernase, the wild type S. coelicolor racemase 
and the double (2M) and triple (3M) variants 
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2-ABA 	 Alanine 
Figure 2.7.3: Structures of Arg, 2-ABA and Ala 
From the substrate specificity data presented in Figure 2.7.2, it can be seen that the only 
substrate that the variants have novel activity for is arginine. The activities of the E. coli 
racemase and the wild type S. coelicolor racemase for arginine were found to be 0.003 
and 0.002 mOD/minIig respectively. The activity of the double mutant towards arginine 
was 0.017 mOD/min/pg and for the triple mutant, 0.151 mOD/min/tg. The double 
mutant is ten times more active towards arginine than the wild type and almost ten times 
less active than the 3M. The data implies that the triple variant contains a mutation that 
is important for racemase activity, 1374N. However, the double mutant does have some 
increased activity towards arginine, implying that either or both of the mutations N222D 
and 1195T aid racemisation of the novel substrate. 
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2. Results and Discussion 
2.8 	Conclusions and Future Work 
The current project has developed a new high-throughput screen that can be applied to 
many different classes of enzymes. This is similar to the biosynthetic tree screening 
model proposed by Sutherland .60 The screen relies on the in vivo production of an 
enantioselective compound by the enzyme of interest, which is then a substrate for an 
enantioselective FAD-dependent oxidase, also expressed in vivo. 
Amino acid racemases were chosen as candidate enzymes to study the two-plasmid 
screen as they have a covalently bound cofactor and they do not require any additional 
substrates for enzyme action. Using amino acid racemases also tested the 
enantioselective part of the screen, since if the oxidase was not able to distinguish well 
between enantiomers many false positive results would have been generated. Three 
amino acid racemase genes were isolated from gDNA and cloned into vectors for 
subsequent enzyme analysis. The racemase from S. coelicolor is documented in genomic 
research sites as putative. The work carried out here into the substrate specificity of this 
racemase is the first carried out according to the current literature and it can now be 
claimed that this gene encodes a racemase for which alanine appears to be the best 
substrate. 
Once amino acid racemase libraries were successfully generated, the first round of 
screening of the S. coelicolor racemase library identified enzymes with possible novel 
activity towards arginine. Subsequent, more detailed analysis of the variant activity 
confirmed that the novel screen had identified an alanine racemase that accepted 
arginine as a substrate. Comparison with the literature revealed that the 1374N mutation 
was in the same region as a previously published study that had shown that site-directed 
mutagenesis of a neighbouring residue increased the substrate specificity. 93  The 
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published work had not mutated the racemase to be active towards arginine. However, 
the work carried out here introduced a residue that opened the entrance to the active site 
to allow larger amino acids entry. 
The work carried out in this project showed that the two-plasmid screening system could 
be used to analyse variant enzyme libraries and detect novel activity from a background 
of inactivity. 
The two-plasmid screen is versatile and could now be developed for a range of enzyme 
screening projects. Future work could see competent cells made containing the second 
plasmid with the D-amino acid oxidase gene. When a reaction of interest produces a D-
amino acid, the genes to be screened can be cloned and used to transform the competent 
cells. It would also be possible to screen for enzymes that produced L-amino acids as 
broad substrate L-amino acid oxidases have been discovered. 1  1  2 If the reaction of 
interest produces an amine, the enantio selective amine oxidase developed by Turner and 
co-workers could be used, again stored in competent cells on a plasmid.1° Thus a whole 
screening system based on FAD-dependent oxidases could be made available when 
screening for reactions that create simple organic molecules. 
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3. Materials 
3.1 Materials for Microbiology 
3. 1.1 LB Medium 
Per litre: Tryptone 10 g, Yeast Extract 5 g, NaCl 10 g. Sterilise by autoclaving, 121°C 
for 20 mm 
3.1.2 LB/agar Medium 
Per litre: Tryptone 10 g, Yeast Extract 5 g, NaCl 10 g, Agar 15 g. Sterilise by 
autoclaving, 121°C for 20 mm 
3.1.3 soc Medium 
Per litre: Yeast extract 0.5 % w/v, Tryptone 2.0 % w/v, NaCl 10 mM, KC1 2.5 mM, 
MgC12 10 mM, MgSO4 10 mM, Glucose 20 mM. Sterilise by autoclaving, 12 1°C for 20 
mm 
3.1.4 Antibiotic Stock Solutions 
Ampicillin 	50 mg/ml dH20 
Chloramphenicol 	34 mg/ml EtOH 
Kanamycin 	50 mg/ml dH20 
Sterilise by 0.2 tM filtration. Stock solutions are 1000 times the working concentrations. 
3.1.5 IPTG Stock Solution 
IPTG 	 1 M in dH20 
Sterilise by 0.2 tM filtration. 
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3.1.6 Spheroplast Preparation Buffer 
Sucrose 20 mM in dH20, Lysozyme to a final concentration 0.2 mg/ml 
3.2 Materials for Molecular Biology 
3.2.1 Bacterial Resuspension /Lysis Buffer —Genomic DNA extraction 
Na2EDTA.2H20 1.861 g, Tris Base 0.606 g, Dissolve in 80 ml dH2O. Add 10 % Tween-
20 5 ml, 10 % Triton X-100 5 ml. pH to 8.0 with HC1. Final volume to 100 ml with 
dH2O. Sterilise by 0.2 iM filtration. 
3.2.2 Bacterial Deproteinisation Buffer —Genomic DNA extraction 
Guanidine HC1 28.659 g dissolved in 70 ml dH20, added 100 % Tween-20 20 ml and 
made up to a final volume of 100 ml with dH20 and sterilised by 0.2 tM filtration. 
3.2.3 Agarose Gel Sample Loading Sample Buffer 
Glycerol 30 % (v/v), EDTA 20 mM, Bromophenol blue 0.2 % (w/v) 
3.2.4 TAE (Tris acetate EDTA buffer) 50x 
Tris base 242g, acetic acid 57.1ml, 0.5M EDTA pH 8.0 lOOml 
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3.3 Materials for Protein Purification 
3.3.1 Phosphate buffer 
A 1 M solution of the dibasic KH2PO4 was prepared. A I M solution of the monobasic 
K2HPO4 was prepared. For pH 8.0, 94 ml of the monobasic solution was mixed with 6 
ml of the dibasic solution. For pH 7.0, 61.5 ml of the monobasic solution was mixed 
with 38.5 ml of the dibasic solution. 
3.3.2 Ammonium Sulfate Precipitation 
A saturated ammonium sulfate solution was made by adding solid ammonium sulfate to 
water until no more dissolved. 
3.3.3 Cu and Ni Affinity Chromatography 
Activating metal solutions: 0.1 M CuSO4, 0.1 M Ni504 
Binding Buffer: pH 8.0 50 mM Phosphate buffer, 300 mM KC1 
Elution Buffer: pH 8.0 50 mM Phosphate buffer, 300 mM KC1, 1 M Imidazole 
Column Stripping Buffer: 0.5 M EDTA 
3.3.4 Anion Exchange Chromatography 
Start Buffer: 20 mM Phosphate buffer, pH 8.0, or pH 7.0 
Elution Buffer: 20mM Phosphate buffer, pH 8.0 or pH 7. 0, 1M NaC1 
Following optimisation 
Start Buffer: 50 mM Tris-I-TC1, pH 8.0, 50 mM NaCl, 50 tM PLP. 
Elution Buffer: As start buffer, +1 M NaC1 
3.3.5 Hydrophobic Interaction Chromatography 
Start Buffer: 20 mM Phosphate buffer, 50 jiM PLP, pH 7.0 or 8.0, 1 M Ammonium 
sulfate 
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Elution Buffer: 20 mM Phosphate buffer, 50 jiM PLP, pH 7.0, or pH 8.0 
Following optimisation 
Start Buffer: 50 mM Tris-HC1 buffer, 50 jiM PLP, pH 8.0, 1 M Ammonium sulfate 
Elution Buffer: 50 mM Tris-HC1, pH 8.0, 50 mM NaCl, 50 jiM PLP 
3.3.6 SDS PAGE Running Buffer 
Tris/HC1 pH 8.3 50 mM, Glycine 380 mM, SDS 2 % (w/v) 
3.3.7 Protein gel sample loading buffer 
150 mM Tris.HC1 pH 6.8, SDS 1 % (w/v), Glycerol 50 % (v/v), Bromophenol blue 
0.01 % (w/v), or Laemmli Sample Buffer (BioRad, 161-0737) 
3.3.8 Western Blotting Buffer 
10 mM 3-(cyclohexylamino)-1-propane sulfonic acid (CAPS) pH 11, 10 % v/v methanol. 
3.3.9 Coomassie blue staining solution 
Ethanol 50 %, acetic acid 10 %, Coomassie blue R250 0.2 % (w/v) 
3.3.10 De-staining solution 
Ethanol 25 %, acetic acid 10 % 
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4. Experimental 
4.1 Identifying alternative racemases 
The sequence of the P. putida putative gene was obtained from www.tigr.org. A BLAST 
search was carried out using this as the query sequence on all gDNA stocks held in the 
group. The search matrix used was the default BLOSUM62. Sequences returned by the 
program were given an expected, or E-, value providing a measure of the significance of 
an alignment. This statistical value reveals how closely matching the query sequence is 
to the returned sequence. Results returned with E values less than 0.01 were examined, 
as these sequences were unlikely to be related by chance alone. 
4.2 DNA Analysis and Manipulation 
4.2.1 Horizontal agarose gel electrophoresis 
Ix TAE agarose was heated until the agarose was completely dissolved. It was cooled to 
approximately 45°C before the addition of ethidium bromide, final concentration 
approximately 50 jig/L (or SYBR® Safe stain, Invitrogen), and allowed to set. DNA 
samples containing loading buffer were loaded into the wells alongside a DNA 
molecular weight marker. The gel was run at 100 V and visualised with UV radiation on 
a trans-illuminator. 
4.2.2 Purification of DNA fragments using gel electrophoresis 
Bands were cut under UV radiation from the gel rapidly to avoid over-exposure of the 
DNA. Bands were purified using the QlAquick gel extraction kit (QIAGEN) according 
to the manufacturer's protocol. 
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4.2.3 Purification of genomic DNA 
50 ml cultures of P. putida ATCC47064 at approx 0D600 2 were harvested at 6 000 rpm, 
15 min and subjected to DNA purification using the QIAGEN blood and cell culture 
DNA extraction kit. Eluted DNA was stored at —20°C. 
4.2.4 Purification of plasmid DNA 
3-5ml bacterial cultures were harvested and the plasmid DNA extracted using the 
Qiagen QlAprep spin miniprep kits. Eluted DNA was stored at —20°C. 
4.2.5 DNA Quantification 
DNA concentrations were determined by spectroscopy (Eppendorf BioSpectrometer) at 
a wavelength of 260 nm. Purity was assayed on the basis of the A260/A280 ratio, where a 
value of approximately 1.8 corresponds to pure dsDNA. 
4.2.6 Restriction endonuclease digestion of DNA 
All enzymes used were purchased from New England Biolabs Inc. (NEB) and were 
purchased with the appropriate buffer (1 Ox concentrate). Digests were carried out at 
37°C for a minimum of 1 h, maximum of 4 h, or overnight at room temperature. Double 
digests were performed in the appropriate buffer as recommended by NEB, table 4.5. 
Enzymes in digest 	 Buffer Recommended 
NdeI, BamHI 	 BamHI 
EcoRI, Ban'iHI 	 EcoRI 
Spe!, HindIII 	 Buffer 2 
Hindu!, EcoRI 	 EcoRl 
Table 4.5: Buffers for double digests 
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4.2.7 Vectors used 
The following vectors were used for cloning: pET16b, pTTQ18, and pINGE2. All were 
already held in the laboratory by colleagues. pINGE2 was obtained from Ingenza Ltd 
and is a modified version ofpTTQl8, containing a second multiple cloning site. 
4.2.8 Dephosphorylation of plasmid DNA 5' termini 
To reduce the possibility of vector re-ligation, shrimp alkaline phosphatase (SAP) from 
Promega was used to dephosphorylate the 5' termini of all vectors after digest. Reaction 
buffer was supplied 1 Ox concentrate. Reactions were performed, according to the 
protocol supplied, at 37°C for 15 min followed by heat-inactivation of the phosphatase 
at 65°C for 15 mm. The reaction mixture was cleaned using the Qlagen PCR Cleanup 
kit. 
4.2.9 DNA Ligation 
Trial ligations were carried out and the optimum vector:insert ratio found for a 1.2 kbp 
insert and a 6 kbp vector was found to be 3:1. All subsequent ligations were performed 
with a vector: insert ratio of approximately 3:1. Total reaction volumes varied between 
10-20 tl according to DNA concentrations. T4 DNA ligase from NEB was used, 
supplied with reaction buffer (I Ox concentrate). Ligations were left at room temperature 
for a minimum of 1 h before use in transformations. 
4.2. 10 Oligonucleotides for Racemase cloning 
Primers to amplify the desired gene sequences were designed and ordered from Thermo 
Electron® and Sigma Genosys®. Sequences shown in tables 4.1-4 
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For Vector Cleavage site Sequence 5'- 	3' 
pET I 6b NdeI GCT CTA GAC ATA TGC CCT TTC GCC GTA CCC TTC TGG 
pETI 6b BamHI ATA GGA TCC ATC ATC AGT CGA CGA GTA TCT TCG GG 
pTTQ 18 EcoRl GAC CCC GTT ATG AAT TCT ATG CCC TTT CGC CGT ACC 
pTTQ 18 BaniHI Same as for vector pETI6b 
pINGE2 Spel GCT TAT CTA GAC TAG TCC CTT TCG CCG TAG GGT TCT GG 
pINGE2 HindIII CGG AAG CTT GAT GAG TCG ACG AGT ATG TTC GGG TTG G 
Table 4. / :Primerstbr cloning P.putida putative racemase gene 
For Vector Cleavage site Sequence 5' 4 3' 
pTTQ 18 	EcoRl 
	
GGT TAT CTA GGA ATT GGA TAA AGC TTT GGG GAG AAG 
TG 
pTTQ I 8 	BamHI 	ATC GGA TCG TGA TGA CTA GAG GTA TAA TAG TGG AG 
Table 4.2: Primers for cloning B. subtilis air gene 
For Vector Cleavage site Sequence 5' -* 3' 
pTTQ 18 	EcoRl 
	
GCT TAT GTA GGA ATT GGA GGA CAA AAG CTT TT TAG AGA 
GAT ACG 
pTTQ 18 	BamHI 	ATA GGA TGG TGA TGA TTA ATl Gd FAT All LAG ClU C 
Table 4.3: Primers for cloning B. subtilis dal gene 
For Vector Cleavage site Sequence 5' 4 3' 
pTTQ 18 	EcoRI 
	
GCT TAT GTA GGA ATT GGA GGG AGA CAA GTG GGG GGG 
GG 
pTTQ 18 	BarnHI 	ATA GGA TCG TCA TCA 'FIG Gil (JAG UTA (JAG (JGU CUU 
Table 4.4: Primers for cloning S. coeiicolor air gene 
4.2.11 Polymerase Chain Reaction (PCR) 
PCR was used to isolate the racemase genes from their respective genomic DNA 
sources. The Pfu Turbo® Hotstart polymerase from Stratagene® was used for all 
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reactions. Deoxynucleoside triphosphates (dNTP's) were supplied from Sigma® 
containing 10 mM of each of the four deoxynucleotides, recommended amount 1 p1 per 
50 p1 reaction volume. 
4.2.11.1 PCR of putative racemase gene from P. putida 
PCR reagents: 
Template DNA 40 ng 
Primer forw (10 tM) 3 p1 
Primer rev (10 tM) 3 	t1 
dNTPs 3 p1 
Reaction buffer (I Ox) 5 pd 
Pfu Turbo® Hotstart polymerase 1 	j.tl 
DMSO 5p1 
dH20 to 50 p1 
The reaction mixture was prepared on ice and the polymerase was added immediately 
before the PCR tube was transferred to the PCR machine. From a large PCR screen the 
following program was successful: 
(1)95°C 	 10mm 
95°C 	 2mm 
50°C 	 1 min 30 
72°C 	 2 min 30 
Go to (2) rpt x30 
72°C 	 10 mm 
6°C 	 Hold 
Results analysed by horizontal agarose gel electrophoresis, 4.2.1. (During PCR screen 
annealing temps of 50< and <60 produced bands of correct size) 
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4.2.11.2 PCR of putative alanine racemase from S. coelicolor 
A screen of different concentrations of dNTP's/DNA/primers over a range of annealing 
temperatures resulted in identical reagents and conditions needed for amplification as 
those in section 4.2.7.2. 
4.2.11.3 PCR of dal gene from B. subtilis 
Initial PCR reactions were carried using colonies of B. subtilis, but was unsuccessful. 
Genomic DNA was prepared and PCR was succesful. 
Template DNA 	 40 ng 
Primer forw (10 M) 	 3 ! 
Primer rev (10 j.tM) 	 3 il 
dNTPs 	 2 t1 
Reaction buffer (1 Ox) 	 5 p.1 
Pfu Turbo® Hotstart polymerase 	1 p.1 
DMSO 	 2.5 p.1 
dH20 	 to 50 p.1 
The same programme used was identical to that in section 4.7.2.2. 
4.2.12 Creation of plasmids pJLM1O1, pJLM201 and pJLM301 
The amplified P. pulida racemase gene (1.2 kbp) was inserted into pINGE2 using Spel 
and HindIII restriction sites to create pJLM1O1, (6.0 kbp). The amplified S. coelicolor 
putative racemase air gene (1.2 kbp) was inserted into pTTQ 18 using EcoRI and BamHI 
restriction sites to create pJLM201 (5.7 kbp). The B. subtilis alanine racemase dal gene 
(1.2 kbp) was inserted into pTTQ18 using EcoRI and BamHI cloning sites to create 
pJLM301 (5.7 kbp). 
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4.2.13 Sequencing PCR ofpJLM101, pJLM201, and pJLM301 
Sequencing primers (Sigma) were designed to align with the DNA sequence prior to the 
gene start sequence, then at approximately 300bp, 600 bp, and 900 bp from the start. The 
length of the sequence results allowed sufficient overlap to align. Reverse primers were 
also designed to copy the complementary strand at the same positions. 
Vector Annealing position Sequence 5'4 3' 
pJLM 101 Prior to start GGCCTTCTGCAGTTCTGGCA 
pJLMIOI 300 bp TGCCCTGCGTGGCGGTGGC 
pJLMIOI 600 bp CAAGCTGGTCGCGCTGATGAC 
pJLMIOI 900 bp CCGTGGGCTATGACCGCACC 
pJLMIOI 900 bp (redesigned) CCGTCGGTTACGACCGCACC 
pJLM20 I Prior to start GTTGACAATTAATCATCGGC 
pJLM20I 300 bp TCATGTGCTGGCTGTGGACGC 
pJLM20I 600 bp CGGGAGATGACGGCCTACGC 
pJLM201 900 bp GCTCGGCTACGCGGACGGCA 
pJLM30I Prior to start GTTGACAATTAATCATCGGC 
pJLM30I 300 bp GGCAATCGCTGCTGAGTATGACG 
pJLM30I 600 bp CCGCTGCCGTTAAAGAATCTAATGGTCC 
pJLM301 900 bp GGGAAAACGCCTGAAAATTGCCG 
Plasmid DNA was prepared using E.coli Top 10 cells, section 4.2.4. The reagents were 
prepared in a 0.2 ml PCR tube: 
ABI Prism BigDye Terminator v3. 1 Ready reaction mix 2 p1 
Sequencing primer (1 pmol/p1) 	 3.2 p1 
Template DNA 	 150-300 ng 
dH2O 
	 up to 10 p1 
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PCR Programme: 
95°C 1 mm 
96°C 30s 
50°C 330 s 
60°C 4 mm 
Go to (2) rpt x30 
72°C 10 mm 
6°C Hold 
Samples were then taken to the SBS Sequencing Service, Ashworth Laboratories, at the 
University of Edinburgh. 
4.2.14 Creation of Low Copy Number Oxidase Plasmids 
4.2.14.1 PCR of pPOT3 heat inducible promoter 
Forward (5' CGCCACTAGTACCTTGCCGATCAGCCAAACG) and reverse (5' 
GGCCTGCAGGGGATCTTCAGTCAGTCAGC) primers were purchased from Sigma 
Genosys to amplify the heat inducible promoter from pPOT3 and introduce SpeT and 
Ps/I restriction sites (respectively, underlined) for cloning. The PCR was carried out as 
follows: 
Template DNA 40 ng 
Primer forw (10 	M) 3 jil 
Primer rev (10 jiM) 3 jil 
dNTPs 1 jil 
Reaction buffer (1 Ox) 5 jil 
Pfu Turbo® Hotstart polymerase 1 jil 
dH20 to 50 jil 
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PCR programme: 
95°C 10 min  
95°C 1 min 30 
50°C 1 min 30 
72°C 1 min 30 
Go to (2) rpt x30 
72°C 10 mm 
6°C Hold 
4.2.14.2 Creation ofpJLM4Ol 
The PCR product (approximately 900 bp) was gel purified and digested with SpeI and 
PstI. The vector pTrp200 was digested with the same enzymes and dephosphorylated. 
Ligation and subsequent transformation into ToplO cells produced colonies that were 
grown in 10 ml LB/Kan. DNA isolation and digest using SpeT and Ps/I confirmed the 
creation of pJLM40 1. 
4.2.14.3 Creation of pJLM402 
The D-amino acid oxidase gene from T. variablis was donated by Ingenza in the plasmid 
pPOT3(DAAO). The primers used for oxidase amplification were also obtained from 
Ingenza and the PCR was carried out as follows: 
Template DNA 40 ng 
Primer forw (10 jiM) 3 jil 
Primer rev (10 jtM)  
dNTPs  
Reaction buffer (1 Ox) 5 p.1 
Pfu Turbo® Hotstart polymerase 1 p.l 
dH20 to 50 p.1 
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PCR programme: 
95°C 10 min  
95°C 1 mm 
50°C 1 min 30 
72°C 1 min 30 
Goto(2)rptx3o 
72°C 10 min  
6°C Hold 
The resulting PCR band was purified by excising from an agarose gel after 
electrophoresis. The insert and pJLM401 were digested using BamHI and PstI. 
pJLM40I was dephosphorylated. Ligation and transformation into ToplO cells afforded 
colonies that were grown in 10 ml LB/Kan. DNA isolation and digest using BamHI and 
PstI, and sequencing confirmed the creation of pJLM402. 
The primers used for sequencing were purchased from Sigma Genosys, 
BamHI site prior to oxidase gene: ACGCAAGTTCTTAAGAAGGAGATATAC 
Sequencing carried out as detailed in section 4.2.13. 
4.2.14.4 From pGL12 to pJLM501 using Quikchange 
The heat inducible promoter and oxidase gene were excised from pJLM402 as one 
length of DNA and placed into pTrp338 by Ingenza to create a low copy vector 
containing the oxidase. 
To remove one BamHI site from pGL12 to enable removal of the amino acid oxidase 
gene and replacement with any other gene using the other BamHI site, the following 
primers were purchased from Sigma: 
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Forward GAGCTCGGTACCCGGCCATCCTTGAGGAAATACTTACCC and reverse 
GGGTAAGTATTTCCTCAAGGATGGCCGGGTACCGAGCTC The Quikchange 
PCR reagents were mixed as follows, as described by the Stratagene Quikchange manual. 
Template DNA 40 ng 
Primer forw (final 125 ng) 10.5 p1 
Primer rev (final 125 ng) 10.5 	tl 
dNTPs 1 p1 
Reaction buffer (1 Ox) 5 il 
Pfu Turbo® Hotstart polymerase I 	jtl 
dH20 to 50 p1 
PCR programme: 
(1)95°C 	 30s 
95°C 	 30s 
55°C 	 1 mm 
68°C 	 7mm 
Goto(2)rptxl8 
68°C 	 10 min  
6°C 	 Hold 
DpnI restriction enzyme (1 p1) was added to the crude PCR product, the reaction was 
mixed by gentle pipetting and spun for 1 min at maximum speed in a micro-centrifuge. 
The digestion of methylated DNA was allowed to proceed at 37°C, 200 rpm for 1 h. 1 p1 
of this mixture was then added to E. coli XL 1-blue chemically competent cells 
(Stratagene) on ice. After 30 min incubation on ice, the cells were heat shocked at 42°C 
for 45 seconds and placed back on ice for 2 min. Pre-warmed LB (500 p1) was added 
and incubated at 200 rpm, 37°C for 1 hour. The transformation mixture (100 p1) was 
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spread onto a LB agar plate containing kanamycin. Colonies picked the following day 
were used to inoculate 10 ml LB/Kan. Purification of the plasmid DNA and digest using 
BamHI confirmed the removal of one of the BamHI sites, and sequencing confirmed this. 
The primers used for sequencing were purchased from Sigma Genosys, 
BamHI site prior to Oxidase gene: ACGCAAGTTCTTAAGAAGGAGATATAC 
Area of BamFIl site removed by Quikchange: TCTGGCGGTGATAATGGTTGC 
Sequencing carried out as detailed in section 4.2.13 
4.2.15 Error-Prone PCR (epPCR) and QuikChange PCR 
4.2.15.1 epPCR and preparation of primers for Quikchange 
Diversify1M PCR Random Mutagenesis Kit from BD Biosciences (Catalogue number 
K1830-1) was purchased and the protocol followed to produce approximately 2.7, 4.8, 
and 8.1 mutations per kbp. epPCR was carried out on all cloned racemases. Primers 
were the same as those used in section 4.2.10 for initial racemase amplification. The 
conditions are shown: 
Mutations per 1 kbp 2.7 4.8 8.1 
PCR Grade Water 38 	l 35 p1 32 p1 
1 OX Titanium Taq Buffer 5 p1 5 p1 5 p1 
MnSO4 (8 mM) 2 p1 4 p1 4 p1 
dGTP (2 mM) 1 p1 2 p1 5 p1 
50x Diversify dNTP mix 1 p1 1 p1 1 p1 
Primer mix (10 LM each primer) 1 p1 1 p1 1 p1 
Template DNA (1 ng/p1) 1 p1 1 p1 1 p1 
TITANIUM Tag Polymerase 1 p1 1 p1  1111 
Total Volume 50 il 50 p1 50 p1 
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68°C 1 min 30 
Go to (2) rpt x25 
68°C 1 mm 
(7) 4°C Hold 
The PCR product was purified by gel electrophoresis and digested using the restriction 
sites introduced by the primers. After digestion, the PCR product! Quikchange primers 
were blunt ended using Kienow. 
epPCR fragment, digested and purified 	60 pJ 
Klenow 	 2 t1 
Buffer 2 	 7 t1 
dNTP's2mM 	 0.9d 
Alternatively, the Kienow was added to the digest without purification. This reaction 
mixture was left at room temperature for 20 mm, and the DNA purified using the Qiagen 
PCR Cleanup kit. The resulting Quikchange PCR primers were used immediately or 
stored at -20°C. 
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4.2.15.2 Quikchange Whole Plasmid PCR to create mutant libraries 
Template DNA to be used was always freshly prepared using BL2 1 (DE3) E. coli cells 
(or using any cells that are dam+). 
Template DNA 	 100 ng 
Primers 	 125 ng 
dNTP's (100 mM each) 	0.5 tl 
Pfu Buffer 	 5 tl 
DMSO 	 5jil 
dH20 	 to a final volume of 49 j.tl 




55°C 1 mm 
68°C 8 mm 
Goto(2).Rptxl8 
(5) 68°C 10 mm 
(7) 4°C Hold 
The crude PCR product had DpnI restriction enzyme (1t1) added and the reaction was 
mixed by gentle pipetting and spun for 1 min at maximum speed in a micro-centrifuge. 
The digestion of methylated DNA was allowed to proceed at 37°C, 200 rpm for 1 h. 1 p1 
of this mixture was then added to E. coli XL 1-blue chemically competent cells 
(Stratagene), thawed on ice. After 30 min incubation on ice, the cells were heat shocked 
at 42°C for 45 s and placed back on ice for 2 mm. Pre-warmed LB (500 p1) was added 
and incubated at 200 rpm, 37°C for 1 h. 2 x 200 j.xl of the transformation was spread onto 
LB agar plates containing antibiotic. 
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2 ml LB/Amp was added to each plate the following day and the colonies scraped from 
the agar with a plastic sterile loop. The library of variant DNA was isolated from the 
colonies using the Qiagen miniprep kit and stored at -20°C. 
4.3 Growth of P. putida for genomic DNA extraction 
Glycerol stocks of P.putida ATCC 47054 were available at -80°C in the laboratory. 
Streaks were made onto Nutrient Broth/agar plates and incubated at 30°C overnight. 
Single colonies were used to inoculate 500 ml Nutrient broth and grown at 30°C, 200 
rpm, in baffled flasks. Genomic DNA was extracted, section 4.2.3 and stored at 4°C. 
4.4 Growth and Transformation of E. co/i 
4.4.1 Transformation of E.coli BL21(DE3) with plasmid DNA by heat shock 
Batches of one shots (50 jd) competent cells were supplied by Invitrogen' TM. BL21(DE3) 
cells were used when transforming pET16b(racemase) vectors and BL2I(DE3)pLysS 
and Top 10 cells were used for all pINGE2 and pTTQI 8 plasmids. 
Cells were thawed on ice. 1-2 pA of plasmid DNA was added and mixed by tapping 
the tube. 
After incubation on ice for 30 mm, the cells were placed in a water bath at 42°C for 
30 s exactly and quickly returned to the ice. 
After 2 mm, 250 pA of pre-warmed SOC (42°C) was added and cells were left at 
3 7°C, 200 rpm for 1 h. 
(4) Cells were then plated onto pre-warmed (37°C) LB/Agar/Antibiotic and incubated at 
37°C overnight. 
When transforming libraries, 900 pA SOC was added, and 250 pA was spread onto larger 
LB plates. 
165 
Materials and Methods 
4.4.2 Growth of E. coil 
From the overnight plates, single colonies were picked and used to inoculate 1 Oml 
LB/Amp at 200 rpm, 37°C. These cultures were used for DNA analysis and 
manipulation. When larger culture volumes were required, 100 il of the starter culture 
was placed into 50-250 ml LB/Amp. For protein analysis, the 0D600 was measured until 
it was between 0.4 and 0.6 and protein expression was induced by the addition of IPTG 
(final concentration of 1 mM). 
Cells were harvested by centrifugation; volumes of 1.5 ml at 13 000 rpm for 2 min using 
a desktop centrifuge, medium sized cultures (<50 ml) at 4000 g for 10 min using a 
Sorvall swing bucket rotor, and larger volumes (>50 ml) at 6000 g for 10 mm. The 
supernatant was removed and the cell pellet resuspended in 100 mM phosphate buffer, 
pH 8.0. This was stored at —80°C. 
4.4.3 Transformation of E. coil XL1 -Red with plasmid DNA by heat shock 
XL1-Red competent cells were supplied from Stratagene®. 
Method 1 
100 pi cells were thawed on ice. 1. 7d of fl-mercaptoethanol was added to each shot 
(giving a final concentration of 25mM). 1-2 pA of plasmid DNA was added and mixed 
by tapping the tube. 
After incubation on ice for 30 mm, the cells were placed in a water bath at 42°C for 
45 s exactly and quickly returned to the ice. 
After 2 mm, 950 pA of pre-warmed SOC (42°C) was added and cells were left at 
37'C, 200 rpm for 1 h. 
50 pA Cells were then plated onto pre-warmed (37°C) LB/Agar/Antibiotic and 
incubated at 37°C overnight. 
9ml LB/ampicillin was added to the remaining transformation, and grown at 37°C 
overnight. 100 jil of overnight culture was used to inoculate a second 10 ml 
LB/ampicillin, and grown overnight. The sub-culturing was repeated up to 6 times. 3 ml 
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of final culture was harvested and the plasmid DNA extracted to produce the first library 
of variants. 
Method 2 (from 'Methods in Molecular Biology, Vol 231, Directed Evolution 
Library Creation. Methods and Protocols) 
50 tl Cells were thawed on ice. /J-mercaptoethanol was added, giving a final 
concentration of 25 mM. After 10 mm, 1-2 jil of plasmid DNA was added and mixed by 
tapping the tube. 
After incubation on ice for 30 mm, the cells were placed in a water bath at 42°C for 
45 s exactly and returned to the ice for 2 mm. 
1 ml of pre-warmed SOC (42°C) was added and cells were left at 37°C, 200 rpm for 
1 h. 
200 pA Cells were then plated onto pre-warmed (37C) LB/Agar/Antibiotic and 
incubated at 37°C overnight. 
2 ml LB/Amp was added to the plate the following day and the colonies scraped 
from the agar with a plastic sterile loop. This was added to 10 ml LB/Amp, and the 
OD600 measured. The OD was then diluted to approximately 0.0005 in 200 ml and 
grown overnight. When the OD of the culture reached 2-2.5 (after 12-24 h), the cells 
were again diluted to produce an 0D600 of 0.0005. The sub-culturing was repeated up 
to 6 times. 3 ml of final culture was harvested and the plasmid DNA extracted to 
produce the library of variants. 
4.4.4 Co-transformation of Racemase and Oxidase for screening 
One shot ToplO cells from InvitrogenTM were used. The normal protocol for 
transformation was followed. However, when adding the plasmid DNA to the thawed 
cells, equal concentrations of racemase and oxidase DNA must be added, with a total 
volume added of 5 pA or less. 
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When transforming libraries, 900 d Soc was added, and 250 pA aliquots were spread 
onto larger (15 cm diameter) LB plates. 
4.5 Protein Purification and Analysis 
Unless otherwise stated, all work was carried out at 4°C 
4.5.1 Obtaining the CFE 
BugBuster Protein Extraction Reagent (Novagen, 71370-4) was used. To 1 g (wet cell 
weight) cell pellet, 5 ml BugBuster reagent was added. 10 pi Lysonase (provided with 
BugBuster), 50 pA Protease inhibitor cocktail (Sigma, P8849), and 0.3 mM (final 
concentration) PMSF were added and the cell resuspended. The mixture was left 
spinning at room temperature for 10-15 mm, and the cell debris was removed by 
centrifugation at 16000 rpm, 4°C for 20 mm. The CFE was placed immediately at 4°C. 
4.5.2 Ammonium sulfate precipitation 
4.5.2.1 Removing the protein pellet up to 40 % saturation 
Method 1 
The CFE was placed at 4°C on a stirrer plate. Solid ammonium sulfate was added slowly 
to the stirring solution, to ensure complete dissolution after each addition. Once the 
desired percent saturation was reached, the sample was centrifuged at 4000 rpm for 30 
minutes to obtain a '0-40 %' pellet. The supernatant was removed and subjected to a 
second ammonium sulfate precipitation 
Method 2 
To minimise areas of high concentration of ammonium sulfate salts, producing 
unnecessary precipitation, a saturated ammonium sulfate solution was prepared. To a 
stirring CFE solution at 4°C, saturated ammonium sulfate was added dropwise, until the 
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final saturation was 40 %. The sample was centrifuged and the supernatant removed for 
subsequent analysis, or further precipitation. 
4.5.2.2 Obtaining the 40-70 % ammonium sulfate precipitated protein 
To the stirring supernatant from 4.5.2.1, solid ammonium sulfate was added slowly until 
70 % saturation had been reached. The sample was centrifuged at 4000 rpm for 30 mm, 
and the supernatant discarded. The pellet was resuspended in the minimum amount of 
buffer, required for loading onto the proceeding column, and desalted using a PD10 
column 
4.5.3 PD10 desalting 
Desalting of the freshly purified protein from the ammonium sulfate precipitation was 
carried out to prepare the protein for anion exchange chromatography. Disposable 
Amersham Bioscience PD-10 desalting columns were used (Amersham Biosciences). 
The column was equilibrated with 25 ml of the proceeding column equilibrating buffer. 
Exactly 2.5 ml of the protein sample was loaded onto the top of the column and the flow 
through discarded. 3.5 ml of the same buffer was applied to the top of the column and 
the flow through collected. 
4.5.4 SDS-PAGE Analysis 
Analysis of the purity of protein and expression samples was done using SDS PAGE. 
Pre-cast gels were purchased (BioRad, SDS 10-15% polyacrylamide gel) and either New 
England Biolabs markers (P77085) or BioRad Kaleidoscope protein markers (161-0375) 
were used to analyse protein weights. The molecular weights of the NEB standard 
proteins are 175, 83, 62, 47.5, 32.5, 25, 16.5 and 6.5 kDa, and the BioRad standards are 
250, 150, 100, 75, 50, 37, 25, 20, 15, 10 kDa. 20 t1 of the protein sample was mixed 
with 20 p1 of the Laemmli loading buffer (BioRad, 161-0737), incubated at 95°C, and 
centrifuged at max speed in a desktop centrifuge for 1 mm. 10-30 p1 of protein sample 
was loaded onto the SDS PAGE gel, already submerged in SDS PAGE running buffer. 
The electrophoresis was carried out at 150 V for 90 mm. The gel was placed into 
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staining solution for a minimum of 1 h (preferably overnight) and then dc-stained to 
develop the bands. 
4.5.5 Western Blot 
A western blot was carried out to transfer protein for sequencing. An SDS gel was run as 
described in 4.5.4. However, prior to staining, the gel was washed thoroughly with 
dH20, and then with Blotting Buffer. The gel was placed into a semi-dry blotting 
apparatus, next to a polyvinylidiene fluoride (PVDF) membrane, and sandwiched 
between two 5 mm filter papers. The filter papers were prepared by soaking in HPLC-
grade methanol for 5 mm, followed by equilibration in blotting buffer for a further S 
mm. The electrophoresis was carried out at 150 mA for 2 h. The PVDF membrane was 
stained for 20 s with Coomasie blue, and immediately placed into 50 % methanol to de-
stain. The gel was also stained to assess efficiency of the protein transfer. Once de-
stained, the PVDF membrane was air-dried and the band corresponding to the protein of 
interest was cut out. The sample was then sent for N-terminal sequencing, to Dr Jeff 
Keen at the Proteomics Facility, Institute of Membrane and Systems Biology LIGHT 
Laboratories, University of Leeds, Leeds, LS2 9JT. 
4.5.6 BCA Protein Assay- Protein Quantification 
To determine protein concentrations, a BCA Protein Assay kit from Pierce 
Biotechnology (23227) was used. A standard curve was produced for each assay as the 
colour development measured has no end point. Diluted albumin standards (BSA) were 
prepared at concentrations of 2, 1.5, 1.0, 0.75, 0.50, 0.25, 0.125, 0.025, and 0 mg/mi. In 
triplicate, 25 t1 of each of the standards, and the unknown samples were added to 200 jtl 
of the 'working reagent' supplied, in a micro-titre plate. The plate was mixed on the 
plate reader shaker for 30 s, and then covered and incubated at 37°C for 30 mm. The 
plate was allowed to cool to room temperature, (approx 10 mm), and the absorbance at 
562 nm measured. Using the standards, a plot of concentration vs. absorbance was 
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made, and the absorbencies of the unknown samples were used to estimate the protein 
concentrations. 
4.5.7 Akta Purification 
All chromatography was carried out using an Akta Explorer from Amersham 
Biosciences. The Akta was housed in a chilled cabinet, therefore all runs were carried 
out at 4°C. When not in use, all Akta tubing contained 20 % ethanol. Weekly washes 
with 0.1 M NaOH were carried out to remove any residual protein and salts. 
4.5.7.1 Ni2 and Cu2 affinity Chromatography 
1 ml Hi-trap chelating HP columns were used (Amersham 17-0408-01). When not in 
use, columns were stored in 20 % ethanol at 4°C. To use, columns were manually 
washed with 5 ml dH20, charged with 5 ml metal salt solution, and washed with 
equilibration buffer (5 ml). The filtered CFE was loaded and the column attached to the 
Akta. The flow rate was set to 1 ml/min and the machine was used to create a linear 
gradient from 0 to 100 % elution buffer. The fraction content was recorded using UV 
absorbance at 280 and 425 nm (280 nm for general protein content, and 425 to analyse 
the PLP cofactor). Once the run was complete, the fractions of interest were assayed in 
the solution phase. 
4.5.7.2 Anion Exchange Chromatography 
A Hi-trap Ion exchange selection kit was tested, (Amersham 17-6002-33). After 
screening, 1 ml ResourceQ columns from Amersham Biosciences (17-1177-01) were 
used, containing a quaternary ammonium bonded phase. Columns were stored at 4°C. 
To use, the column was attached to the machine and washed with 10 ml dH2O at a flow 
rate of 2 ml/min. The column back pressure for the columns in the selection kit was set 
at 0.3 MPa. The column back pressure for the ResourceQ column was set at 1.5 MPa. 
Once washed, the columns were equilibrated with start buffer. The protein sample was 
filtered (0.2 tM) and loaded onto the column using the sample loop (2.5 ml, or 10 ml, 
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sample size ideally half of the loop capacity). The proteins were eluted with a gradient 
increasing to 100 % elution buffer (increasing salt gradient). The fractions were analysed 
by measuring absorbance at 280 and 425 nm. Fractions of interest were assayed using 
the solution phase assay. Once the run was finished, the column was washed with start 
buffer, then dH20, and finally 20 % ethanol. 
4.5.7.3 Hydrophobic Interaction Chromatography 
A Hi-Trap HIC selection kit was purchased from Amersham Biosciences (11-0034-53). 
After screening, 5 ml Hi-trap Phenyl Sepharose HP Columns were purchased (17-5195-
01). When not in use, columns were stored in ethanol, at 4°C. 
To use, the column was attached to the machine and washed with 10 ml dH20 at a flow 
rate of 2 ml/min. The column back pressure for all columns was set at 0.3 MPa. Once 
washed, the columns were equilibrated with elution buffer (low salt), followed by start 
buffer (high salt). The protein sample was filtered (0.2 tM) and loaded onto the column 
using the sample loop (2.5 ml, or 10 ml, sample size ideally half of the loop capacity). 
The proteins were eluted with a gradient increasing to 100 % elution buffer (decreasing 
salt gradient). The fractions were analysed by measuring absorbance at 280 and 425 run. 
Fractions of interest were assayed using the solution phase assay. Once the run was 
finished, the column was washed with elution buffer (low salt), then dH20, and finally 
20 % ethanol. 
4.6 Assays for Racemase Activity 
4.6.1 The solution phase assay 
4.6.1.1 Proof of principle assay 
Alanine racemase and D-amino acid oxidase were obtained from Sigma, (Alanine 
racemase from G. stearothermophilus, A8936, D-amino acid oxidase from Porcine 
kidney, A1914). The stock 50 ml chromogenic assay mixture contained the following: 
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4-aminoantipyrine (4-AAP), 1 M 	37.5 il (final cone 0.75 mM) 
2 % (w/v) 2,4,6-tribromo-3-hydroxybenzoic acid 
(TBHBA) in DMSO 
	
500 !Il (final conc 0.02 % (w/v)) 








up to 50 ml 
Assay mixture, racemase, oxidase, and horseradish peroxidase were then added to a 96 
well plate and incubated at 37°C. The reaction was monitored by measuring the 
absorbance of the colorimetric product ( = 29400 M 1 ) at 510 nm with a plate reader 
(Molecular Devices, Versa Max tunable micro-titre plate reader). 
4.6.1.2 Sensitivity of D-amino acid oxidase in the solution phase assay 
According to 4.6.1.1, assay mixtures containing the following substrate concentrations 
were made: 
L-Ala(mM) Ho 9 8 7 6 5 4 3 2 1 0 
D-Ala(mM) 0 1 2 3 4 5 6 7 8 9 10 
Oxidase, HRP, and water were added to the wells to a final volume of 200 p1. The 
reaction was followed on the Molecular Devices micro-titre plate reader. 
4.6.1.3 Determining activities of cells expressing racemase 
The whole cells obtained by 4.2.2 were used for the assay to evaluate potential racemase 
activity. To determine if any racemase activity was present, 180 id of the assay mix was 
added to single wells in a U-shaped 96-well micro-titre plate containing, 
Horseradish peroxidase, lmg/ml 
	
5 p1 
D-amino acid oxidase 
	
5 p1 (to 0.2 U per well) 
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Whole cells in phosphate buffer 	 10 tl 
The plate was then incubated at 37°C and the reaction monitored by measuring the 
absorbance of the colorimetric product (c = 29400 M) at 510 rim with a plate reader 
(Molecular Devices, Versa Max tunable micro-plate reader). Time points were taken 
every 30 s over a period of 1 h 30 min and absorbance plotted as a function of time. 
4.6.1.4 Optimisation of the solution phase assay 
A smaller amount of assay solution of 2x concentrate was used to minimise pipetting 
errors and ensure stock solution was re-made frequently. 
4-aminoantipyrine (4-AAP), 1 M 	15 tl (final concentration 0.75 mM) 
2 % (w/v) 2,4,6-tribromo-3-hydroxybenzoic acid 
(TBHBA) in DMSO 	 200 jil (final conc 0.02% (w/v)) 
Potassium phosphate buffer 1 M, pH 8.0 	2 ml 
Substrate, L-Alanine 	 20 mM 
MilliQ H20 	 up to 10 ml 
Use 100 p1 per well in the assay. The amount of HRP (1 mg/ml) used was increased to 
10 ji1, and the D-amino acid oxidase (purchased from Sigma) was made up to 20 U/ml 
(0.2 U/10 p1, according to the activity reported by the vendors). The remaining 80 p1 is 
available for whole cell suspensions/CFE/water, allowing for minimal significant 
pipetting errors. 
4.6.2 The solid phase assay 
4.6.2.1 Small scale screening of one enzyme 
After transformation and cell recovery (section 4.4.1) the cells were plated onto 7.5 cm 
diameter nitrocellulose membranes laid over LB/Amp/Agar plates. These were 
incubated overnight at 37°C to allow colonies to form. The membrane was removed 
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from the plates and placed at —20°C for a minimum of 24 h to allow partial cell lysis. 
An assay mix was prepared to the following recipe (recipe is for four plates): 
1 x 3,3'-diaminobenzidine tablet (Sigma(g) 
Potassium phosphate buffer 1 mM 	 40 ml 
Screening substrate (usually L-amino acid) 	 10 mM 
Horse radish peroxidase (10 il per plate of 4 mg/ml solution) 	40 tl 
Porcine kidney D-amino acid oxidase (1 U per plate) 	 4 U 
4 x 10 ml volumes of molten 2 % agarose (w/v in dH20) at approximately 55°C were 
prepared. To each 10 ml of 2 % agarose, 10 ml of assay mix was added and poured over 
membrane. The plates were left at room temperature to allow any colour to develop. 
4.6.2.2 Screening cells containing the racemase and the oxidase 
After transformation of library DNA, 250 p1 recovered cells were spread onto 15 cm 
diameter nitrocellulose membranes on LB/Amp/Kan. These were incubated overnight at 
30°C. The following day, the membrane was lifted from the LB/antibiotic plate, laid on 
an LB/antibiotic/IPTG containing plate and incubated overnight at 37°C to induce 
expression of the racemase and the oxidase. The membrane was then placed at -20°C 
overnight to partially lyse the cells. The assay mix was prepared as follows: 
To cover 2 plates of 15 cm diameter 
1 x 3,3'-diaminobenzidine tablet (Sigma®) 
Potassium phosphate buffer 1 mM 	 50 ml 
Screening substrate (usually L-amino acid) 	 10 mM 
Horse radish peroxidase (50 p1 per plate of I mg/ml solution) 	100 .tl 
2 x 25 ml volumes of molten 2 % agarose (w/v in dH20) at approximately 55°C were 
prepared. To each aliquot of 2 % agarose, 25 ml of assay mix was added and poured 
over membrane. The plates were left at room temperature to allow any colour to 
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develop. Hits were picked and placed into 10 ml LB/Amp/Kan and left to grow 
overnight at 370C. 
4.6.2.3 Re-assay of Co-transformed hits 
Hits from overnight cultures were mini-prepped to obtain a mixture of oxidase and 
racemase DNA. Initially the separation of the two plasmids was carried out by gel 
electrophoresis, followed by excision of the smaller band from the gel, corresponding to 
the racemase, and purification. After optimisation, the DNA mixture was subjected to a 
digest with Spel and NdeI, cutting the oxidase only, 4 times. 
The purified racemase was then co-transformed using fresh oxidase to confirm that 
novel activity was not due to the former oxidase. 
4.6.3 HPLC analysis of 2-ABA Racemisation 
All HPLC methods/sample preparationlderivatisation were from Ingenza 
The instrument used was an Agilent 1200 series HPLC comprising a vacuum degasser, 
quaternary pump, auto-sampler, thermo-stated column compartment and diode array 
detector (DAD). The column used was a Phenomenex HyperClone ODS (C18) 5u 150 x 
4.6 mm, at 25°C. The flow rate was 1 ml/min. The gradient was isocratic, and detection 
measured at 338 nm. 
4.6.3.1 Preparation of OPA/N-isobutyryl-L-cysteine reagent 
Phthaldialdehyde (0.05 g) and N-isobutyryl-L-cysteine (0.110 g) were dissolved in 0.5 
ml methanol. The final volume was made up to 5 ml using 0.4 N potassium borate buffer, 
pH 10. This solution was used immediately. 
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4.6.3.2 Column equilibration 
The column was washed for 30 min with 20 % 10 mM potassium phosphate buffer pH 
7.0 (Mobile phase A), 80 % acetonitrile (Mobile phase B), followed by equilibration 
with 84 % A and 16 % B. Column temperature was 25°C. 
4.6.3.3 2-Amino butyric acid (2-ABA) racemisation 
A 0.5 g pellet of cells expressing racemase was resuspended in 10 ml 10 mM potassium 
phosphate buffer. 12 mM (R)-amino butyric acid (2-ABA) or 12 mM (S)-2-ABA was 
added. Immediately a 1 ml sample was removed. The reaction was placed at 37°C for 15 
h and a second 1 ml sample removed. 
4.6.3.4 Sample preparation for HPLC analysis 
A lml sample was heated at 95°C for 10 mm, and then centrifuged at 13 000 rpm for 2 
mm. 250 p1 of the supernatant was added to 750 p1 HPLC grade water. The solution was 
then filtered through a 0.2 tM filter into an HPLC vial 
4.6.3.5 Derivatisation protocol 
Using the Agilent 1200, 16 p1 0.4 N potassium borate buffer, pH 10 was drawn into the 
mixing loop, followed by 16 p1 of the OPA/N-isobutyryl-L-cysteine reagent. 8 p1 of the 
2-ABA-containing sample was drawn into the loop, and mixed for 6 cycles. The mixture 
was then held in the loop for 2 min before injection onto the column. Retention time for 
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Appendix 1: P. putida racemase gene alignment with sequenced gene plus translation 
10 	 20 	 30 	 40 
Rputidarac 	. 	I 	 31 
pJLM101gene IATGGGTACTPIIGTICCCTTTCGCCGTACCCTTCTGG(*10E]1 40 
M 	T S P F R R T L L A A 
50 	 6D 	 70 	 80 
P.puticlarac ICCCTGG 	 71 
pJLMIOI gene 
L A L L I T 	0 A 
30 	 1(X) 	 110 	 120 
P.putida rac 	G 	A 	 111 
pJLM10I gene CGI GigCAC4TGTCGATGGACAACGGCACCAICtqiG[g_gTITGI 120 
A P P L S M D N 	T T A L 
130 	 140 	 150 	 150 
P.putlda rac IACCGTGCAAAACAGCATIGCCTGGGTCGAATCAGCGCCA 151 
T V 0 N S N A W V E V S A 
pJLM101gene JACCGTGCAAAACAGCAPC4GCCTGGGTCGA4AITCAGCGCCPII 160 
T V 0 N S N A W V E I S A 
170 	 150 	 130 	 20) 
P.putida rac IGCGCCCTGCCACAACATCCGCAtGc1TGCAGGCCGi CT 191 
S A L 0 H N I R T L 0 A E L 
pJLM101gene IGCGCCCTGCPAICACAACATCCGCACICTITGCAGGCCG4AIJ1 200 
S A L 0 H N I R T L 0 A E L 
210 	 220 	 230 	 240 
_ ....................I 
P.putidarac IGGCCGGCAAGTCCAAGCTGTGCCGTGCTCAAGGCIGATI 231 
A 	K S K L C A V L K A D 
pJLMIOI gene IGGCCGGCAAGTCCAAGCTGT(TIGCCGTGCTCAAGGCt(1GATI 240 
A 	K S K L C A V L K A D 
250 	 260 	 270 	 250 
P.putida rac IGCCTATGGCCACGGTITCGGCCTGGTIATGCcIITCGATC 271 
A Y 	H C 	C L V M P S I 
pJLM101gene IGCCTATGGCCACGGTkTCGGCCTGGTIGATGCCI(TCGATCPI 280 
A Y C H C V C L V M P S I 
290 	 300 	 310 	 320 
P.putida rac 
	 311 
I A 0 1 V P C V A V A S N E 
pJLM101gene JTIGCCC*GGCGTGCCCTGCGTGGCGGTGGCCAGCAACGAI 320 
I A 0 C V P C V A V A S N E 
300 	 340 	 350 1. 
 P.pulidarac IGGAGGCCCGCGTGGTCCGCGCCAGTGGCTTCACCGGGCAN 351 
E A R V V R A S 1 F T 	0 
pJLNt101gene IGGAGGCCCGCGTGGTCCGCGCCAGTGGCTTCACCGGGCAAI 360 
E A R V V R A S 	F T 	0 
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370 	 330 	 393 	 403 
P.puticlaracCTGGTGCGGGTACGCCTGGCCAGCCTCAGCG4AGcTGGAA 391 
L V R V R L A S L S E L E 
pJLM101gene ICTGGTGCGGGTACGCCTGGCCAGCCTCAGCG AGLTGGAAg 400 
L V R V R L A S L S F V E 
410 	 420 	 430 	 440 
Ppuhdarac 	 431 
pJLM101gene C[ACICTTGCAGTACGACATGGAAG PICTGGTGGGCA TLQg 440 
D A L 0 Y D M F E L V 	S A 
4513 	 4510 	 470 	 4510 
P.putida rac 	GAATTITIGCCCGCCAGGcICGP1TIGCCATCGCCGGCGCCATI 471 
E F A R Q A D A I A A R H 
pJLM101gene CIGAATTICIGCCCGCCPIACTICGP.ICIGCCATCGCCCPIGCGCCATI 480 
E F A R 0 L D A I A F R H 
400 	 500 	 510 	 520 
P.putida rac 	 511 
pJLMIOI gene IGGCAA(CIJCTTGCGCATICICACIcITGGCICICTCA*ITCCAGC( 520 
K P L R I H L A L N S S 
530 	 540 	 550 	 560 
P.pulida rac IGCATGAGCCGCAACGGGGTICGAGATCCACICITGGTCCG( 551 
C M S R N 	V E M A T W S 
pJLM10I geneGCATGAGCCGCAACGGGGTIAIGAGAT(PICCACtTITGGTCCG( 560 
C M S R N 	V E M T T W S 
570 	 590 	 590 	 510 
P.putida rac CCGTGGCGAAG 	GCP49gACCGACCAGAAGCACCTCI 591 
pJLMIOI gene ICCGTGGCGAAGC(TITGCA(GIIITIACCGACCAGAAGCACCTCI 600 
R 	E A L Q V T D 0 K H L 
610 	 620 	 630 	 640 
. I
P.putidarac IAAGCTGGTCGCGCTGATGACCCACTTIcIGCCGTGGAAGACPl 631 
K L V A L M T H F A V E D 
pJLM101gene IAAGCTGGTCGCGCTGATGACCCACTTITIGCCGTGGAAGACPI 640 
K L V A L M T H F A V E D 
650 	 660 	 670 	 680 
P.putida rac AGPA 671 
pJLMIOI gene 	 680 
K D D V R K 	L A A F N F Q 
690 	 700 	 710 	 720 
_ 	..............I P.putidarac IGACCGACTGTITGATCAAGCACGCCGCTGGACCGCAGc1 711 
I D W L I K H A R L D R S 
pJLM101gene IGACCGACTGc*ITGATCAAGCACGCC*IGCTGGACCGCAG 720 
T 0 W L I K H A K L D R S 
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730 	 740 	 750 	 750 
P.putidarac IAAGCTCACCCTGCACGCCGCCAACTCGTTCGCTACGCTGq 751 
K L T L H A A N S F A T L 
pJLM101gene IAAGCTCACCCTGCACGCCGCCAACTCGTTCGCTACGCTG( 760 
K L T L H A A N S F A T L 
770 	 750 	 792 	 503 
P.putidarac 	GTGCCGGAAGCGCGCCTGGACATGGTIAfC /AGGTG 791 
pJLMIOI gene [GTGCCGGAAGCGCGCCTGGACATGGTIdQ CIA CIGGTG(  800 
E V P F A R L D M V R T 
810 	 920 	 830 	 840 
P.putidarac ICGCGCTGTTCGGGACACCGTGCC(GCGCACCGAGT4 831 
pJLM101gene JCGCGCTGTTCG(TIGACACCGTGCC(AGC ICACCGAGTACI 840 
A L F 	0 T V P S H T E Y 
850 	 860 	 870 	 850 
P.putidarac AA aT 	ATGCAGTTCAPTCGcJAc1GTGGcIGcGTGcI 871 
pJLM101gene CdQ 	 83o 
Q R A M 0 F K S R V A A V 
890 	 900 	 910 	 920 
P.putidarac IACAGCTTICCGGCCGGCACIACCGTIGCITIGACCGCACI 911 
pJLM1OI gene IACAGCTCICCGGCCGGCAPTIACCGTIC1T[LjCIGACCGCACI 920 
H S Y P A 	N T V 	Y D R I 
920 	 940 	 950 	 92) 
P.putidarac 	 951 
pJLM101gene 	 960 
F T L A R 0 A R L A N I T 
970 	 920 	 992 	 1000 
P.putidarac 	 C TCCGPTC1TACCGCCGG(TAffl1CIACCAACAI 991 
pJLMIOI gene IGTCG CIT TITCCG CIG TITACCGCCGG CGJIT JTJACCAAC 1000 
V 	Y S D 	Y R R A F T N 
1010 	 1020 	 1920 	 1040 1.  
P.putidarac IAGGGCCATGTGCTGATCAACGGCCACCGTGTGCCGGTCGTI 1031 
K 	H V L I N 	H R V P V V 
pJLM101gene IAGGGCCATGTGCTGATCAACGGCCACCGTGTGCCGGTCGTI 1040 
K (I H V L I N G H R V P V V 
1050 	 1060 	 1070 	 1920 
Pputidarac IGGGCAAGGTGTCGATGAACACGCTGATGG11CTIThACcI 1071 
pJLM101gene IGGGCAAGGTGTCgATGAACACGCTGATGGTIGICIjjTIACcI 1080 
K V S M N I L M V 0 V T 
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Appendix 1: P. putida racemase gene alignment with sequenced gene plus translation 
iCX)J 	 110) 	 1110 	 1130 
P.putidarac IGACTTCCc1TIGATGTGAAGGGGGTIAACGAAGTGGTGCTGTI 1111 
D F P 0 V K 	 N F V V L 
pJLM101gene IGACTTCCcGATGTGAAqGGGGcAACGAAGTGGTGCTGTI 1120 
D F P D V K 	 N F V V L 
1130 	 1140 	 1150 	 1150 
.I 
P.putidarac ITCGGCAAGCAGGCCGGGGGCGAAATCACCCAGGCCG AT 1151 
F 	K Q A 	 F I T Q A E M 
pJLM101gene ITCGGCAAGCAGGCCGGGGGCGAAATCACCCAGGCCGP4J1 1160 
F 	K Q A . 	E I T 0 A E M 
1170 	 1150 	 1190 	 1200 
P.putidarac IGGAAGATCAGGCGCGTTGCTCGCCGTTITGTACACcI 1191 
F E I N 	A L L A D L Y I 
pJLM101gene IGGAAGA1CIATCAP1TIGGCGCGTTGCTCGCCG*CITGTACACCI 1200 
F D I N 	A L L A D L Y T 
1210 	 1220 	 1230 
P.pulidarac I91AITGGGGCP4.ATTCCAACCCGAAGATACTCGTCGACI 1227 
pJLM101gene j]1TGGGGC*TTCCAACCCGAAGATACTCGTCGACI 1236 










Appendix 2: Alignment of all protein sequences chosen for cloning 
10 	 20 	 30 	 40 
Rputicia 	MPFRRTLLAASLALLITGQAPLYAAPPLSMNGTNEi!TVQ 40 
S.coelicolor ---------------------------- MSTTARRDADA 12 
Bsub (dal) 	---------------------------------- NK P F 6 
Bsub(alr) ------------------------------------IkL 4 
VWEVSfS LR LK 
lb 
YT,1 
RDJVJEIDLS 	iKENVMKKHItcLY.VK N V_ 
REVIEVNLI VKKNLR IRRHIPKSKVK NY 
KSK;
RS SD I 
V 
	
YAV V SEE 	VV T
R Tj!!L 	TLQE L L P.
K LDI SCL V tILDE 	ISLLL 	P 
 SEL V SVEE IVLi T P 
iKi] 
UL 




LKVDT L VKTEEEVQE1VM iLRN 





EIJILRVT_ LVIiSHF DE1jI r 
FIE 
E I: 
LK 	VFTHF T DELEj 	LMQFERFKELI LLi 
• 'LRT LFHFST DEPDIâ_I1LQIEKFF L SF LK • 




S.coeiicolor P EjRJ1  PA 1IT. Hris 	 248 
Bsub(daI) - - - 	Ni 	C 	AAG IR K GF.jAF 	 231 
Bsub(alr) 	LP__YAic AAA 1AF 	FSA.L' 	L 	236 
u r u r r KNJK SV 	 T VEYT FS 
SL 
Di'iIFQLRIITL STLSHVK iRI.1SVSY. 
:7 	i ø1UI'AKL.ELSLK M i YVKTMRilTVSY TYW 
71 
T RDSL ijj YSI
D 
JYFRTNK VLITK VPV 
T cETUL VPL V 	LIfSS 	VLV'1lV 
I TVPV Y L( •ILVLI 
i TLPI V 	 LSNR VL VPV_____ 
189 
Appendix 2: Alignment of all protein sequences chosen for cloning 
	
370 	 380 	 390 	 40D 
P.putidaKVSMNLMVDV D D K_A
A 
K EITEME 385 
S.coelicolorRI MDQFVVDL D_EP_-  G. • 	ETDj!j! B.sub (dal)RIMDQFMVEL' 	E P R • dISMDEI 	347 
- 	RVTMDIMVL EN E kø 	Ea —_",K 
1. 	 420 	 4W 	 440 
Szoelicolor JiVT  I Y E I jj I IS R VP R V Y V N E 	ir E• 	iii LTINYEVTISSRVpRMFLEN IV LL PV' 1 387 
- 	ML ETINYEVVSTLSRIPRYID IKV PVLV 
- S 11¼ 	 409 
Szoelicolor 	391 
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Appendix 3: S. coelicolor air gene alignment with sequenced gene plus translation 
10 	 20 	 30 	 40 
Scoealr 	 a tgagcgagacaac tgcItIcggcgggacgcggacgl 34 
M S E I T A R R D A D 
pJLN20I gene IATGAATITC1GAGCGAGACAACTGCIdCGGCGGGACGCGGACC 40 
M N S S E T T A R R D A D 
50 	 60 	 70 	 80 .
Scoealr 	lcggtactgcgcgcccgggccgagatcgacctggccgccctI 74 
A V L R A R A E I D L A A L 
pJLJV20I gene ICGGTACTGCGCGCCCGGGCCGAGATCGACCTGGCCGCCCTI 80 
A V L R A R A E I D L A A L 
20 	 100 	 110 	 120 
Scoealr 	lgcgggccaacgtacgcgcactgcgcgaacgggcccccgggI 114 
R A N V R A L R E R A P 
pJLN20I gene IGCGGGCCAACGTACGCGCACTGCGCGAACGGGCCCCCGG( 120 
R A N V R A L R E R A P 
130 	 140 	 150 	 160 
.I .... I....I. 
Scoealr 	Igcggctctcatggccgtcgtcaaggcggacgcctacggccl 154 
A A L M A V V K A D A Y 
pJLN201gene 1GCGGc t c tCATGGCCGTCGTCAAGGCGGACGCCTACGGCd 160 
A A L M A V V K A D A Y 
170 	 180 	 120 	 200 
Scoealr 	Iacggcgcga t cccc tgcgcccg tgcggccg t cgcggccggl 194 
H 	A I P C A R A A V A A 
pJLN201gene IACGGCGCGATCCCCTGCGCCCGTGCGGCCGTCGCGGCCGC 200 
H 	A I P C A R A A V A A 
210 	 220 	 230 	 240 
Scoealr 	It g cg a cc t gg c t cgg ca c cg c ca ccc cg c agg agg ccc t ci 234 
A T W L 	I A T P 0 F A L 
pJLNQOlgene ITGCGACCTGGcTCGGCACCGCCACCCCGCAGGAGGCCCTd 240 
A T W L i T A T P 0 E A L 
250 	 260 	 270 	 280 
.... 
Scoealr gccctgcgcgcggcggagccaggcctgccggacgacg tad 274 
	
A L R A A F P 	L P D D V 
pJLN2OI gene IGCCCTGCGCGCGGCGGAGCCAGGCCTGCCGGACGACGTACI 280 
A L R A A E P 	L P D D V 
220 	 3(X) 	 310 	 320 
Scoealr 	IggatcatgtgctggctgtggacgcccggcgggccctggcgI 314 
R I M C W L W I P C C P W R 
pJLNeOlgene IGGATCATGTGCTGGc tGTGGACGCCCGGCGGGCCCTGGC 320 
R I M C W L W T P 	 P W R 
330 	 340 	 350 	 360 
Scoealr 	IggaggcggtcgaggcccgtctcgacgtgtccgtcagcgcgI 354 
E A V F A R L D V S V S A 
pJLJV201gene IGGAGGCGGTCGAGGCCCGTCTCGACGTGTCCGTCAGCGC( 360 
F A V E A R L D V S V S A 
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Appendix 3: S. coelicolor air gene alignment with sequenced gene plus translation 
370 	 380 	 360 	 403 ........... . .. ........I....I .........I M W A M E E V T 	A A R A 
pJLJV201gene IATGTGGGCCATGGAGGAGGTCACCGGGGCGGCCCGGGCGGI 400 
M W A M E F V I 	A A R A 
410 	 420 	 430 	 440 
.... .I....I.I
Scoealr 	IccggggtgcccgcgcgcgtgcagctcaaggccgacaccggI 434 
A 	V P A R V Q L K A D T 
pJLN201gene ICCGGGGTGCCCGCGCGCGTGCAGcTCAAGGCCGACACCG( 440 
A C V P A R V Q L K A D T 
450 	 460 	 470 	 480 
.I....I.I 
Scoealr 	icctcgggcggggcggctgccagcccggcgcggactgggagI 474 
L 	R C 	C Q P 	A D W E 
pJLN20I gene ICCTCGGGCGGGGCGGCTGCCAGCCCGGCGCGGACTGGGAC 480 
L 	R 	 C Q P 	A D W F 
4901. 	 50) 	 510 	 520 
Scoealr 	Icggctgg tcggggccgcgc tgcgggccgaggaggaggggcj 514 
R L V 	A A L R A F E E C 
pJLNr20I gene 1CGGcTGGTCGGGGCCGCGCTGCGGGCCGAGGAGGAGGGGCI 520 
R L V 	A A L R A F F F C. 
530 	 540 	 550 	 800 
.I 
Scoealr 	itgctgagagtcaccgggctctggtcccacttcgcctgcgcI 554 
L L R V T . L W S H F A C A 
pJLJV201gene ITGCTGAGAGTCACCGGGcTCTGGTCCCACTTCGCCTGCGd 560 
570 	 580 	 560 	 600 
Scoealr 	IC g a c g a g cc c g g cc a ccc c t cc a t c g cc g ccc a g c t c a ccl 54 
D F P C H P S I A A 0 L T 
pJLJV201gene ICGACgAGCCCGGCCACCCCTcCATCGCCGCCcAGcTcAC 600 
D E P C H P S I A A 0 L I 
610 	 620 	 630 	 640 
Scoealr 	lc g tttccggg a g at g ac gg cctacg ccga g ca g cggggccI 634 
R F R F M T A Y A F 0 R 
pJUV20I gene ICGTTTCCGGGAGATGACGGCCTACGCCGAGCAGCGGGGCCI 640 
R F R F M T A Y A F 0 R 
650 	 660 	 670 	 680 
Scoealr 	Itgcg tccc g a g gt g cggcacatcgccaactcgccggccacI 674 
L R P F V R H I A N S P A T 
pJLN201gene ITGCGTCCCGAGGTGCGGCACATCGCCAACTCGCCCGCCAd 680 
L R P F V R H I A N S P A T 
660 	 70) 	 710 720 .
Scoealr 	IcctcaccctccccgacgcccacttcgacctcgtccggcccI 714 
L I L P D A H F D L V R P 
pJUV201gene ICCTCACCCTCCCCGACGCCCACTTCGACCTCGTCCGGCCd 720 
L I L P 0 A H F 0 L V R P 
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Appendix 3: S. coelicolor air gene alignment with sequenced gene plus translation 
730 	740 	750 	760 
Scoealr 	IggcatcgcgatgtacggtgtctcaccgagccccgagatcgI 75 
	
I A M Y 	V S P S P F I 
pJLNr201gene IGGCATCGCGATGTACGGTGTCTCACCGAGCCCCGAGATC 760 
I A M Y 	V S P S P E I 
770 	780 	750 	8(X) 
Scoealr 	lgcaccccggccgacttcgggctgcgccccgtgatgacgctI 794 
T P A D F 	L R P V M I L 
pJLiVQOlgene IGCACCCCGGCCGACTTCGGGCTGCGCCCCGTGATGACGCTI 800 
T P A D F 	L R P V M I L 
810 	820 	830 	840 
Scoealr 	Iggccgcctc g ct gg ccct gg tcaagcaggtccccggcggcI 834 
A A S L A L V K 0 V P 
pJLN201gene IGGCCGCCTCGCTGGCCCTGGTCAAGCAGGTCCCCGGcGGd 840 
A A S L A L V K 0 V P 
850 	600 	870 	880 .
Scoealr 	IC a c g g c g t c a g c t a c g g g c a cc a c t a c a cc a ccc cc g g c gJ 874 
H 	V S Y 	H H Y T T P 
pJUVQOlgene ICACGGCGTCAGCTACGGGCACCACTACACCACCCCCGGCC 880 
H . V S 'i' 	H H Y T T P 
890 9110 910 920 
Scoealr 	la g accaccctcgg cctcg tcccg ctcgg ctacg c gg ac ggI 914 
F T T L 	L V P L 	Y A D 
pJLN2Olgene IAGACCACCCTCGGCCTCGTCCCGCTCGGcTACGCGGACG( 920 
F T T L H; L V P L C Y A D 
920 	940 	950 	960 
Scoealr 	lcatcccccgg cac g cctcctccag c gg ccccg t g ct gg tcl 95 
I P R H A S S S 	P V L V 
pJLN201gene IcATCCCCCGGCACGCCTCCTCCAGCGGCCCCGTGCTGGTCI 960 
I P R H A S S S 	P V L V 
970 	980 	920 	1 000 
Scoealr 	ig ac gg caa g t gg c g caclglg tc g c ggggcggatcgcgatggI 994 
D C K W R T V A 	R I A M 
pJLN20I gene IGACGGCAAGTGGCGCAC1TIGTCGCGGGGCGGATCGCGATG( 1000 
D I; K W R T V A 	R I A M 
1010 	1020 1030 	1040 
Scoealr 	Iacca g t tcg tc g tcg acct ggg c gggg acc gg ccc g a g ccl 1034 
D 0 F V V D L .1 	D R P E P 
pJLNQOI gene IACCAGTTCGTCGTCGACCTGGGCGGGGACCGGCCCGAGCd 1040 
D 0 F V V D L I -I 	 D R P E P 
1050 	1(X)) 1070 	1080 
....I
Scoealr 	lggg c g cc g a gg c gg t g ct g t tcgg accgg gcgaccgcggcl 1074 
C A E A V L F C P H D R H 
pJLNQOI gene IGGGCGCCGAGGCGGTGCTGTTCGGACCGGGCGACCGCGGCI 1080 
193 




1101 )	 1110 	 1120 
Scoealr 	IgagcccaccgccgaggactgggcccaggcggcgggcaccaI 1114 
E P T A E D W A 0 A A 	T 
pJLN20I gene IGAGCCCACCGCCGAGGACTGGGCCCAGGCGGCGGGCACCAI 1120 
E P T A F D W A 0 A A 	T 
1130 	 1140 	 1150 	 11(X) 
Scoealr 	It cgcg t acgaga t cg t cacccgga t cggaagccggg t ccci 1154 
I A Y F I V T R I 	S R V P 
pJUV201gene ITCGCGTACGAGATCGTCACCCGGATCGGAAGCCGGGTCCd 1160 
I A 'i' F I V T R I 	S R V P 
1170 	 1180 
Scoealr 	IgcgcgtctacgtCaacgaatgal 1176 
pJUV20I gene IGCGCGTCTACGTCAACGAATGPI 1182 
R V Y V N F * 
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Appendix 4: B. subtilis dal gene alignment with sequenced gene plus translation 
10 	 20 	 30 	 40 
asubcial 	 atgagcacaaaacct t t t tacagagatacgtggg 3 
M S T K P F Y R D T W 
pJUVE301gene IATGAATITdGAGCACAAAACCTTTTTACAGAGATACGTGG( 40 
M N S S T K P F Y R D T W 
50 	 60 	 70 	 30 
asubdal 	lcggaaat tgact tgtccgcgataaaggaaaatgtcagcaal 74 
A E I D L S A I K E N V S N 
pJLNBOlgene ICGGAAATTGACTTGTCCGCGATAAAGGAAAATGTCAGCAPI 80 
A E I 0 L S A I K E N V S N 
50 	
1(10 
110 	 120 
Bsubdal 	ItatgaaaaaacatatcggtgaacatgtccacttgatggcaI 114 
M K K H I 	E H V H L M A 
pJLNBOlgene ITATGAAAAAACATATCGGTGAACATGTCCACTTGATGGCAAJ 120 
M K K H I 	F H V H L M A 
130 	 140 	 150 	 160 
asubdal 	IgttgtgaaagcaaacgcctacgggcatggtgatgcagaaaI 154 
V V K A N A Y 	H ... D A F 
pJLIVt301gene IGTTGTGAAAGCAAACGCCTACGGGCATGGTGATGCAGAAAI 160 
V V K A N A Y 	H 	D A E 
170 	 180 	 150 	 2(X) 
Bsubdal 	icagcaaaggctgctcttgacgcaggtgcttcatgcttggcI 194 
T A K A A L 0 A 	A S C L A 
pJLM301gene ICAGCAAAGGCTGCTCTTGACGCAGGTGCTTCATGCTTGG(1 200 
T A K A A L D A 	A S C L A 
210 	 220 	 230 	 240 
.I....I. 
Bsubdal 	lcgtggccattttggatgaagcgatttcactgcgcaaaaagI 234 
V A I L D E A I S L R K K 
pJLNt301gene ICGTGGCCATTTTGGATGAAGCGATTTCACTGCGCAAAAA( 240 
V A I L D F A I S L R K K 
250 	 260 	 270 	 280 
Rsubdal 	IggattgaaggcgcctatattggtgcttggcgcggttccccI 274 
L K A P I L V L . A V P 
pJLNt301gene IGGATTGAAGGCGCCTATATTGGTGCTTGGCGCGGTTCCCd 280 
L K A P I L V L .. A V P 
250 	 30) 	 310 	 320 
asubdal 	lcggagtatgtggcaatcgctgctgagtatgacgtgaccttI 314 
P F Y V A I A A F Y 0 V T L 
pJLNBOlgene ICGGAGTATGTGGCAATCGCTGCTGAGTATGACGTGACCTTI 320 
P E Y V A I A A E Y D V T L 
330 	 340 	 350 	 350 
asubdal 	laacaggttattctgttgaatggcttcaggaggcagcccgcI 354 
T 	Y S V F W L 0 F A A R 
pJLNt301gene IAACAGGTTATTCTGTTGAATGGCTTCAGGAGGCAGCCCGd 360 
T 1. Y S V E W L 0 F A A R 
IM 
Appendix 4: B. subtilis dal gene alignment with sequenced gene plus translation 
370 	 380 	 30 	 400 
H I K K 	S L H F H L K V 
pJLNt301gene ICACACGAAAAAAGGTTCTCTTCATTTTCATCTGAAGGTCC 400 
H I K K 	S L H F H L K V 
410 	 420 	 430 	 440 
B.subdal 	latacggggatgaacagacttggtgtaaaaacagaggaagaI 434 
D T 	M N R L 	V K T E F E 
pJLJVI301gene IATACGGGGATGAACAGACTTGGTGTAAAAACAGAGGAAGPl 440 
D T 	M N R L C V K T F F F 
450 	 460 	 470 	 480 
asubdal 	la g ttca g aac g t g at gg caattcttgaccgcaaccctcgtI 474 
V 0 N V M A I L D R N P R 
pJLNt3O19ene IAGTTCAGAACGTGATGGCAATTCTTGACCGCAACCCTCGTI 480 
V 0 N V M A I L D R N P R 
480 	 50) 	 510 	 520 
Rsubdal 	It taaag t g caaa gggg tat t tacccat t t t g c g aca g c ggl 514 
L K C K C V F T H F A T A 
pJLNt3OI gene ITTAAAGTGCAAAGGGGTATTTACCCATTTTGCGACAGCGCI 520 
L K C K (i V F T H F A T A 
530 	 540 	 550 	 560 
Rsubdal 	latgaaaaagaaagaggctatttcttaatgcagtttgagcgI 55 
D F K E R 	Y F L M 0 F F R 
pJLNE301gene IATGAAAAAGAAAGAGGCTATTTCTTAATGCAGTTTGAGCC 560 
D F K F R 	Y F L M Q F F R 
570 	 580 	 580 	 60) 
asubclal 	Ic t t t a a ag ag c t g at t g c t ccg c t g c cg t t a a ag a at c t al 59 
F K E L I A P L P L K N L 
pJLJVt301gene ICTTTAAAGAGCTGATTGCTCCGCTGCCGTTAAAGAATCTPl 600 
F K E L I A P L P L K N L 
610 	 620 	 630 	 640 
asubclal 	lat gg tccact g c g c g aaca g c g ccgctggactccggctgaI 634 
M V H C A N S A A .: L R L 
pJLNt3Olgene IATGGTCCACTGCGCGAACAGCGCCGCTGGACTCCGGCTGAI 640 
M V H C A N S A A 	L R L 
650 	 550 	 670 	 680 
Bsubdal 	laaaaaggcttttttaatgcagtcagattcggcatcggcatI 674 
K K 	F F N A V R F . I 	M 
pJLNBOlgene IAAAAAGGCTTTTTTAATGCAGTCAGATTCGGCATCGGCATI 680 
K K C F F N A V R F 	I C M 
680 	 780 	 710 	 720 
asubdal 	igtatggcct tcgcccgtctgctgacatgtcggacgagatai 714 
Y 	L R P S A D M S D F 
pJLNI301gene IGTATGGCCTTCGCCCGTCTGCTGACATGTCGGACGAGATAI 720 
Y 	L R P 5 A D M S D E I 
196 
Appendix 4: B. subtilis dal gene alignment with sequenced gene plus translation 
730 	 740 	 750 	 760 
Rsubclal 	IccgtttcagctgcgtccggcatttaccctgcattcgacacI 754 
P F 0 L R P A F T L H S T 
pJUVE3O19ene ICCGTTTCAGCTGCGTCCGGCATTTACCCTGCATTCGACACI 760 
P F 0 L R P A F I L H S T 
770 	 760 	 760 	 803 
....I....I....I....I. 
asubdal 	ItgtcacatgtcaaactgatcagaaaaggcgagagcgtcagI 794 
L S H V K L I R K 	F S V S 
pJUVt3Olgene lTGTCACATGTCAAACTGATCAGAAAAGGCGAGAGCGTCA( 800 
L S H V K L I R K 	E S V S 
810 	 820 	 830 	 840 
Rsubdal 	Ictacgg a g cc g a g tacacagcggaaaaagacacatggatcI 834 
Y 	A F Y I A E K D T W I 
pJLNr301gene ICTACGGAGCCGAGTACACAGCGGAAAAAGACACATGGATCI 840 
Y 	A F Y T A F K D T W I 
850 	 600 	 870 	 880 
.... 
asubdal 	Iggg ac gg t g cct g tagg cta t g cg g acg g ctggctccgaaj 874 
I V P V 	Y A D 	W L R 
pJLNt301gene IGGGACGGTGCCTGTAGGCTATGCGGACGGCTGGCTCCGAP1 880 
T V P V 	Y A D 	W L R 
850 900 	 910 	 920 
asubdal 	Iaat t g aaa ggg accg acatcct t g t g aa ggg aaaacgccti 914 
K L K 	T 0 I L V K 	K R L 
pJLNt301gene IAATTGAAAGGGACCGACATCCTTGTGAAGGGAAAACGCCTI 920 
K L K 	T D I L V K 	K R L 
930 	 940 	 960 	 960 
asubclal 	Ig aaaat t g cc gg cc g aat t t g catggaccaat t tatggtgj 954 
K I A C R I C M 0 Q F M V 
pJLNt3O19ene IGAAAATTGCCGGCCGAATTTGCATGGACCAATTTATGGT( 960 
K I A . R I C M D Q F M V 
970 	 980 	 995 	 1030 
B.subdal 	Ig a g ct gg atca gg aatatccg cc ggg cacaaaa g tcacatl 994 
F L D Q E '{ P P C T K V T 
pJLNrIOI gene IGAGCTGGATCAGGAATATCCGCCGGGCACAAAAGTCACATI 1000 
E L D 0 F Y P P C T K V T 
1010 	 1020 	 1030 	 1040 
Bsubdal 	Itaatagg cc gg ca ggggg at g aatatatttccatqclatgaI 1034 
L I C R Q . D F Y I S M 0 F 
pJLNr301gene ITAATAGGCCGGCAGGGGGATGAATATATTTCCATGGATGPJ 1040 
L I C R Q C D F Y I S M D F 
1950 	 1030 	 1070 	 1080 
Rsubdal 	IgattgcaggaaggctcgaaaccattaactatgaggtggccI 1074 
I A 	R L F I I N Y E V A 
pJLNt301gene IGATTGCAGGAAGGCTCGAAACCATTAACTATGAGGTGGCd 1080 
197 
Appendix 4: B. subtilis dal gene alignment with sequenced gene plus translation 
iJ 	 1160 	 1110 	 1120 
Bsubdal 	It g t a c a a t a ag t t cc c g t g t t ccc cg t a t g t t t t t g g a a al 1114 
C T I S S R V P R M F L E 
pJLN01gene ITGTACAATAAGTTCCCGTGTTCCCCGTATGTTTTTGGAAAAJ 1120 
C I I S S R V P R M F L E 
1130 	 1140 	 1150 	 1160 
Rsubdal 	lat ggg a g tataatggaagtaagaaatcctttattgcaggtI 1154 
N ( S I M F V R N P L L 0 V 
pJLN(01gene IATGGGAGTATAATGGAAGTAAGAAATCCTTTATTGCAGGTI 1160 
N 	S I M E V R N P L L 0 V 
1170 
Rsubdal 	aaatataagcaattaaI 1170 
pJLJVBOigene C4AATATAAGCAATTAJJ 1176 
N I S N * 
198 



































































































Appendix 5: Alignment of S. coelicolor Air library (mutator strain) with wild 
Colony H 
Colony I 
210 	 220 	 230 	 240 
parent 201 GCGGCCGGTG CGACCTGGCT CGGCACCGCC ACCCCGCAGG 
Colony  
Colony B 







250 	 260 	 270 	 280 
parent 201 AGGCCCTCGC CCTGCGCGCG GCGGAGCCAG GCCTGCCGGA 
Colony A 
Colony B 




Colony 	.......... 	.......... 	..A ................. 
Colony H 
Colony I 
220 	 30) 	 310 	 320 










330 	 340 	 350 	 360 










370 	 380 	 320 	 400 













410 	 420 	 430 	 440 










450 	 463 	 470 	 480 










490 	 500 	 510 	 520 
parent 201 ACTGGGAGCG GCTGGTCGGG GCCGCGCTGC GGGCCGAGGA 






Colony 	.......... 	.......... 	.... T 
Colony H 
Colony I 
530 	 540 	 550 	 560 











Appendix 5: Alignment of S. coelicolor Air library (mutator strain) with wild type 
parent 201 GCCTGCGCCG ACGAGCCCGG CCACCCCTCC ATCGCCGCCC 









610 	 620 	 630 	 640 
parent 201 AGCTCACCCG TTTCCGGG A GATGACGGCC TACGCCGAGC 
Colony A 
Colony B 







650 	 6W 	 670 	 680 










690 	 750 	 710 	 720 










730 	 740 	 750 	 760 









Appendix 5: Alignment of S. coelicolor Air library (mutator strain) with wild type 
Colony H 
Colony I 
770 	 780 	 720 	 80) 










810 	 820 	 830 	 840 










850 	 860 	 870 	 880 










890 	 9)3 	 910 	 920 










930 	 940 	 950 	 950 












970 	 980 	 980 	 iCIX) 







Colony 	.......... 	.......... 	.... T 
Colony H 
Colony I 
1010 	 1020 	 1030 	 1040 










1050 	 1060 	 1070 	 1080 










iC) 	 1180 	 1110 	 1120 











Appendix 5: Alignment of S. coelicolor Air library (mutator strain) with wild type 
1130 	 1140 	 113) 	 113) 










1170 	 1183 	 1183 











Appendix 6: Alignment of S. coelicolor Air and novel activity racemase 
10 	 20 	 30 	 40 













EQ 	 EQ 	 70 	 80 













80 	 103 	 110 	 120 












130 	 140 	 180 	 180 





























laD 	 laD 	 200 


















































L AL V KQV P GG 
290 	 303 	 310 	 320 
parent201 HGVSYHHYT TP:ETTL LV PL YAD I PR HASSS: PVLV 
21 final 
207 






























G G DR P E PG A E 
383 
A V L FGPGDRC 














EPTAEDWAQA ATIAYEIVT RI:SRVPRVY VNE* 
N ...... 	.......... 	...* 
* N 	...... ... 	....... ... 
* N ...... 	.......... 	... 
* N 	...... ... 	....... ... 
N ...... 	... ....... 	...* 
* N 	...... .......... ... 
* N ...... 	.......... 	... 
* N 	...... .......... ... 
* N ...... 	... 	....... 	... 
* N 	...... .......... ... 
N ...... 	.......... 	...* 
* N 	...... .......... ... 
208 

































MN S S ETTARR 
50 
RSAL MAVVK S 
C AAL MAVVKA 
C A ALMA V V K A 
90 
LELRAA- -CI 
L AL R A A E P C L 
LALRAAEPGL 
130 












TG L AVY C VS P 
PG I AMYGVSP 
PG I AMYGVSP 
290 
C HG V S Y G H H Y 
GHGVSYGHHY 
C HG VS Y C H H Y 
330 












N AYG H GAVPC 
DAYGHGA I PC 
DAYGHGA I PC 
100 
- QC - R I MCWL 
PDDVR I MCWL 
PDDVR I MCWL 
140 
AARAAGRTAR 
A ARA AG VP AR 
A ARA AG VP AR 
180 
QAEGTVOVTG 
E E E C L L RVT G 
E E E G L L R VT C 
220 
EKE C; V D P E V R 
E 0 R C L R P E V R 
EQ R C L R P E V R 
280 
S P EL T P AOL 
SPE I GTPADF 
SPE I GTPADF 
31?0  
VIES ETH L AL 
TTPGETTLGL 






AAHT I  AYE I V 
AAGT I AYE I V 
AAGTNAYE I V 
30 
AE I DLDAVRA 
AE I DLAALRA 
AE I DLAALRA 
7 
ARAAQ EAS- AA 
ARAAVA AC- AT 
A R A A V A A C; A I 
110 
WTPGG PWREA 




VOL KADTG L G 










CL RP AMT L RA 
CL R P V MT LA A 
CL RPVMT L AA 
310 
VPAYADC I P 
VPLGYADG I P 
VPLIC YADG I P 
30 




TR I GGRVPRV 




N VRAL RE RAP 
NVRALRERAP 
60 
WL GI AT P E EA 
WL GT AT P Q EA 
WLCTATPQEA 
120 





RC CC Q PG ADW 
RCGCQPCADW 
200 
PGHPS I RLQL 
PGHPS I AAQL 







S L AL VKOVPG 
S L AL VKQVPG 
320 
RN A 8CR C P V L 
RHASSSGPVL 




E A V L F G P C DR 
YLGGLE 380 
YVNE* - 394 
YVNE* 	394 
209 
